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Abstract 
          Aggregation of the abundant neural proWHLQ Į-synuclein 
FRQWULEXWHV WR FHOOXODU WR[LFLW\ LQ 3DUNLQVRQ¶V GLVHDVH :H KDYH
created transgenic nematodes carrying fusion constructs 
HQFRGLQJKXPDQĮ-synuclein (S) tagged with YFP (V) and/or CFP 
(C) as a fluorescent marker. Using the unc-54 myosin promoter, 
a synuclein-YFP (unc-54::SV (NI)) fusion construct was 
abundantly expressed in the body wall muscles of Caenorhabditis 
elegans. Permanent integrated lines were successfully generated 
for unc-54::V (NI), unc-54::S+V (I), unc-54::SC+SV (I), unc-
54::C+V (I), and unc-54::CV (I) using gamma irradiation. The 
outcrossed transgenic synuclein strains were radiation sensitive 
and have shorter life span and lower pharyngeal pumping 
compared to wild type N2 and unc-54::V (I) worms. 
Fluorescence Resonance Energy Transfer (FRET) was measured 
for all the transgenic strains. The unc-54::SC+SV (I) worms 
showed FRET signals intermediate between the negative (unc-
54::C+V (I)) and positive (unc-54::CV (I)) control strains. 
Confocal images were taken to confirm the presence of FRET. 
FRET signals increase markedly during early adult life in unc-
54::SC+SV (I) worms. RNA interference by feeding was 
performed in unc-54::SC+SV (I) worms to knock out the Hip-1 
co-chaperone function, thereby increasing the FRET signal. unc-
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54::SC+SV (I) fusion worms  were also exposed to pesticides 
such as chlorpyrifos and rotenone, and we observed an increase 
in the size and intensity of fluorescent aggregates thereby 
increasing the FRET signal. Finally we have quantified reactive 
oxygen species (ROS) for unc-54::SC+SV (I) fusion worms  and 
NL5901 strains by using the H2DCF-DA assay, showing that ROS 
levels were increased by pesticide exposure. 
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Chapter 1.       Introduction 
 
1.1 Neurological disorders in Humans 
 
Neurodegenerative diseases are increasingly common as 
average lifespan increases (Marsh and Thompson 2004). 
Although the majority of such disorders are spontaneous 
(showing no evidence of heritability), a minority are inherited. 
Genetically, such familial neurodegenerative diseases leading to 
neuropathology are often caused by dominant mutations in a 
single gene (e.g. Huntingtin; Zeitlin et al. 1995), though some 
recessive mutations are also known (e.g. DJ-1; Bonifati et al. 
2003). Although the wild-type gene and the disease causing 
mutation(s) may be known, the mechanisms that lead to 
pathology are not. For example, various genes which become 
mutated in CAG repeat (polyglutamine or polyQ) diseases are 
known but the basis of pathology remains complex and not well 
understood (e.g. +XQWLQJWRQ¶V 'LVHDVH >HD]; Marsh and 
Thompson 2004). In most neurodegenerative diseases, 
degeneration of specific neuronal regions takes place, where 
cellular proteins accumulate abnormally and often form 
aggregates that are visible at the light microscope level, 
correlated with the progression of disease (Carrell and Lomas 
1997; Kopito and Ron 2000). Such protein aggregates can range 
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in size from submicroscopic to large (Yang et al. 2002; Kayed et 
al. 2003) the large visible aggregates being referred to as 
LQFOXVLRQV LQ SRO\4 GLVHDVHV DP\ORLG SODTXHV LQ $O]KHLPHU¶V
GLVHDVH RU /HZ\ ERGLHV LQ 3DUNLQVRQ¶V GLVHDVH ,QFOXVLRQV DUH
shown to be highly stable protein aggregates because they are 
insoluble in SDS solution. Examples of neurodegenerative 
diseases include:  
 
i. +XQWLQJWRQ¶V GLVHDVH DQG DW OHDVW  RWKHU &$* UHSHDW
diseases that are caused by polyglutamine expansions in 
the mutant protein (Zoghbi and Orr 2000; Ross 2002).  
ii. $O]KHLPHU¶VGLVHDVH$'DQGRWKHUWDXRSDWKLHVZKLFKDUH
characterized by the accumulation of amyloid plaques and 
QHXURILEULOODU\WDQJOHVWKDWFRQWDLQERWKǃ-amyloid and tau 
protein. 
iii. 3DUNLQVRQ¶s disease which is caused by the accumulation of 
Į-synuclein in Lewy Bodies (Thompson and Barrow 2002; 
Temussi et al. 2003). 
 
 A significant feature of all these diseases is that their 
diagnosis is usually not clear until late in life. These diseases are 
usually related to intellectual dysfunction such as memory loss, 
cognitive deficits and often movement disorders. Once 
symptoms appear, there is a slow progression over the next 10±
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20 years as neuronal functions become more and more 
impaired, ultimately resulting in death. 
1.2 Invertebrate models of neurodegenerative 
diseases 
 
Both the nematode Caenorhabditis elegans (Baumeister 
and Ge 2002) and the fruitfly Drosophila melanogaster (Bernards 
and Hariharan 2001) are well known experimental models 
because of their short lifespan, well characterized development 
and anatomy, sophisticated genetics,  fully sequenced genomes, 
simple transgenic analysis and susceptibility to gene inactivation 
by RNA interference. Many new findings in neurodevelopment 
and neural function have come from studies in these 
invertebrates. For instance, the basic mechanism of apoptosis 
was first found in invertebrates and subsequently in humans 
(Richardson and Kumar 2002). 
 
The modeling of human diseases through transgenic 
expression of human genes in invertebrates has been relatively 
successful. We cannot expect invertebrates to exactly represent 
all aspects of the corresponding human disease but, in spite of 
various differences, there is plentiful evidence that they can 
provide important insights into the human disease. Human 
proteins can be overexpressed in transgenic models, such as 
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overexpression of Į-synuclein in a PD model (Auluck and Bonini 
2002), or of polyglutamine expansions (Warrick et al. 1998)  in 
Drosophila, both of which cause neurodegenration and protein- 
associated cellular inclusions. 
1.3 Neurodegenerative diseases  
1.3.1 +XQWLQJWRQ¶VGLVHDVH 
Huntington's disease is a well-known neurodegenerative 
disorder, which is caused by genetic mutations involving triplet 
CAG repeat expansions that lead to extended polyglutamine 
tracts (Ding et al. 2002). The existence of an expanded 
polyglutamine tract leads to protein aggregation which kills 
neurons in the basal ganglia. Huntington¶V disease is mainly 
caused by mutations in the Huntingtin gene. The molecular basis 
of this disease is expansion of the trinucleotide CAG repeat 
(encoding glutamine) in the Huntingtin gene. Generally, disease 
severity is associated with the extent of CAG expansion. This 
CAG sequence is repeated 6±39 times in normal individuals, 
whereDV LQ +XQWLQJWRQ¶V GLVHDVH SDWLHQWV WKH &$* sequence is 
repeated 36±180 times (Rubinsztein et al. 1996; Sathasivam et 
al. 1997). Due to this abnormal expansion of the CAG repeat 
segment, the resultant huntingtin protein contains a long tract 
composed solely of the amino acid glutamine. This protein 
disrupts the normal function of nerve cells in the basal ganglia, 
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leading to the death of those cells in the long run. The abnormal 
function of these nerve cells in turn results in the signs and 
symptoms of Huntington disease. 
 
The early-onset (severe) forms of HD are associated with 
alleles containing more than 70 repeats; the longest allele was 
found to contain 121 CAG repeats, and about 80% of juvenile 
patients inherit the mutant HD gene from their father (Zuhlke et 
al. 1993). The greater number of cellular divisions that take 
place during spermatogenesis is one possible explanation for this 
unstable expansion of paternal CAG repeats. 
 
The human huntingtin (Htt) protein that carries the 
polyglutamine repeat expansions was expressed in mice, 
resulting in a progressive neurological disorder characterized by 
tremor, abnormal movements, and, in some cases, mild ataxia; 
even the brains of affected mice were slightly smaller than those 
of normal ones (Mangiarini et al. 1996). When these transgenic 
animals were analyzed they provided a shortened Htt protein 
with polyglutamine expansions which was prone to form 
cytoplasmic and intranuclear inclusions that are immunoreactive 
to antibodies raised against ubiquitin and the NH2- terminus of 
Htt (Skinner et al. 1997).  
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               Apart from transgenic mouse models, invertebrate 
models have also been used. One of the polyglutamine 
expansion disorders has been genetically expressed in 
Drosophila. The expression of mutant Spinocerebellar ataxia 
type 3 (SCA3 affecting ataxin-3, also known as Machado±Joseph 
disease gene, MJD) was targeted in the eyes of Drosophila 
resulting in degeneration of the photo receptors (Warrick et al. 
1998). However, a Drosophila +XQWLQJWRQ¶V GLVHDVH PRGHO LV
atypical, in that protein aggregation could not be detected by 
light microscopy (Jackson et al. 1998). 
 
Polyglutamine expansions were also examined in 
C.elegans by expressing Green Fluorescent Protein (GFP) tagged 
polyglutamine fusion constructs in body wall muscle cells under 
the control of the powerful unc-54 major myosin promoter (unc-
54::GFP:polyQ). This resulted in the formation of discrete 
cytoplasmic aggregates during the early stages of 
embryogenesis and also caused a delay in development from 
larval to adult stages (Satyal et al. 2000). 
1.3.2 Alzheimer's disease 
 
$O]KHLPHU¶V GLVHDVH $' LV WKH PRVW FRPPRQ
neurodegenerative disease; as many as 4 million individuals are 
affected in the United States. It is a progressive brain disorder 
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that affects intellectual abilities, including loss of memory and of 
the ability to think and carry out daily activities. It was first 
described by the German physician Alois Alzheimer in 1906. 
Alzheimer's disease is associated with pathological changes in 
the brain. In AD, intramembrane proteolysis takes place where 
the proteolytic cleavage occurs within the lipid bilayer. AD 
neuropathology can be differentiated by the presence of extra-
cellular Amyloid plaques and intracellular neurofibrillary tangles. 
The term Amyloid refers to insoluble protein deposits which 
SRVVHVV D ILEULOODU ǃ-pleated structure. The main component 
IRXQG LQ WKH SODTXH LV WKH ǃ-DP\ORLG SHSWLGH $ǃ1-42 that is 
cleaved by Ǆ-Secretase from human amyloid precursor protein 
(APP); this peptide accumulates in the brains of Alzheimer 
disease patients. APP is the gene that causes early-onset familial 
AD (FAD).  
 
        In mammals, Ǆ-Secretase is a multi-subunit membrane 
protease complex comprising of presenilin, nicastrin, aph-1 
(anterior pharynx-defective 1), and pen-2 (presenilin enhancer 
2). Ǆ-Secretase is made functional through a series of molecular 
changes. Firstly, aph-1 and nicastrin binds to presenilin which is 
the catalytic subunit of Ǆ-Secretase. Secondly, binding of 
presenilin stabilizes the subcomplex, which is then recognised by 
pen-2, to form the multi-subunit protease complex whose 
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activity is brought about by endoproteolysis of presenilin. Hence, 
the enzymatically active Presenilin cleaves the app molecule to 
generate $ǃ1-42 peptides within the SDWLHQW¶V EUDLQ (Takeshi, 
2004). 
          In C.elegans, the identification of sel-12 (presenilin) was 
a result of genetic screening of non multi-vulval revertants of lin-
12 after EMS mutagenesis. Surprisingly, the sel-12 gene is 
similar to the S182 gene product, which has been implicated in 
FAD. The fact that presenilin is central to the Ǆ-Secretase 
enzyme complex and that mutation of sel-12 alleles in C.elegans 
causes recessive egg-laying defect compels us to draw 
connections to the enzymatic functions of sel-12. However, this 
does not give direct indication of its role in the onset of 
al]KHLPHU¶VGLVHDVHLQC.elegans (Diane and Iva, 1995). 
 
+RZHYHU WKH PHFKDQLVP RI $ǃ1-42 neurotoxicity is not 
clear. Amyloid aggregates also contain another protein, called 
tau, which normally passes on chemical messages. These 
proteins form intracellular neurofibrillary tangles that appear like 
threads twisted inside the nerve cells (Hardy et al. 1998). As the 
disease progresses, nerve cells start to die and the whole brain 
shrinks as a result of which the person starts to lose intellectual 
ability. 
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This Amyloid hypothesis has been tested in several 
models. Among these transgenic mice were first developed for 
modeling various features of AD pathology. Mutant forms of APP 
and Tau have been expressed in transgenic mouse models, 
which show evidence of Amyloid plaques as well as 
neurofibrillary tangles, although the relationship between the 
two pathways is not clear. These models exhibit several 
characteristics of AD, such as an age-dependent generation of 
Amyloid plaques, but they did not show all of the signs of 
neurodegeneration observed in human AD (Lewis 2000; Gotz et 
al. 2001; Higuchi et al. 2002; Oddo et al. 2003). Furthermore, 
the mouse model has a relatively long life span and therefore it 
is not suitable for pharmacological screening of new drugs. 
 
Subsequently, simple invertebrate systems such as C. 
elegans and Drosophila were used as models for human 
neurodegenerative diseases because of their short reproduction 
time and well-characterized genomics. These model organisms 
are able to express human genes of interest, and genetic 
screening can be completed in a relatively short period of time to 
identify mutations that lead to age-dependent neurodegenration.  
 
Transgenic C.elegans strains were engineered to express 
Dǃ-amyloid peptide derived from human cDNA clones under the 
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control of the unc-54 promoter. Different sizes of Amyloid 
aggregates were found in the affected worms, just as seen in 
Alzheimer's brain. The worms became paralyzed, whereas in the 
transgenic mice cognitive impairment was observed. In addition, 
the worms lived for only 20 days (Link 1995; Link et al. 2001); A 
similar sequence of events was also demonstrated in a 
Drosophila model of AD (Iijima et al. 2004). 
1.3.3 Parkinson's disease 
 
              3DUNLQVRQ¶V GLVHDVH (PD) is the second most common 
neurodegenerative disease affecting about 1% of people over 65 
years of age.  ,Q  3DUNLQVRQ GHVFULEHG ³VKDNLQJ SDOV\´ a 
progressive neurodegenerative disorder that has an effect on 
movements such as walking, swallowing and writing (Parkinson 
1922). As a movement disorder, it is characterized by tremor, 
rigidity and loss of voluntary movement, primarily due to the 
loss of neurons in a brain region termed the substantia nigra 
(Lang and Lozano 1998). These neurons produce dopamine 
(DA), a chemical messenger that communicates between nerve 
cells and muscles. In the brain, dopaminergic neurons present in 
the substantial nigra produces dopamine that is essential for 
normal motor functions. The message (dopamine) from these 
neurons are transmitted to the motor cortex via neuronal 
projection into the caudate nucleus (CN), which in turn 
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communicates with the neurons in the thalamus (TH) that leads 
to normal motor function. IQ3DUNLQVRQ¶VSDWLHQWVGRSDPLQHUJLF
neurons from the substantial nigra undergo neurodegenration, 
as a result the message is not transmitted. This leads to 
abnormal motor function (Figure 1.1).   
 
Figure 1.1: Dopamine pathways and motor functions. (Taken from the 
book: The Neuron, cell and molecular biology by Irwin B.L and Leonard K.K 
(Authors), 1997). 
           Neurodegeneration and loss of these Dopaminergic 
neurons in the substantia nigra are the key feature of 
Parkinson¶V disease (Kuwahara et al. 2006). Į-synuclein 
aggregation and Lewy body formation are responsible for the 
loss of dopaminergic neurons in the substantia nigra resulting in 
PD (Sharon et al. 2003; Kuwahara et al. 2006). The symptoms 
RI3DUNLQVRQ¶VGLVHDVHEHFRPHHYLGHQWZKHQDURXQGSHUFHQW
of the dopamine has been lost. 95% of cases of PD show no 
evidence of JHQHWLF LQKHULWDQFH DQG DUH WHUPHG ³VSRUDGLF´, 
whereas the remaining 5% are genetically inherited (Dauer and 
Przedborski 2003). 
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Figure 1.2: Electron microscopy pictures of (A) alpha synuclein 
amyloid aggregates and (B) Lewy body (arrows pointing) (adapted 
from Jensen et al. 2000; Antony et al. 2003) 
 
             Į-synuclein is a natively unfolded protein of only 140 
amino acids whose sequence is characterized by 6 imperfect 
repeats and a highly acidic C-terminal region. It has a tendency 
to form fibrillar aggregates which later develop into inclusions, 
such as Lewy bodies (LB), Lewy neurites (LN), and glial 
cytoplasmic inclusions (GCIs). The LB and LN are characteristic 
of 3DUNLQVRQ¶V GLVHDVH 3', and point mutations or gene 
amplification of Į-synuclein are responsible for familial PD 
(Munoz et al. 1997; Kruger et al. 1998; Zarranz et al. 2004). Į-
synuclein aggregation is usually enhanced by mutations in 
selected genes (see below) and also by exposure to toxins 
(Uversky et al. 2002; Lakso et al. 2003). 0XWDWLRQV RI Į-
synuclein often lead to abnormal protein folding and increased 
IRUPDWLRQ RI /%V 0XWDQW IRUPV RI Į-synuclein that are 
associated with inherited (familial) forms of PD are the A30P and 
A B 
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A53T variants (Tofaris and Spillantini 2005). The extent to which 
atypical folding and aggregation of neuronal proteins is directly 
toxic to the cell remains unclear (Tofaris and Spillantini 2005). 
Recently, a third missense Į-synuclein mutation (E46K) has 
been shown to increase amyloid fibril formation within Lewy 
bodies (Choi et al. 2004; Greenbaum et al. 2005; Pandey et al. 
2006). 
 
             Mutations in DJ-1/PARK7 (Parkinson disease autosomal 
early-onset 7), parkin (an E3 ubiquiitin ligase) and PINK1 (a 
mitochondria-targeted kinase) are also known to cause familial 
forms of ParkiQVRQ¶VGLVHDVH (Shimura et al. 2001; Canet-Aviles 
et al. 2004; Silvestri et al. 2005). However, Parkin is known to 
be neuroprotective and helps in maintaining mitochondrial 
function. In the presence of oxidative stress, PINK1 accumulates 
on damaged mitochondria and binds to or phosphorylates Parkin 
triggering apoptosis of the damaged mitochondria (Narendra et 
al. 2010). This pathway helps in maintaining normal 
mitochondrial function.   
 
           A balance between mitochondrial fission and fusion is 
essential for normal mitochondrial function. Recruitment of 
Parkin to damaged mitochondria, may affect mitochondrial 
fission and/or fusion, leading to autophagy (Narendra et al. 
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2008). In Drosophila, Zivizni et al (2010) showed that PINK1 is 
essential to activate Parkin and promote degradation of the 
damaged mitochondria. They also found, that mitofusin (mfn) 
becomes ubiquitinylated on the outer surface of the 
mitochondria in the presence of the PINK1/Parkin complex, and 
upon loss of PINK1 or Parkin function, accumulation of mfn leads 
to elongation of the mitochondria through fusion (Ziviani et al. 
2010). According to Narendra et al. (2008), these findings 
indicate that the PINK1/Parkin pathway has an effect on 
mitochondrial fission and/or fusion. Other evidence suggests an 
accumulation of mitochondrial DNA mutations in PD (Bender et 
al. 2006; kraytsberg et al. 2006). 
  
In the past, mice and rats have been used as a model for 
Į-synuclein overexpression; however it was not clear whether 
adverse effects were due to significant loss of dopaminergic 
terminals or to motor neuron pathology, since motor neurons are 
HVSHFLDOO\VXVFHSWLEOHWRĮ-synuclein in transgenic mice (Sommer 
et al. 2000; van der Putten et al. 2000) 
 
+XPDQ Į-synuclein has been overexpressed In 
Drosophila, resulting in selective loss of dopaminergic neurons 
(Feany and Bender 2000; Auluck et al. 2002). At the beginning 
RI WKH DGXOW VWDJH Į-synuclein causes neurodegeneration, 
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resulting in the gradual loss of > 50% of the dopaminergic 
neurons in the fly brain over several weeks of adult life. Of the 
WKUHHGLIIHUHQWĮ-synuclein isoforms tested (wild type, A30P, and 
A53T), all showed similar effects in this model, although A30P 
was slightly more aggressive and caused behavioral or 
locomotion defects (Feany and Bender 2000). 
 
+XPDQ Į-synuclein overexpression in transgenic C. 
elegans has been directed to different sets of neurons. When 
both ZLOG W\SH DQG $7 IRUPV RI KXPDQ Į-synuclein were 
expressed in dopaminergic neurons (DN cells), motor deficits, 
loss of dendrites and increases in neuronal process breaks, as 
well as loss of DN cells were all observed in the transgenic 
worms (Lakso et al. 2003). 
 
The exact mechanism underlying sporadic Parkinson's 
disease (PD) remains mysterious but there is some evidence 
that environmental factors may be involved in the origin of this 
disorder. Exposure to metals such as manganese, copper, lead, 
iron, mercury, zinc (Gorell et al. 1999), cobalt, cadmium and 
aluminum (Altschuler 1999) have all been implicated as risk 
factors for PD. Pesticides (herbicides and insecticides) have also 
been linked to PD in various epidemiological and experimental 
studies.  
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In vitro studies show that aggregation and fibrillation of 
Į-synuclein can be accelerated by specific pesticides and metals 
(Uversky et al. 2001; Uversky et al. 2002). In vivo studies show 
that exposure of rats and mice to pesticides such as the 
herbicide paraquat (Manning-Bog et al. 2002; McCormack et al. 
2002) and the insecticide rotenone (Sherer et al. 2003) can 
cause disease-associated neuropathologies such as cytoplasmic 
inclusions and dopaminergic degeneration similar to human PD. 
 
 
Figure 1.3: Neurodegeneration pathway in Parkinson's disease 
(adapted from Dawson and Dawson 2003). 
 
           Dysfunction of mitochondrial complex I has been linked 
to sporadic PD, by causing a series of biochemical alterations 
such as oxidative stress, leading to increases in free radicals and 
reduction of ATP levels. Increased free radicals and decreased 
ATP both cause cell death via different pathways. Reduced ATP 
levels lead to neuronal depolarisation (neuronal injury) which 
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further leads to free radical±mediated injury involving nitric 
oxide (NO) and peroxynitrite (ONOO-), eventually causing cell 
death. Also, sustained mitochondrial complex I dysfunction leads 
to Į-synuclein aggregation, leading to proteasomal dysfunction 
and also causing cell death. Parkin is an E3 ubiquitin ligase, 
which plays an important role in proteasomal function by 
recognizing specific substrates for ubiquitinylation and 
subsequent degradation. Thus parkin could be considered as a 
neuroprotective agent. In its absence cells may be unable to 
deal with Į-synuclein aggregates via proteasomal degradation. 
In addition, DJ-1 is also known to be neuroprotective by a 
similar  mechanism leading to cell survival (Dawson and Dawson 
2003). 
1.2 C. elegans as a model organism 
 
     
The nematode Caenorhabditis elegans (Caeno, recent; 
rhabditis, rod; elegans, elegant), is a tiny multicellular, 
eukaryotic, non-parasitic, invertebrate, free-living organism. 
C.elegans was selected as an experimental model by Dr Sydney 
Brenner in 1965 to study the development and behaviour of the 
animal (Brenner 1974). Its anatomy is shown in figure 1.4. 
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Figure 1.4: The two sexes of C. elegans (adapted from Sulston and 
Horvitz 1977). 
C. elegans was used as an experimental model because 
of its small size physically (about 1 mm long) and genomically 
(~100 Mbp), its transparent body, and its ease of cultivation 
including economy. It develops from a fertilized egg to an adult 
worm with a life cycle of only 3 days at 25ºC (Angier 1995; 
Donald 1997). Normally it lives in compost or rotting fruit, where 
it feeds on micro organisms such as bacteria and fungi. It can be 
easily cultivated in large numbers (>10,000 worms/Petri dish) 
on agar plates carrying E.coli as food source in the laboratory; it 
can also be grown in liquid cultures. For long term storage, L1 
larval worms can be frozen down at or below -80°C and can 
subsequently be revived after thawing. The developmental 
pattern of every single somatic nucleus (959 in the adult 
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hermaphrodite; 1031 in the adult male; (Sulston et al. 1983) 
has been traced, of which 302 are in neurons (Donald 1997; 
Horvitz 1997; Wood 1988). C. elegans has direct relevance to 
humans because about 83% of C. elegans genes (DNA or protein 
sequence) are similar to human sequences (Lai et al. 2000) and 
show evidence of common ancestry (i.e. the two sequences are 
probable orthologs by similarity of sequence). In several cases 
when human genes are introduced into mutant C. elegans they 
can functionally replace the C. elegans orthologs. Therefore, 
many C. elegans genes can function similarly to mammalian 
genes. 
C.elegans is the first multicellular organism to have its 
entire genome sequenced. It has a very small genome of about 
100.2Mb (100,269,912 bases) and its genes have been mapped 
to five autosomes and one sex chromosome (C.elegans 
Sequencing Consortium 1998). The simplicity of C.elegans 
genetics has allowed researchers to microinject DNA into the 
worm which can become integrated into the chromosomes, 
leading to the generation of stably-transformed lines (Fire 
1986). This method is known as germline transformation and is 
used for generating transgenic C.elegans strains for 
experimental studies (see section 1.4.1 below for more details). 
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1.2.1 Life Cycle 
The life cycle of C. elegans consists of an embryonic 
stage, four post embryonic larval stages (L1-L4) and the adult 
stage. At the end of each larval stage a new stage-specific 
cuticle is synthesized and the old one is shed (Cassada and 
Russell 1975). Adults mostly reproduce during the first few days 
of adulthood, but are characterized by a relatively long post-
reproductive lifespan (living for up to 21 days in total). In this 
species, 99.9% are self-fertilizing hermaphrodites (see 1.2.3), 
but about 0.1% of the population consists of males which can 
outcross with hermaphrodites.  
1.2.1.1 Embryogenesis 
Embryogenesis involves two different stages: (i) cell 
proliferation and (ii) organogenesis/morphogenesis (Sulston et 
al. 1983). 
1.2.1.1.1 Proliferation 
During this initial stage cells divide from a single zygote 
cell to 558 essentially undifferentiated cells. This stage is further 
subdivided into two phases: The first phase ranges from 0 to 
150 min from the time the zygote is formed to production of 
embryoniF IRXQGHUFHOOVDQG LW WDNHVSODFHZLWKLQ WKHPRWKHU¶V
uterus; the second phase ranges from 150 to 350 min, during 
which cell division and gastrulation is completed (Seydoux and 
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Fire 1994). At about the 30-cell stage the embryo is laid through 
the vulva into the surrounding medium. 
1.2.1.1.2 Organogenesis / morphogenesis 
The developmental event starts at approximately 5.5hrs 
post fertilization and completes by approximately 14 hrs post 
fertilization. During this stage the embryo becomes folded back 
on itself and the whole body of the worm becomes differentiated 
into distinct tissues and organs. The worm can even roll around 
longitudinally inside the egg during this stage (Sulston et al. 
1983). Figure 1.5 shows the stages of development at 22 ºC 
(figure from Sulston et al. 1983). 
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Figure1.5: Embryonic stages of development at 22 ºC (adapted from 
Sulston et al. 1983). The numbers below the horizontal axis show 
approximate time in minutes after fertilization at 22ºC. Fertilization takes 
place at the 0th minute.  First cleavage occurs at approximately 40 min. At the 
150th minute the embryo reaches the 30-cell stage. During this stage the egg 
is laid through the vulva. The embryo undergoes differentiation inside the egg 
and finally at around the 840th minute the animal is hatched out of the egg. 
 
1.2.1.2 Postembryonic development 
Postembryonic development begins 3 hours after 
hatching (Ambros 2000). C.elegans has to pass through four 
larval stages (L1, L2, L3 and L4) to reach adulthood, each stage 
lasting between 7 and 12 h at 20 ºC (Table 1). The rate of 
development depends on the ambient temperature (Table 1), 
since C.elegans is poikilothermic.  
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Table 1.1: Growth parameters of the C.elegans life cycle. (Taken from 
the book: Methods in cell biology, volume 48: Caenorhabditis elegans; 
Modern biological analysis of an organism by Henry F. Epstein (Author) and 
Diane C. Shakes (Editor) Academic Press,1995). 
 
The first stage L1 larva is about 250 µm in length, and 
hatches from the egg at about 13.3 hrs after fertilization at 22ºC 
and this shorter at 25ºC and longer at lower temperatures. 
Again cell division starts when there is food available, though not 
as much as in embryos. During L2 there is an increase in growth 
along with some cell division and expansion of tissues. During L3 
development of the gonad takes place. The size of this larval 
stage is somewhat larger than L2. Vulva development occurs 
during the late L3 and early L4 stage. The final L4 stage can be 
differentiated with the help of an anatomical feature known as 
the ³+DOIPRRQ´ (Johnstone et al. 1997). The somatic cell lineage 
comes to an end at the early L4, and during this stage the 
animal becomes sexually mature, generating sperm cells in the 
hermaphrodite gonad (see 1.2.3 below). Figure 1.6 shows the 
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life cycle of C. elegans at 22ºC (figure from Cassada and Russell 
1975). 
1.2.1.3 Dauer 
At the end of the L1 stage, the animal may enter into an 
alternate L2d stage which then moults into a diapause dauer 
larva under conditions where food is scarce and population 
density or temperature are high (Albert and Riddle 1988). Dauer 
larvae are thin and can move but their mouths are plugged and 
they cannot eat. Interestingly, dauers can remain viable for 
three months. They appear to be non-aging: dauer larvae can 
roam around for months without food and once they come 
across food they directly enter into the L4 stage and live about 
15 more days (Klass and Hirsh 1976). Studying the genes 
involved in entry into/exit from the dauer pathway has led to the 
discovery of an insulin-like signaling pathway that controls 
lifespan via the daf-2 receptor which negatively regulates the 
daf-16 transcription factor (Kenyon 2010). 
1.2.1.4 Adult 
A newly matured hermaphrodite is formed after 45 ± 50 
hrs at 20º C completing its reproductive life cycle. The adult 
hermaphrodite switches to producing eggs in its gonad for about 
3-4 days, after which they still remain fertile. During this period 
they normally produce about 300 self-fertilized progeny each. 
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The life span of a mature adult is about 21 days (Lakowski and 
Hekimi 1998). 
 
Figure 1.6: Life cycle of C. elegans at 22ºC (adapted from Cassada and 
Russell 1975). Numbers in blue next to the arrows shows that how much time 
is taken to complete each stage. Approximately at the 40th min, first cleavage 
takes place inside the egg. During the gastrula (approximately 30-cell) stage, 
eggs are laid out through the vulva. The length of the animal at each stage is 
given in micrometers. 
 
 
 
                 Lifespan determinations (see 2.11) have proved an 
invaluable tool for exploring the effects of genetic mutations that 
alter life span. For example, both daf-2 under-expressing and 
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daf-16 over-expressing mutants prolong lifespan significantly 
(Kenyon 2010). 
1.2.3 Sex determination in C.elegans  
 
Reproduction in C.elegans is normally by hermaphrodite 
self-fertilization. C.elegans has both hermaphrodite and male 
sexes, but no female sex. The predominant sexual form of C. 
elegans is the hermaphrodite ² this animal produces both sperm 
(during L4) and eggs (during adulthood; Maupas 1900). Males 
are rarely found (0.1% of population) and these produce only 
sperms. There are six chromosomes in C. elegans ² five pairs of 
autosomes (chromosomes I, II, III, IV, V) and the sex 
chromosome, X. Hermaphrodites have two X chromosomes 
(designated XX). Males have only one X chromosome 
(designated XO); having only one chromosome instead of a pair 
is called the hemizygous state. This state can be produced by 
the loss of one X chromosome during meiosis or by mating 
(Hodgkin et al. 1979). Males cannot produce progeny on their 
own. However, they can cross-fertilize hermaphrodites. They are 
commonly used in C.elegans genetics for making genetic 
crosses. The predominance of hermaphrodite self-fertilization 
has advantages for maintaining genetic uniformity of strains 
during long-term culture. It also facilitates the recovery of 
homozygous recessive mutations.  
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1.3 Green Fluorescent Protein as a biomarker 
 
             Green Fluorescent Protein (GFP) is composed of 238 
amino acids. It was originally isolated from the jellyfish Aequorea 
victoria, and when exposed to blue light it produces green 
fluorescence. Its excitation and emission wavelengths are 395 
and 509nm respectively. GFP is used as a reporter gene to 
monitor gene expression and protein localization in a variety of 
different organisms and in cell tissue cultures. In addition, GFP 
can be used as a marker in living organisms during growth and 
development (Chalfie et al. 1994).  Previous studies have used 
GFP as a reporter gene in C.elegans in vivo by fusing it to 
varying lengths of polyQ residues (Nollen et al. 2004). Similarly, 
yellow fluorescent protein (YFP) was used as a reporter gene in 
vitro by fusing it to ĮíV\QXFOHLQ (van Ham et al. 2008, 2010).  
1.4 Į-synuclein fusion constructs for in vivo and 
in vitro studies 
            ,Q SUHYLRXV VWXGLHV ĮíV\QXFOHLQ DQG LWV fluorescent-
tagged variants were shown to be capable of aggregating 
spontaneously in vitro (Li et al. 2001; Goers et al. 2003). Van 
Ham et al (2010), showed that ĮíV\QXFOHLQ::YFP formed 
amyloid fibrils which were similar to those formed by wild type  
ĮíV\QXFOHLQ (no reporter gene) in vitro. In our studies, fusion 
FRQVWUXFWVZHUHFUHDWHGE\WDJJLQJĮíV\QXFOHLQZLWKtwo Green 
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Fluorescent Protein (GFP) variants, Cerulean (C) or Venus (V ± 
for the Venus variant of YFP). Thioflavin T binding (Khurana et 
al. 2005) and centrifugation assays (Bodhicharla et al, 
submitted) showed that synuclein and synuclein-containing 
fusion proteins all had the ability to aggregate in vitro.         
 
 
 
Figure 1.7: Fusion protein design (Bodhicharla et al, submitted). A cartoon 
illustrating the construction of the fusion proteins used. The N-terminal fusion 
peptide from the pET-30a vector LV VKRZQ DV D EODFN UHFWDQJOH KXPDQ Į-
synuclein (S) as an open rectangle, Venus (V) as a yellow rectangle and 
Cerulean (C) as a blue rectangle. Each construct is identified by name and 
abbreviation, and the constructs are drawn approximately to scale. The fusion 
genes were designed, cloned and expressed in bacteria by Dr. Jody Winter. 
 
                In neurodegenerative diseases, certain proteins have 
the capability to aggregate in vivo, which is thought to be an 
essential factor in disease development (Dobson 2003). Among 
these are Į-synuclein and its mutant forms (A30P and A53T) 
that are associated with inherited (familial) forms of PD (Tofaris 
and Spillantini 2005). However, although the aggregation 
process has been extensively studies in vitro, much less is 
NQRZQDERXWWKHDJJUHJDWLRQRIĮíV\QXFOHLQin vivo. Van Ham et 
al (2008) showed formation of protein aggregates in the body 
walls of C.elegans in vivo by expressing Į-synuclein tagged with 
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the reporter gene YFP (unc-54::YFP; strain NL5901). In our 
studies, transgenes encoding mixtures of both CFP- and YFP- 
tagged synuclein (SC+SV) were injected into the gonad of an 
adult hermaphrodite to generate transgenic animals. These 
transgenes are expressed in the body wall muscles of C.elegans 
using unc-54 myosin promoter (unc-54::SC+SV) . This strain 
can potentially be used WR PRQLWRU ĮíV\QXFOHLQ DJJUHJDWLRQ in 
living worms using FRET (see below; Bodhicharla et al, 
submitted).  
1.5 Generation of transgenic strains for use in 
this study  
            Transgenic strains are usually created by inserting the 
gene of interest into WKH DQLPDO¶V JHQRPH XVLQJ '1$
recombinant technology. This can be done in 3 different ways: 
DNA microinjection, retrovirus-mediated gene transfer (Jaenisch 
1976) and embryonic stem (ES) cell-mediated gene transfer 
(Gossler et al. 1986). DNA microinjection is regarded as the first 
and most successful technique in mice (Gordon and Ruddle 
1981) and this technique has been used in several other animal 
models including C.elegans.  
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1.5.1 DNA microinjection 
 
DNA microinjection is the main technique used to make 
transgenic lines in C.elegans. A DNA construct (plasmid) is 
mixed with a selectable marker and injected into the syncytial 
distal gonad. In the case of GFP fusion genes, a selectable 
marker is unnecessary because expressing transgenic individuals 
can be identified by their fluorescence under a UV microscope. 
Using the unc-54 promoter, a synuclein-YFP fusion construct was 
abundantly expressed in the body wall muscles of Caenorhabditis 
elegans. The injected DNA exists as an extrachromosomal array 
(i.e. not integrated in the chromosome; Mello et al. 1991) which 
segregates randomly and can be lost, but the YFP marker 
identifies which animals still have the array.  The level of 
Transgene expression in multiple injected lines may vary 
depending on copy number and other factors; hence it is 
essential to ascertain phenotype homogeneity by examining 
multiple lines for a particular transgene.  
 
Figure 1.8:  Microinjection: performed by Ademola Adenle (SV, V, C, S+V, 
SC+SV strains) and Declan Brady (CV, C+V, SV+C strains). (adapted from 
Mello et al. 1991; Mello and Fire 1995). 
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1.6 Permanent integrated transgenic lines 
 
          Permanently integrated transgenic lines can be achieved 
following gamma irradiation, which is commonly used in 
C.elegans to produce chromosomal rearrangements (Rosenbluth 
et al. 1985). This material is reviewed in detail in chapter 3 on 
radiation sensitivity. 
1.7 Forster Resonance Energy Transfer (FRET) 
           Forster Resonance Energy Transfer is commonly 
abbreviated as FRET. The underlying mechanism behind FRET is 
the energy transfer between two fluorophores, in this study CFP 
(donor) and YFP (acceptor). This material is reviewed in detail in 
the introduction to chapter 5. 
1.8 RNA Interference 
 
RNA interference (RNAi) involves sequence-specific, 
posttranscriptional gene silencing mediated by double stranded 
RNA (dsRNA). RNAi was first discovered in Caenorhabditis 
elegans by Guo and Kemphues (Guo and Kemphues 1995). Gene 
silencing was activated efficiently by injecting dsRNA 
complementary to target mRNAs, causing their degradation. In 
1998 Andrew Fire and Craig Mello published their study on the 
mechanism of RNA interference (Fire et al. 1998). It was 
previously known that antisense RNA (Izant and Weintraub 
1984), but also surprisingly sense RNA (Guo and Kemphues 
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1995), could cause gene silencing, but the results were 
somewhat unpredictable. The term RNA interference (RNAi) was 
coined to describe the unknown mechanism (Rocheleau et al. 
1997). 
 
It soon became clear that dsRNA acts via 
posttranscriptional mechanisms to degrade the target mRNA 
during RNA interference (Montgomery et al. 1998). Within a year 
RNAi had been rapidly implemented as a method for selectively 
inhibiting gene expression in most laboratory organisms, 
including fruit flies, trypanosomes, plants, planaria, Hydra and 
zebrafish (Tuschl et al. 1999) as well as in mammalian cells 
(Elbashir et al. 2001). Thus, the general applicability of the RNAi 
phenomenon among eukaryotes was established very quickly. 
 
RNAi can be initiated in C.elegans by delivering dsRNA 
into the cells of the worm (Sugimoto 2004), which can be done 
in 4 different ways. (1) Microinjection, (2) Soaking, (3) Harpin 
formation from transgenes with specific regulatory promotors 
and (4) Feeding. 
a) Microinjection 
This method involves injecting the dsRNA into either 
adult or larval worms (Fire et al. 1998). Although it has some 
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disadvantages such as being time consuming and delicate, it 
results in very good gene suppression. 
b) Soaking 
This involves soaking the worms without food for 24 
hours in a dsRNA solution, before returning them to the plates 
and examining them or their progeny for phenotypic changes 
(Tabara et al. 1998; Maeda et al. 2001). 
c) Harpin formation from transgenes with specific 
regulatory promotors  
This method results in stable, heritable worm strains 
where RNAi can be induced (either tissue- or stage-specifically) 
through the use of a specific promoter and a gene construct 
including double stranded harpin structures in the resultant 
transcript (Sugimoto 2004). 
d) Feeding 
In this method the worms are fed with inducible dsRNA-
expressing E.coli (Kamath and Ahringer 2003). Some of the 
advantages of this feeding technique are: - (i) it is much less 
labour-intensive than microinjection, and (ii) it can also be used 
for large scale applications of RNAi, saving a substantial amount 
of time. The feeding method is considered to work best for late 
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larval development, behavior and longevity studies as well as for 
genome-wide screening (Kamath et al. 2003). 
 
C.elegans has been examined for RNAi resistant mutants 
(Tabara et al. 1999), resulting in the identification of four genes 
causing RNAi deficiency, termed rde-1/-2/-3/-4. Germline 
transmission of the RNAi signal requires rde-1 but it is not 
required for interference (Grishok et al. 2000).  
The molecular machinery involved in RNA interference 
can be demonstrated by introducing dsRNA into a cell. It first 
becomes cleaved by the enzyme Dicer to form small interfering 
RNAs (siRNA) which are approximately 21-25 nucleotides in 
length (Elbashir et al. 2001). siRNA then binds to the RNA-
induced silencing complex (RISC) and is unwound. The antisense 
RNA forms a complex with RISC that binds to its corresponding 
mRNA, and the RISC complex then cuts the mRNA strand, which 
is subsequently degraded.  
 RNAi already plays an important role in C.elegans 
research, particularly since several libraries of RNAi bacterial 
strains are now available that cover > 80% of the known genes 
in C.elegans (Kamath et al. 2003). Figure 4 shows the 
mechanism of RNAi (from Lehner et al. 2004) 
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Figure 1.9: The mechanism of RNAi and RNAi delivery methods 
(adapted from Lehner et al., 2004). Double-stranded RNA is cut into short 
pieces (siRNA) by the endonuclease Dicer. The antisense strand is 
incorporated into the RISC complex that guides the repeated cleavage of 
homologous mRNAs. 
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1.8.1 RNAi screening of polyglutamine 
aggregation in C.elegans  
+XQWLQJWRQ¶V GLVHDVH LV D ODWH-onset neurodegenerative 
condition caused by polyglutamine expansions within the human 
huntingtin gene (see 1.3.1). A C.elegans model for this disease 
was established by creating transgenic C.elegans strains with 
varying lengths of polyglutamine repeat sequence fused to GFP. 
During polyglutamine fusion protein aggregation, protein 
misfolding is associated with the length of the polyglutamine 
expansion and age-dependant changes. Genome-wide RNAi was 
used to identify genes that might limit or promote polyglutamine 
aggregation. Screening identified 186 genes, which when 
suppressed resulted in the premature appearance of protein 
aggregates (Nollen et al. 2004). 
 
In HD patients, the mutant huntingtin protein has 34-86 
CAG repeats, whereas the wild type Htt protein has only 11-34 
CAG repeats (Duyao et al. 1993). At a threshold of about 36 
CAG repeats, protein aggregation and cellular dysfunction 
increases resulting in development of HD (Karpuj et al. 1999).  
In order to test this hypothesis, Morley et al (2002) expressed 
polyQ (Q0 to Q82) in C.elegans. Fluorescence was diffuse in Q0, 
Q19, Q25, Q33 and Q35, but fluorescent aggregates could be 
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seen in Q44, Q64 and Q82. However, Q40 animals had a few 
aggregates in some cells and diffuse fluorescence in others. This 
shows that the higher the repeat length the more the polyQ 
protein aggregates. From this experimental data they were able 
to support the threshold hypothesis of polyQ-mediated toxicity 
(Morley et al. 2002).  
1.8.2 51$L VFUHHQLQJ RI Į-synuclein aggregation 
in C.elegans 
More recently similar transgenic strains have been 
FRQVWUXFWHG XVLQJ Į-synuclein fused to the GFP sequence. 
Genome-wide RNAi screening was done to identify the genes and 
cellular processes that are involved in age-UHODWHG Į-synuclein 
aggregation. 80 genes were identified from this process, which 
when knocked down resulted in premature increases in the 
number of inclusions. Genes that are related to aging such as 
sir-2.1 and lagr-1 were also found during this process. This 
suggests that there may be a lLQNEHWZHHQFHOOXODUDJHLQJDQGĮ-
synuclein aggregation (van Ham et al. 2008). 
1.8.3 Comparison between previous RNAi studies 
Genes that function to suppress polyglutamine 
aggregation (Nollen et al. 2004) were compared with those that 
can suppress Į-synuclein aggregation (van Ham et al. 2008). A 
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large variety of proteasomal genes and chaperones were found 
to be involved in polyglutamine aggregation in C.elegans, and 
similar genes have been implicated in other protein aggregation 
and misfolding diseases. Unexpectedly, very few such genes 
ZHUH IRXQG WR DIIHFW Į-synuclein aggregation. Only two genes 
were identical in both of these aggregation studies. 
 
Process 
 
Cosmid no 
 
Gene 
 
Function 
 
RNA synthesis 
and processing 
 
 
 
 
Y116A80.35 
 
 
 
 
 
Uaf-2 
 
 
 
 
 
Similartity to 
splicing factor 
U2AF 35 kDa 
subunit 
 
 
Energy 
metabolism 
 
T14F9.1 
 
vha-15 (phi-52) 
 
ATPase coupled 
proton transport, 
Vacuolar ATP 
synthase sub 
 
Table 1.2 7ZR LGHQWLFDO JHQHV LQ SRO\JOXWDPLQH DJJUHJDWLRQ DQG Į-
synuclein aggregation (adapted from Nollen et al. 2004; van Ham et al. 
2008). 
 
 
However, we have identified several cases where 
functionally related genes (effectively carrying out a similar job), 
often coding for related proteins, are found in each of the two 
lists. This shows that the processes involved in dealing with 
these aggregated proteins are probably similar; in several cases 
these gene products may carry out a similar function in different 
cellular compartments because Į-synuclein aggregation occurs in 
endomembrane-bound vesicles whereas polyglutamine 
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aggregation seems to occur in the cytosol and nucleus but not 
within inclusion bodies. 
Polyglutamine  
Aggregation 
Alpha-synuclein 
Aggregation 
 
Gene 
 
 
Function 
 
Gene/Cosmid 
no 
 
Funcion 
 
phi-53 
 
 
DNA primase, 
small subunit 
 
 
pri-2 
 
Eukaryotic-type 
DNA primase, 
large subunit 
 
hsp-1 
 
Member of the 
heat shock 
HSP70 protein 
family/EEVD 
 
 
R151.7 
 
 
Hsp90 protein 
 
hsp-6 
 
Member of the 
heat shock 
HSP70 protein 
family 
  
 
Phi-4 
 
Putative splicing 
factor 
 
 
Rsp-7 
 
Splicing factor, 
arginine/serine-
rich 
 
uaf-2 
 
 
Similarity to 
splicing factor 
U2AF 35 kDa 
subunit 
 
 
 
uaf-2 
 
 
Similarity to 
splicing factor 
U2AF 35 kDa 
subunit 
 
 
phi-11 
 
 
Similarity to 
splicing factor 3b 
subunit 1 
 
  
 
 
lit-1 
 
 
 
Serine/threonine 
protein kinase of 
the MAP kinase 
subfamily 
 
 
 
F12A10.6 
 
 
Serine/threonine 
kinase (haspin 
family) 
 
phi-2 
 
 
Member of the 
RNA helicase, 
DEAD-box 
protein family 
 
 
Rcq-5 
 
DEAD/DEAH box 
helicase 
 
phi-3 
 
 
Member of the 
DEAD or DEAH 
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box ATP-
dependent RNA 
helicase family 
 
 
mog-5 
 
 
Member of the 
RNA helicase, 
DEAH-box 
protein family 
 
  
 
phi-33 
 
 
Similarity to 
ubiquitin 
carboxyl-terminal 
hydrolase 8 
 
 
math-24 
 
MATH domain, 
Ubiquitin 
carboxyl-terminal 
hydrolase 7 
 
Table 1.3: comparison betZHHQ SRO\JOXWDPLQH DJJUHJDWLRQ DQG Į-
synuclein aggregation (adapted from Nollen et al. 2004; van Ham et al. 
2008) 
 
1.9 Environmental Toxicology LQ 3DUNLQVRQ¶V
disease 
                Numerous experimental studies using animal models 
have shown that exposure to environmental agents may play a 
vital role in PD pathogenesis. Since PD pathogenesis does not 
develop suddenly, these animal models have usually been 
exposed to neurotoxic agents. Also, environmental agents such 
as metals, solvents, carbon monoxide and N-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine have been shown to cause PD-like 
symptoms (Klawans et al. 1982; Langston and Ballard 1983; 
Tanner 1989; Uitti et al. 1994), as well as various pesticides and 
herbicides. Conversely, other agents such as nicotine and 
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caffeine are known to alleviate the symptoms of PD (Ross et al. 
2000; Ross and Petrovitch 2001; Martyn and Gale 2003).  
 
               Environmental stressors such as copper, iron, zinc, 
aluminium, paraquat and dieldrin (Li et al. 2001; Sun et al. 
2005; Fernagut et al. 2007; Bharathi et al. 2008) have been 
shown to play a role either directly or indirectly in the 
GHYHORSPHQWRI3DUNLQVRQ¶V-like symptoms both in vitro and in 
vivo.  In addition, mixtures of metals and pesticides have been 
shown to act synergistically in prompting the formation of 
fibrils in vitro using purified synuclein (Uversky et al. 2002). 
6LPLODUO\ǃ-amyloid aggregation was also aggravated by metal 
ions both singly (Drago et al. 2008) and in combination (Ryu 
et al. 2008). One reason for metal and pesticide induced 
aggregate formation may be due to the indirect effect of 
reactive oxygen species (ROS) production (Allsop et al. 2008). 
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1.9.1 Neurotoxicity of Pesticides  
1.9.1.1 Chlorpyrifos 
 
                  
Figure 1.10: Chemical structure of chlorpyrifos (Adapted from Wu and 
Laird 2004). 
 
 
               Chlorpyrifos is an organophosphate insecticide which 
is commonly used in agriculture to control insect pests. Reports 
have also shown that chlorpyrifos exposure is lethal to fresh 
water fish. Since chlorpyrifos inhibits the enzyme 
acetylcholinesterase (AChE), one would expect that exposure to 
chlorpyrifos might cause severe effects in other organisms as 
well. In addition, chlorpyrifos may inhibit DNA synthesis and 
alter development (Slotkin 2004; Eaton et al. 2008). In utero 
exposure to chlorpyrifos caused retardation in growth (Sherman 
1996), and hence its use has been restricted in households, 
hospitals and schools. AChE is an enzyme that breaks down 
acetylcholine (neurotransmitter) into acetate and choline groups 
in the synaptic cleft (Smegal 2000). By binding to the active site 
of AChE, chlorpyrifos prevents the breakdown of acetylcholine in 
central nervous system (CNS).  As a result, chlorpyrifos leads to 
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neuronal cell overstimulation followed by  neurotoxicity and 
death (Karanth and Pope 2000). 
 
                   Several reports (Auman et al. 2000; Crumpton et 
al. 2000) have investigated the fundamental molecular 
mechanisms of chlorpyrifos action, in terms of inducing neuronal 
apoptosis. According to these authors, inhibition of 
acetylcholinesterase is independent of chlorpyrifos-induced 
apoptosis. In previous studies, rats were used as an in vivo 
model, where cortical neurons (which are particularly susceptible 
to neurodegeneration) were directly cultured from newborn 
animals. Several signalling pathways such as ERK 1/2, JNK and 
p38 MAP kinase are involved in neuronal apoptosis (Davis 2000; 
Hetman and Xia 2000). Growth and neurotrophic factors trigger 
the ERK 1/2 signalling pathway whereas oxidative and 
environmental stresses trigger the JNK and p38 signalling 
pathways. It was shown that JNK and p38 cause apoptosis upon 
activation by chlorpyrifos, while ERK1/2 (as a growth promoting 
pathway) defends against this apoptosis. A balance between the 
apoptosis pathway activated by oxidative/environmental stress 
and the survival pathway activated by growth/neurotrophic 
factors is key to determining the fate of cortical neurons (Xia et 
al. 1995). These findings also show that chlorpyrifos induces 
oxidative stress, which is a common pathway for several of the 
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HQYLURQPHQWDOIDFWRUVLPSOLFDWHGLQVSRUGLDF3DUNLQVRQ¶VGLVHDVH 
± including rotenone (next section), paraquat (Berry et al. 2010) 
and dieldrin (Kanthasamy et al. 2005). 
1.9.1.2 Rotenone 
 
 
Figure 1.11: Chemical structure of rotenone (Adapted from Uversky 
2004). 
 
           Rotenone is a complex ketone by nature, present in the 
roots of Lonchocarpus species. It was initially used as a fish 
poison but nowadays it is generally used as an insecticide. 
Rotenone is biodegradable and extremely lipophilic. Due to its 
lipophilicity, rotenone can cross cellular membranes and the 
blood-brain barrier without the help of transporters. Within the 
cell it is accumulated in the mitochondria (Talpade et al. 2000), 
where it blocks the electron-transport chain and hence oxidative 
phosphorylation (Schuler and Casida 2001). Specifically, 
rotenone inhibits complex I, increases ROS production, and 
causes oxidative damage to proteins, lipids and DNA. Fibril 
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formation by Į-synuclein is one of the known types of protein 
damage induced by rotenone. As a consequence of these 
multiple effects, rotenone induces apoptosis of the damaged cell 
(Uversky 2004).  
 
            Previous studies show that intravenous exposure to 
rotenone causes PD like symptoms. Since rotenone is a complex 
I inhibitor, it suppresses the activity of mitochondria leading to 
depletion of dopaminergic neurons causing neuronal cell death. 
Rotenone also stimulates the formation of Į-synuclein protein 
aggregates leading to cell death (Betarbet et al. 2000; Sherer et 
al. 2003). In vitro studies show that rotenone speeds up the 
fibril formation of Į-synuclein (Uversky et al. 2001; Uversky et 
al. 2002).  
 
             Exposure to rotenone in rats showed severe effects on 
mitochondria because of its inhibition of mitochondrial complex I 
inhibitor (Betarbet et al. 2000). Similarly, chronic rotenone 
exposure in Drosophila caused behavioural effects, especially 
locomotor dysfunction due to the loss of dopaminergic neurons 
in the brain (Coulom and Birman 2004).  
 
             C.elegans is an excellent in vivo model to reveal the 
mechanisms of toxicity of pesticides (Leung et al. 2008). 
Rakesh Kumar Bodhicharla 
46 
 
Rotenone exposure inhibits mitochondrial NADH dehydrogenase 
present in the mitochondrial complex I. In order to confirm the 
role of mitochondrial NADH dehydrogenase in rotenone toxicity, 
a C.elegans mutant strain (gas-1) was developed. This strain 
contains a mutation in the 49-kDa mitochondrial complex I 
subunit. Gas-1 mutants showed increased sensitivity to 
rotenone, proving that NADH dehydrogenase is a key target for 
rotenone in the cells (Ishiguro et al. 2001). 
 
 
Compound 
 
Strains 
investigated 
 
 
Observations 
 
References 
 
 
 
 
 
 
 
 
Rotenone 
 
gas-1(fc21) 
 
Increased 
sensitivity to 
rotenone under 
hyperoxia 
 
 
(Ishiguro et al. 
2001) 
 
pdr-1, djr-1.1 
RNAi 
 
Increased 
vulnerability to 
rotenone 
 
 
(Ved et al. 
2005) 
 
 
lrk-1 RNAi 
 
Overexpression of 
wild-type human 
LRRK2 strongly 
protects 
against rotenone 
toxicity 
 
 
(Wolozin et al. 
2008) 
 
Table 1.4: Rotenone toxicity to C.elegans 
 
 
              The E3 ligases pdr-1 (parkin orthologue) and djr-1.1 
(DJ-1 orthologue), and the membrane associated kinase Irk-1 
have been implicated in the pathogenesis of PD in a C.elegans 
model, and have also been reported to show sensitivity to 
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rotenone. Ved et al. (2005) have shown the involvement of pdr-
1 and djr-1.1 in rotenone toxicity by gene knock-out 
experiments. To confirm the role of LRRKs (mixed lineage 
kinases) in PD, Wolozin et al, (2008), ablated the C.elegans 
membrane associated kinase Irk-1 and observed increased 
sensitivity to rotenone. On the other hand, over-expression of 
human LRRK2 in C.elegans was observed to confer protection 
against rotenone.  
1.10 Oxidative stress  
 
               Oxidative stress plays a vital role in 
neurodegenerative diseases and especially in Parkinson¶V disease 
(Jenner 1998). When there is an imbalance in the production of 
reactive oxygen species (ROS), the cell is subjected to oxidative 
stress. ROS include peroxides, such as hydrogen peroxide and 
peroxynitrite, and free radicals such as the superoxide, nitric 
oxide and hydroxyl radicals. These are produced due to 
instability in the redox state of tissues and they can damage all 
cell components including proteins, membrane lipids and DNA 
through oxidation.  
 
         The superoxide radical (O2í) which can give rise to the 
more damaging hydroxyl radical (HO) in the presence of iron 
and other redox-active metals (Fenton reaction). However, 
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superoxide radicals are normally converted by the enzyme 
superoxide dismutase (SOD, which exists in both mitochondrial 
and cytosolic forms) into oxygen and hydrogen peroxide. This 
latter is in turn converted into water and oxygen by catalases, or 
through a cyclical reaction converting two molecules of reduced 
glutathione (GSH) into the oxidised form (GSSG), catalysed by 
glutathione peroxidise enzymes (Ozgocmen et al. 2006). 
  
Figure 1.12: Formation of free oxygen radicals (adapted from Ozgocmen 
et al. 2006). 
 
 
               Oxidative stress can also cause cell death, either via 
apoptosis or necrosis (Lennon et al. 1991).  In order to combat 
oxidative stress, every cell has several defence and repair 
mechanisms, including the enzymes mentioned above. 
Antioxidants such as vitamin C and E or reduced glutathione 
(GSH) are also used as a defence mechanism against the toxic 
effects of ROS. Oxidative stress is aggravated due to reduced 
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antioxidant potential. Hence antioxidants such as superoxide 
dismutase, glutathione peroxidise, vitamin E etc can be used as 
supplements to protect the cell from oxidative stress (Ebadi et 
al. 1996).   
 
Figure 1.13: oxidative stress pathways in a dopaminergic neuron (adapted from 
Andersen 2004). Steps 1 to 13 are described in the text below. 
.  
            Figure shows the oxidative stress pathways involved 
within a dopaminergic neuron. (1) The neurotransmitter 
dopamine is taken into the dopaminergic neuron by the 
dopamine transporter (DAT); (2) Similarly dopamine is taken 
into synaptic vesicles by vesicular monoamine transporter 
(VMAT2); (3) Į-synuclein aids in dopamine release from the 
synaptic vesicle; (4) dopamine is oxidized to dopamine quinone 
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(DAQ); (5) DAQ produces potential mitochondrial inhibitors such 
as metabolites or conjugates of 5cysDAQ; (6) oxidative stress is 
produced by mitochondria; (7) Į-synuclein oxidation; (8) 
tagging of Į-synuclein by ubiquitin and subsequent degradation 
by the proteasome; (9) oligomerization of Į-synuclein; (10) 
proteasomal dysfunction caused by oligomeric Į-synuclein; (11) 
oxidative by-products such as 4-hydroxynonenol (4-HNE) 
interact with the proteasome further inhibiting its function; (12) 
glial cell production of oxidative stress; and (13) stimulation of 
programmed cell death (Andersen 2004). 
   
          Dexter et al (1989) showed that dopaminergic neurons in 
the substantia nigra undergo neurodegeneration due to oxidative 
stress LQ 3DUNLQVRQ¶V SDWLHQWV Oxidative stress also causes 
increased protein misfolding leading WR DFFXPXODWLRQ RI Į-
synuclein aggregates in the substantia nigra (Takeuchi et al. 
2002). 
 
 
 
 
Rakesh Kumar Bodhicharla 
51 
 
Aims  
 
 To generate permanent integrated transgenic lines using 
gamma irradiation. 
 To investigate the apparent radiation sensitivity of 
transgenic synuclein-expressing worms. 
 Characterization of transgenic and wild type worms in 
terms of. 
 Life cycle 
 Brood size 
 Sterility 
 Life span 
 Pharyngeal pumping 
 Longevity 
 FRET analysis for all the transgenic strains and wild type 
worms.  
 FRET analysis for unc-54::SC+SV (I) fusion worms using 
confocal imaging. 
 FRET analysis for unc-54::SC+SV (I) fusion worms and 
YFP fluorescence for NL5901 in terms of aging. 
 RNA interference directed against Hip-1 in unc-54::SC+SV 
(I) fusion worms.  
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 Protein aggregation in unc-54::SC+SV (I) and positive 
control unc-54::CV (I) fusion worms following treatment 
with the pesticides chlorpyrifos and rotenone. 
 Quantification of Reactive Oxygen Species production in 
unc-54::SC+SV (I) and NL5901 employing the H2DCF-DA 
assay. 
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Chapter 2.   Materials and Methods 
            Suppliers of all materials and equipments used in this 
project are listed in Appendix 2.  
2.1 Bacterial Preparation 
 
Preparation of bacterial stocks was done using a laminar 
flow hood and a flamed platinum loop under sterile conditions. 
2.1.1 E.coli P90C Strain 
 
    E.coli P90C is a mutant strain with the lac-operon 
GHOHWHG 7KLV LV WR SUHYHQW EDFWHULDO LQWHUIHUHQFH ZLWK WKH ǃ-
galactosidase assay when using lacZ reporter strains. It was 
selected based on its lacZ- phenotype and it also does not 
possess antibiotic resistance (Miller, 1972). P90C colonies were 
streaked onto separate plates of S-Gal LB agar (Sigma) 
alongside a parallel plate with a lacZ+ E.coli strain, such as 
HT115, and incubated overnight at 37ºC. The colonies on the 
lacZ+ control plates were dense and black whereas the lacZ- 
colonies appeared off-white in colour. This was done periodically 
to check that the P90C strain had not become contaminated. 
Concentrated suspensions of P90C bacteria in 25gl-1 of high salt 
LB broth (Melford laboratories Ltd) were kept at 4°C in 50ml 
sterile tubes for up to 6 months for use as bacterial food. 
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2.2 Plate Culture of C.elegans 
 
2.2.1 Preparation of Nematode Growth Medium 
(NGM) plates 
Nematode Growth Medium (NGM) was prepared by 
adding NaCl, Agar, Peptone and Cholesterol as described below 
(Brenner 1974).  
NaCl 3.0 g.l-1  
Agar 17.0 g.l-1 
Peptone* 2.5 g.l-1 
                (*or up to 20 g.l-1) 
Cholesterol (5 mg.l-1 stock in 
ethanol) 
0.5 mg.l-1 
 
*Higher concentrations of peptone were sometimes used in high peptone 
plates to encourage bacterial and nematode growth. 
 
Table 2.1: Composition of nematode growth medium 
 
 
             After being autoclaved, the mixture was allowed to cool 
to 60ºC in a water bath. Once cooled, further additions of 1M 
CaCl2 (1ml per l), 1M MgSO4 (1ml per l), and 1M potassium 
phosphate buffer pH 6.0 (25ml per l) were added with stirring 
because they tend to form insoluble calcium and/or magnesium 
phosphate crystals. 
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CaCl2 1 mM 
MgSO4 1 mM 
Potassium Phosphate Buffer pH 6.0 40 mM 
 
Table 2.2: Additions to NGM agar (final concentrations). 
 
 
              The potassium phosphate buffer (1M, pH 6.0) was 
prepared by titrating 500 ml acidic KH2PO4 (1M) with basic 
K2HPO4 (1M) until pH 6.0 was reached. The resultant solution 
was dispensed into 150 ml aliquots, autoclaved and stored at 
4ºC. 
The complete NGM mixture was then poured into 3.5cm, 
9cm or 14 cm Petri dishes, and allowed to solidify. Using sterile 
technique, a glass spreader was used to spread a dense 
suspension of P90C bacteria evenly over the plate. Alternatively, 
the NGM could be formulated with additional peptone (up to 20 
g.l-1) in order to facilitate the growth of a denser bacterial lawn. 
Plates were incubated overnight at 37ºC to allow the bacterial 
lawn to grow and then kept at room temperature for short period 
of time (a few days) because plates may dry out if kept for a 
longer periods. Alternatively, the plates could be stored in a 
fridge at 4ºC for up to several weeks. Plates stored at 4ºC were 
allowed to warm up at room temperature (15-20ºC) before use. 
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2.3 Worm Culture 
 
2.3.1 Subculturing and Transferring Worms 
 
Using sterile technique, a flamed scalpel was used to cut 
the agar into small pieces from a 1 week old plate containing 
worms.  Small pieces of agar were transferred onto fresh plates 
containing bacteria. Individual worms could be picked up under a 
microscope by using the flattered tip of a platinum wire pick. 
This was constructed by heat sealing a small piece of 32 gauge 
platinum wire into the end of a glass pipette and gently 
hammering flat the end of the wire. This flat end of the wire was 
flamed first, and then dipped into the bacterial suspension to 
make it stickier and more attractive to worms. Once this was 
done the worms could be picked individually and transferred 
onto fresh 3.5cm plates. Worms were then incubated at either 
15 or 20ºC for 3-4 days, allowing them to grow and reproduce. 
2.3.2 Harvesting and Washing of Worms 
  
2.3.2.1 K-Medium 
 
            In order to help ensure consistency between batches of 
K-medium, a 25 X concentrate was made up and frozen down in 
40 ml aliquots. These were then defrosted and made up to 1 litre 
in volumetric flasks before being dispensed and autoclaved. 
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The final constituent concentrations in 1 X K-medium were as 
follows (Williams and Dusenbery 1990) 
KCl 32 mM 
NaCl 53 mM 
 
Table 2.3: Components of K-Medium 
 
2.3.2.2 M9 Buffer 
 
For 1 Litre:  
KH2PO4   3 g 
Na2HPO4     6 g 
NaCl       5 g 
MgSO4 (1M)   1 ml 
dH2O    1 L 
 
Table 2.4: Composition of M9 Buffer 
 
           M9 buffer was prepared as above, dispensed and 
autoclaved for 15 minutes. Worms were harvested by washing 
them off the cultured plates with approximately 1-2 ml of K-
medium or M9 buffer. 
2.3.2.3 Transferring worms. 
 
The worms were transferred to 50 ml centrifuge tubes 
and allowed to settle on ice. Normally adult worms take 10-15 
minutes to settle, leaving behind a supernatant containing worm 
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debris and bacteria as well as some small larvae.  This 
supernatant was removed carefully without disturbing the worm 
pellet and fresh K-Medium or M9 buffer was added, again 
allowing the worms to settle for 10-15 minutes. This whole 
process was repeated several times until the supernatant was 
clear and essentially free from bacteria. Finally the tubes were 
centrifuged at 2500 rpm for 2 minutes and the supernatant was 
removed. 
2.3.3 Synchronization of Worm Cultures 
2.3.3.1 Filtration 
Plates containing worms were washed with either sterile 
K-Medium or M9 buffer (as described above) and the worm 
suspension passed through a sterile 5µm nylon mesh filter 
(Wilson Sieves, Nottingham); a population of mostly L1 and in 
some cases L2 larvae washed through in the filtrate (Mutwakil et 
al. 1997). The filtered larvae were allowed to settle on ice or at 
4ºC in the fridge for at least 60 min or centrifuged at 3000 rpm 
for 5 minutes. After removing the supernatant, the larval pellet 
was resuspended with 500µl of K-medium. After resuspension 
equal aliquots of larvae were distributed in small drops onto 
fresh NGM plates and incubated at 15 to 25ºC. After several 
days, the developmental stage of the worms was checked to 
determine whether the adults were producing eggs, at which 
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point the worms were ready to be harvested. Adults retained in 
WKH ǋP ILOWHU ZHUH UHVXVSHQGHG ZDVKHG DQG FOHDQHG DV
described above. 
2.3.3.2 Egg Isolation 
 Worms were washed off the culture plates using M9 
buffer or K-medium, and the worm suspension was transferred 
into 50ml centrifuge tubes. Worms were then allowed to settle 
on ice for 30 minutes or spun at 3000rpm for 5 minutes. The 
supernatant was removed and 10 volumes (relative to the pellet) 
of freshly prepared egg isolation solution were added and 
vortexed thoroughly. Egg isolation solution consists of alkaline 
hypochlorite (described below) and is used to kill and breaks 
open the adult worms and larvae. Only the eggs can survive this 
procedure, provided that they are not exposed for more than 10 
minutes in total. After 6-7 minutes, the worm suspension was 
centrifuged for 3 minutes at 3000 rpm, then again the 
supernatant was removed and fresh M9 buffer or K-Medium was 
added. The washing process was repeated 2-3 times until the 
supernatant became clear. The pellet containing the surviving 
eggs and worm debris was resuspended in small volume of 
medium to form a slurry, which was then spotted onto fresh 
NGM plates, and incubated at 15-25ºC. 
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NaOH 20 g.l-1 
NaOCl 
(13.5 to 16% commercial stock) 
2.16-2.56% 
 
Table 2.5: Composition of Egg Isolation Solution 
 
           NaOCl stock is at a concentration of 13.5 to 16% 
available chlorine (Aldrich, Dorset, United Kingdom). Due to the 
tendency of the sodium hypochlorite to break down over time, 
the egg isolation solution was made up fresh monthly and stored 
at 4ºC. 
2.3.4 Cleaning contaminated C. elegans stocks 
 C. elegans stocks may become contaminated with other 
bacteria, yeasts or mould. Mould could be removed by 
transferring the worms onto fresh plates. Bacterial contaminants 
and yeast were easily removed by treating adult worms with egg 
isolation solution as mentioned in section 2.3.3.2, in order to kill 
the contaminants and all worm stages other than embryos 
protected within the egg shell. 
 In order to remove mould contaminants from C. elegans 
stock plates a scalpel or spatula was sterilized in a flame and a 
piece of the agar was removed from the contaminated plate. The 
piece of agar was placed at the edge of a clean bacterial plate. 
The worms were allowed to crawl off the agar and across the E. 
coli P90C lawn to the opposite side of the plate. Once the worms 
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have reached the other side of the plate, individual animals were 
picked with the help of worm picker (using a flamed scalpel or 
spatula) and placed near the edge of another clean plate. The 
whole process was repeated until the contaminants were 
removed. 
2.4 Freezing Live Worms 
 Among the different developmental stages of C.elegans, 
only L1 and L2 larvae are expected to survive the freezing 
process. Freezing worms can be done only when the worms have 
very few bacteria in their gut because of the risk of rupture, 
which would reduce their chances of survival upon thawing. 
Worms were frozen down in two different ways: ± (i) Culture 
plates were allowed to grow for 2 to 3 days at 15 - 25°C and 
washed with small volumes of either M9 buffer or K-Medium as 
above; (ii) alternatively eggs were isolated from a synchronized 
culture of gravid adults and allowed to hatch in M9 buffer 
without added bacteria for 24 hours at 15ºC. This produced a 
bacteria-free culture of synchronized L1 larvae. In either case, 
an equal volume of freezing down solution (Table 2.6) was 
added to the worm suspension and the mixture dispensed in 1ml 
aliquots into autoclaved 1.5 ml microcentrifuge tubes. These 
were mixed by inverting the tubes several times, then labeled, 
placed in polystyrene boxes and stored at -80ºC. In order to 
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check the degree of survival, one aliquot was taken out of the 
freezer, thawed quickly by hand-holding or in a 37º C water 
bath, and then plated onto fresh NGM plates. If very few worms 
survived the freezing process, then the whole procedure was 
repeated. 
For 1 Litre:  
Glycerol 240ml 
NaCl 5.84 g.l-1 
KH2PO4 (1M) pH 6.0 
 
50ml 
dH2O 
 
710ml 
 
Table 2.6: Components of Freezing down Solution 
 
               This mixture was autoclaved, and finally sterile 30 µl 
of MgSO4 (1M) was added per 100ml of solution. 
2.5 Protein Extraction from C.elegans 
This protocol was based on that used in the Pasquinelli 
lab (adapted from Reinhart and Ruvkun 2001). Worms were 
washed off from the plates using M9 buffer and rocked for 20 
minutes at room temperature to make the worms digest bacteria 
in the gut. Once again they were washed with M9 buffer and 
transferred into microcentrifuge tubes. These were centrifuged 
for 30 seconds at 5000 x g to give a worm pellet at the bottom 
of the tube. For eggs, the tubes were stood at room temperature 
for 2-3 minutes, and then centrifuged at 1000 x g (at higher 
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speeds eggs have a tendency to pellet inside the walls of the 
tube). Before freezing the worms/eggs in a mixture of dry ice 
and ethanol, the packed worm volume was noted. An equal 
volume of 2 X SDS buffer (Table 2.7) was added to the frozen 
pellet and boiled for 15 minutes; samples were vortexed once 
after 7-8 minutes. For eggs (only), samples were homogenized 
using a hand-held homogenizer before boiling. The insoluble 
material was then pelleted by spinning the tubes at 10,000g for 
5 minutes. The supernatant containing solubilised cellular 
proteins was removed and stored in a separate tube. 
10% SDS  2ml(4% final) 
0.5M Tris HCl, pH 6.8  1ml(100mM final) 
Glycerol  1ml( 20% final) 
dH2O 1ml 
 
Table2.7: 2 X SDS buffer (5ml) 
 
2.6 SDS-polyacrylamide gel electrophoresis (SDS 
PAGE) 
This technique, first described by Laemmli (1970) is used 
to separate proteins based on molecular weight. During the 
protein extraction excess SDS is added to denature the proteins. 
The denatured proteins become negatively charged when SDS 
binds to the amino acid chain. This negative charge is 
proportional to the length of the protein and hence the molecular 
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weight of the protein. The denatured proteins are then separated 
by polyacrylamide gel electrophoresis. 
2.6.1 Preparation of gel 
 SDS-PAGE was performed using a SE 250 Mighty Small 
II electrophoresis kit. Before use, the glass plates were cleaned 
using 100% methanol to remove all traces of grease and dirt 
that may interfere while casting the gel. The percentage of 
acrylamide used in the gel was based upon the molecular weight 
of the proteins under investigation. Normally a 12% acrylamide 
gel was used in this study. Components of the resolving gel were 
mixed and poured between the glass plates, after the addition of 
 ǋO RI IUHVKO\ SUHSDUHG  DPPRQLXP SHUVXOSKDWH $36
DQGǋO RI111¶1¶-Tetramethylethylenediamine (TEMED) 
as polymerization catalysts. Before the gel polymerized a 
solution of 0.1% SDS was slowly added on top of the resolving 
gel. This ensured that a flat interface was obtained between the 
resolving and stacking gels. The gel was allowed to set for about 
30 minutes.  
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 Running Stacking 
30% Acrylamide  39.6ml              1.3ml 
Distilled water                             33.9ml 6.1ml 
1.5M Tris-HCl pH8.8                     25ml  
0.5M Tris-HCl pH6.8                      2.5ml 
10% SDS                                    1ml 0.1ml 
10% ammonium persulphate 
(fresh)                         
0.5ml                0.05ml 
TEMED   0.05ml              0.01ml 
 
Table 2.8: Components of SDS-PAGE gel 
 
 
Once the resolving gel had polymerized, the SDS solution 
was poured off from the surface of the gel. The stacking gel was 
made up (as above) and added on top of the resolving gel. After 
DGGLQJǋORI IUHVK$36ǋO7(0('ZDVDGGHG WR WKH
stacking gel solution. Before the gel polymerized a comb was 
inserted into the liquid stacking gel, which was allowed to set for 
60mins. The comb was carefully removed and the gel placed 
between baths of electrophoresis buffer before loading protein 
samples (see next section). 
2.6.2 Sample preparation and gel electrophoresis 
Protein samples for gel electrophoresis were diluted by 
mixing with 5x Loading buffer (0.635 M Tris HCl, pH 6.8, 4% 
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SDS, 25% glycerol, 500 mM DTT and 0.05% w/v bromophenol 
blue). These diluted samples (and also molecular weight 
standards) were boiled at 80-90ºC for 5 minutes and then 
placed on ice. The samples were briefly centrifuged to remove 
any insoluble material. 
 
The upper and the lower reservoirs of the gel apparatus 
were filled with electrophoresis buffer (25 mM Tris-HCl pH 8.6, 
1902 mM glycine and 0.1% SDS (w/v)). Prior to loading the 
samples, the wells were pipetted out to remove any 
unpolymerized acrylamide. Finally electophoresis was performed 
at 100 volts for 1.5 hours.  
2.6.3 Coomassie Staining 
The staining solution was first prepared by dissolving 
0.25% Coomassie Blue R-250 in a mixture containing 40% (v/v) 
methanol and 10% (v/v) acetic acid in water. Prior to use this 
staining solution was filtered through Whatman 3MM paper, to 
remove undissolved solids. After electrophoresis the gel was 
soaked in staining solution for 20 minutes with gentle agitation. 
The staining solution was decanted and the gel destained using 
Destain solution (30% methanol and 10% acetic acid, both v/v). 
Once the gel had been sufficiently destained, it was placed in 
water for 10 minutes to fully hydrate the gel prior to drying. The 
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gel was dried onto Whatman 3mm paper and covered with Saran 
wrap, then dried for 2 hours at 80oC under vacuum. Gels to be 
blotted were not stained with Coomassie or dried. 
2.7 Western Blotting 
 This technique is used to identify a specific protein in a 
given protein sample. Gel electrophoresis is used to transfer the 
size-separated proteins from an SDS-PAGE gel onto a protein-
binding membrane (nitrocellulose or PVDF).  
2.7.1 Electrophoretic transfer 
 Polyvinylidene difluoride (PVDF, Immobilon P, Millipore) 
membranes were used for the blotting process. These have a 
high binding capacity and give lower backgrounds than 
nitrocellulose, and are therefore commonly used for blotting. The 
stacking gel was removed from the separating gel and discarded. 
The separating gel was then placed on two pieces of 3MM 
Whatman blotting paper pre-soaked in transfer buffer (Table 
2.9). Prior to blotting a piece of PVDF was cut to the size of the 
gel, soaked in 100% methanol and then in 1 x transfer buffer in 
which it was rocked for 2-3 minutes. The membrane was then 
laid over the separating gel, ensuring that no air bubbles were 
trapped between the gel and the PVDF membrane. Two more 
pieces of pre-soaked 3MM Whatman blotting paper were placed 
RYHUWKHWRSRIWKH39')PHPEUDQHDQGWKHUHVXOWLQJµVDQGZLFK¶
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was enclosed in an Electro-transfer cassette. The blotting 
cassette was placed into the transfer tank with the gel side of 
the sandwich closest to the cathode and the membrane side 
closest to the anode. The tank was filled with transfer buffer and 
the blot was electrophoresed for 1 hour at constant 100V using 
plate electrodes in the high intensity position.  
Tris 30.3 g.l-1 
Glycine 144 g.l-1 
 
Table 2.9: 10 x Transfer Buffer 
 
10 x Transfer Buffer 100ml 
Methanol 200ml 
10% SDS 10ml 
dH2O 700ml 
 
Table 2.10: 1 x Transfer Buffer 
 
 
The efficiency of Western blotting was determined using 
prestained protein markers (SDS-7B, Sigma) which were also 
run on the gel. Additionally Coomassie staining could be done 
afterwards to show that no protein bands were left in the gel. 
Once the transfer was completed the blotting cassette was 
disassembled. The membrane was then transferred into a plastic 
tray containing transfer buffer to prevent the membrane from 
drying. 
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2.7.2 Developing the Membrane 
             Blocking of non-specific protein binding was achieved 
by placing the membrane in 1× Tris Buffered Saline (TBS) + 
10% Marvel (non-fat milk powder) overnight.  The membrane 
was then washed 5 times for 5 minutes in 1× Tween Tris 
Buffered Saline (TTBS) containing 0.05% (v/v) Tween 20. After 
blocking the membrane, 1× TBS + 10% Marvel +anti- synuclein 
primary antibody (Sigma) at a 1:2000 dilution was incubated 
with the membrane for 1 hour with gentle agitation. After the 
primary antibody incubation, the membrane was washed 5 times 
for 5 minutes in TTBS to remove unbound primary antibody. The 
membrane was then incubated for 1 hour in 1× TTBS + 10% 
Marvel with secondary antibody (Bio-Rad anti-Rabbit IgG at a 
1:10000 dilution). After the secondary antibody incubation, the 
membrane was again washed 5 times for 5 minutes in TTBS.  
Tris-HCl pH7.6 20 mM 
NaCl 136 mM 
 
Table 2.11: Tris buffered saline 
 
Tris-HCl pH7.6 20 mM 
NaCl 136 mM 
Tween 20 0.5ml/L 
 
Table 2.12: Tween Tris buffered saline 
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2.7.3 Enhanced Chemiluminescence Detection 
(ECL) 
                7KLVIROORZHGWKHNLWPDQXIDFWXUHU¶VSURWRFRO7KHUPR
scientific). Equal volumes of two ECL solutions (SuperSignal 
West Femto Trial Kit /enhancer solution and stable peroxide 
solution) were mixed, and then the membrane was soaked in 
this ECL solution for a minute before removing the excess 
solution. The blot was covered with cling film, and then placed 
inside the gel documentation machine (Bio-Rad Chemi Doc XRS). 
Photographs were taken using the Chemiluminescence setting by 
exposing the blot with a 60 second exposure time. 
 2.8 Construction of Synuclein-Venus fusion 
 
(Note: this work was performed by Dr. J.Winter prior to 
the start of my project, and therefore the methods used are not 
described in detail). 
Venus-<)3 9 DQG KXPDQ Į-synuclein (S) were PCR 
amplified and cloned into pGEMT Easy with restriction sites 
added to the ends as follows: 
x NcoI-Synuclein-Csp45I 
x Csp45I-Venus-SacI 
 
Cloned genes were then excised from pGEMT Easy using 
the above restriction enzymes, and ligated into pET-30a either 
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singly or in pairs. pET-30a was double digested with NcoI and 
SacI prior to ligation. For double ligations, NcoI-Synuclein-
Csp45I and Csp45I-Venus-SacI were simultaneously ligated into 
pET-30a to produce gene fusions (Bodhicharla et al, submitted). 
The following products were subcloned into pET-30a in this way: 
x Synuclein-Venus SV 
x Venus V 
 
Figure 2.1: Construction of Synuclein-Venus (SV). (Adapted from 
Bodhicharla, 2007, MRes Thesis, University of Nottingham). 
 
 
                   Transgene fusion constructs including Venus (V), 
Cerulean (C), Synuclein-Venus (SV), Synuclein + Venus (S+V), 
Synuclein-Cerulean + Synuclein-Venus (SC+SV), Cerulean-
Venus (CV) and Cerulean + Venus (C+V) were also constructed 
using the same cloning procedure. 
 
    cDNA synuclein 
NcoI Csp45I Sp6 
Linearised 
pGEMT-vector 
NcoI Csp45I 
 
pGEMT-easy Vector 
cDNA synuclein 
Csp45I 
    cDNA Venus 
T7 
 
Csp45I SacI 
 
pGEMT-easy Vector 
cDNA Venus 
Excise with NcoI and Csp45I Excise with Csp45I and SacI 
+ + 
pET-
30a 
Excise with NcoI and SacI 
     NcoI       
 
pET-30a 
Synuclein-Venus 
Triple ligation 
     Saci 
 ligation  ligation 
Linearised 
pGEMT-vector 
SacI Sp6 T7 
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2.9 Testing of unc-54::S+V (NI) fusion gene 
transmission rate after Microinjection 
Fluorescing L4 worms were identified under a 
fluorescence microscope (Olympus Model SZX12) equipped with 
filters for distinguishing CFP and YFP fluorescence. Fluorescence 
was measured with a CFP excitation/emission filter (440/480nm) 
and an YFP excitation/emission filter (500/545nm) combination. 
Using a platinum wire pick, a total of 10 worms were individually 
transferred onto 10 different 3.5 cm diameter NGM plates. After 
incubation at 20°C for 3 days, the worms would have started to 
produce F1 offspring. Because this is a non-integrated line, there 
will be both fluorescent and non-fluorescent offspring present. 
Percentage of transmission was calculated simply by counting 
fluorescent versus non-fluorescent worms. Out of those 10 
plates, transmission rates varied between 20% and 60%. Plates 
with a low transmission rate were used for subsequent gamma 
irradiation.  
2.10 Integrating extrachromosomal arrays using 
Gamma Radiation 
 An unc-54::S+V (NI) fusion line showing 20% 
transmission of  the extrachromosomal transgene array was 
irradiated with gamma rays (Gamma cell unit with a 137Caesium 
source; Nordion international Inc). Thirty fluorescing L4 animals 
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carrying the transgene array were transferred onto each of 
several 3.5cm plates. The plates carrying these worms were 
irradiated for different lengths of time to find the dose required 
for chromosomal integration, resulting in 100% transmission. 
The standard dose of gamma radiation used for this purpose in 
the literature is between 2000 and 4000 rad (Rosenbluth et al. 
1985). After irradiation, worms were selfed onto individual plates 
and incubated at 20°C for 2 days. Once they started to produce 
offspring, several hundred F1 progeny carrying the 
extrachromosomal array were selfed onto individual plates and 
again incubated at 20°C for 2 days. After two days, all of these 
plates were screened for lethality and sterility. At this stage, the 
percentage transmission rate will be about 75%. If properly 
irradiated, the percentage of lethality and sterility among F1 
progeny should be between 10-15%. From the F2 progeny two 
F2 transformants were picked from each F1 and selfed onto 
separate plates. These plates were screened for 100% 
transmission of the array to the F3; such a strain should carry a 
homozygous integrated array. The percentage of integrants 
obtained is generally very low, between 1-2%. In this way, we 
were able to generate a permanent integrated transgenic line for 
unc-54::S+V (I). This process (section 2.8 and 2.9) was then 
repeated for the following strains. 
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Strains  Sucess 
unc-54::SV 
(NI) 
unc-54 promoter fused to synuclein 
coding sequence tagged with YFP at its 
C terminus. 
 
No 
unc-
54::SC+SV 
(I) 
unc-54 promoter fused to synuclein 
coding sequence tagged with YFP at its 
C terminus, plus (in equal amounts) 
unc-54 promoter fused to synuclein 
coding sequence tagged with CFP at its 
C terminus. 
 
 
Yes  
unc-54::V 
(I) 
unc-54 promoter fused to YFP. Yes 
unc-54::C 
(NI) 
unc-54 promoter fused to CFP. No  
unc-54::CV 
(I) 
unc-54 promoter fused to CFP linked 
directly to YFP. 
Yes  
unc-
54::C+V (I) 
unc-54 promoter fused to CFP plus (in 
equal amounts) unc-54 promoter fused 
to YFP. 
 
Yes  
unc-
54::SV+C 
(NI) 
unc-54 promoter fused to synuclein 
coding sequence tagged with YFP at its 
C terminus plus (in equal amounts) 
unc-54 promoter fused to CFP. 
 
No  
 
Table 2.13: Transgenic strains 
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2.10.1 Back-crossing 
  All the transgenic lines showing 100% transmission 
were bred with N2 males to get rid of mutations that were 
caused by irradiation. To begin with, 12 young N2 males were 
placed onto a fresh plate with several L4 stage unc-54::S+V (I) 
hermaphrodites. The plate was incubated at 20°C for 2 days. 
Several hermaphrodites were picked from the 1st generation and 
the mating process was repeated over 5- 6 generations, such 
that the resulting transgenic fusion strains should carry no 
unwanted mutations. For those strains that could not be 
integrated successfully, non-irradiated lines showing high 
WUDQVJHQH WUDQVPLVVLRQ  ZHUH VHOHFWHG IRU FXOWXUH EXW
did not require outcrossing.  
2.11 Determination of sterility for all transgenic 
worm strains and N2 wild type worms after 
gamma radiation. 
              Several 3.5cm plates each carrying 30 fluorescing L4 
transgenic worms were irradiated for different lengths of time 
(section 2.10). After irradiation these P0 worms were selfed onto 
individual plates and incubated at 20ºC for 2 days. Once they 
started to produce offspring, the worm plates were screened to 
check whether any of the worms were dead or sterile (not laying 
eggs). The offspring were allowed to develop at 20ºC until larvae 
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reached the L4 stage. Several hundred F1 progeny from the P0 
generation carrying the extrachromosomal or integrated 
transgene array were selfed onto individual plates.  Again these 
plates were incubated overnight at 20ºC for 2 days until they 
produced offspring. Several hundred plates were screened again 
to check whether any of the worms were dead or sterile.  
2.12 Determination of life span for transgenic and 
N2 wild type worms 
The life span of worms was determined by picking 
individual hermaphrodites at late L4 stage onto separate plates. 
They were left for 2 hours to produce eggs, then the adults were 
removed and the plate carrying the eggs was labeled with date 
and time. These eggs were allowed to develop at 20ºC until 
larvae reached the L4 stage, when they were transferred onto a 
separate plate and incubated overnight at 20ºC. Next day the 
adults were transferred onto a new plate leaving behind their 
offspring on the old plate.  The same process was repeated until 
the animals stopped producing offspring (usually 3-4 days). The 
adult worms were allowed to grow on at 20ºC, and were 
monitored daily by tapping the adults on the head. Animals were 
considered dead if no movement was observed following 
repeated probing. Once the worms were identified as dead, the 
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date and the time were noted down. The life span of each worm 
was then calculated from egg until death.  
2.13 Determination of motility for transgenic and 
N2 wild type worms 
               Locomotion rates were measured by picking individual 
adult worms from an agar plate with bacteria and transferring 
then onto a bacteria-free plate. Locomotion rates were 
determined by the number of bends each worm performs over 
30 seconds. This is difficult to do on bacterial plates because the 
worms tend to stop moving upon encountering food. Therefore 
all locomotion rates were measured on bacteria free plates with 
10 different worms, at room temperature (~ 20°C) using a 
Fluorescence microscope (Olympus Model SZX12).  
2.14 Determination of pharyngeal pumping rates 
for transgenic and N2 wild type worms 
               Pharyngeal pumping rates were determined by picking 
10 adult worms from an agar plate with bacteria and transferring 
them onto a bacteria-free plate. It was hard to observe 
pharyngeal pumping on agar plates with bacteria because the 
worms tend to hide under the bacteria and pumping sometimes 
also pauses. Pharyngeal pumping was observed for each of the 
Rakesh Kumar Bodhicharla 
78 
 
10 worms for 1 minute at room temperature (~ 20°C) using a 
Fluorescence microscope as above (Section 2.12).  
 
2.15 Determination of sterility for transgenic and 
N2 wild type worms  
                L4 hermaphrodites of the desired genotype were 
individually transferred onto 3.5cm agar plates at 20°C. By the 
next day the L4 hermaphrodites had reached adulthood and 
started to produce their own progeny. They were monitored daily 
from embryo to L4 stage. Once they reached the L4 stage, 
several hundreds of them were selfed onto individual plates and 
each was checked for sterility. If the worms were not producing 
any offspring then the worms were recorded as sterile. The same 
procedure was repeated for all of the transgenic genotypes. 
2.16 Determination of developmental time for 
transgenic and N2 wild type worms  
             The life cycle of worms was monitored by picking 
individual hermaphrodites at late L4 stage on to separate plates. 
After 2 hours they started to produce their own offspring (eggs), 
then the adults were removed and the plate carrying the eggs 
was labeled with date and time. Eggs were allowed to grow at 
20ºC until larvae reached adulthood and began to lay eggs (egg-
laying adults). The date and the time were again noted. The 
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developmental time for each worm was calculated from egg to 
egg laying adult.  
 
2.17 Determination of brood size for transgenic 
and N2 wild type worms  
                 L4 hermaphrodites of the desired genotype were 
individually transferred onto agar plates at 20°C. The 
hermaphrodites were transferred to fresh plates at 24 hour 
intervals. The progeny left behind were counted at late larval to 
adult stages by flaming worms one by one. An embryo was 
scored as being dead if the egg had not hatched after 24 hours 
at 20°C. The brood size of each animal was calculated as the 
sum of both non-hatched and hatched progeny. The same 
procedure was repeated for all of the genotypes. 
2.18 Fluorescence Resonance Energy Transfer 
(FRET) Analysis for transgenic and wild type 
worms.  
              Six different worm strains (unc-54::C+V (I), unc-
54::SC+SV (I), unc-54::CV (I), unc-54::C (NI), unc-54::V (I) 
and N2 wildtype worms) were washed off the plates using K-
medium and transferred into 15 ml tubes. The worms were 
washed several times to get rid of bacteria. Equal aliquots of 
each strain were transferred into a black non-fluorescent 96 well 
Rakesh Kumar Bodhicharla 
80 
 
plate (Nunc Ltd, from Fischer Scientific, Loughborough, UK) with 
3 replicates per strain. Worm suspensions were stirred during 
dispensing so that each aliquot contained roughly the same 
number of worms (±5-8%). Each well contained 200 µl of K-
medium with 1000-2000 worms, depending on strain. While 
stirring one such worm suspension, several 5µl aliquots of 
worms were counted (53±6; n=6) to check on the consistency 
of these aliquots; given the inaccuracies of micro-pipetting small 
volumes (5 µl), it is likely that worm numbers were even more 
consistent across replicate wells when using larger (50 µl) 
samples of worm suspension. Once the worms have been 
transferred into the 96 well black plates, these were kept on ice 
for 5 minutes to allow the worms to settle. The plate was read 
using a Wallac Victor 1420 Multilabel Counter for detection of 
FRET, as described below.  
 
             The transgenic strain express one or both of the yellow 
(YFP; Venus, V) or blue (CFP; Cerulean, C) variants of Green 
Fluorescent Protein (GFP). Forster Resonance Energy Transfer 
(FRET) is possible from a CFP donor to a YFP acceptor only when 
these moieties are in very close proximity (e.g. within a protein 
aggregate). Fluorescence was measured with a CFP excitation 
filter (430nm narrow band pass) and a YFP emission filter (530 
nm narrow band pass) using the Victor 1420 instrument. Each 
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well was scanned at the base of the U-bottomed well, where the 
worms settle. 
2.19 FRET Analysis for unc-54::SC + SV (I) fusion 
worms during aging. 
                The unc-54::SC+SV (I) fusion worms were grown at 
20 ºC for several days to allow them to produce offspring, at 
which point L1 filtration was performed (section 2.3.3.1) The 
synchronised cultures were incubated at 20 ºC for two days until 
the worms reached the L4 stage. The worms were washed off 
the plate using K-medium and transferred into 15 ml tubes, 
washed several times to get rid of bacteria and transferred into a 
96 well black plate. After allowing the worms to settle on ice for 
5 minutes, FRET measurements were taken as described above 
(section 2.17). After this, the worms were transferred back into 
fresh plates. These were again incubated at 20 ºC for 2 days for 
the worms to reach adulthood, and then the worms were again 
washed and filtered to remove the L1 larvae which might 
interfere with the FRET signal. FRET measurements were 
repeated for the adult worms as mentioned above. Further, FRET 
measurements were taken after another 2 days (i.e. on days 1, 
3 and 5 after L4). 
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2.19.1 Fluorescence Imaging in C. elegans 
                After FRET measurements, the worms were 
immobilised using 10 mM sodium azide and 50% (v/v) glycerol 
and then mounted on a slide, taking care to avoid air bubbles. 
The cover slip was sealed using nail polish to prevent the worms 
from drying out. The worm slides were examined using a Leica 
TCS SP2 Confocal Laser Scanning Microscope (CLSM) for high 
resolution pictures, using Z stacking for maximum depth of field. 
The unc-54::SC+SV (I) fusion worms were imaged using a 40x 
lens. In order to make sure that all the images were uniform in 
terms of changes in fluorescence, all the samples were analyzed 
on the same day with the same settings on the microscope. All 
photographs comparing two conditions used the same gain 
settings and other parameters such as 8-bit images, 515x 512 
pixels, field of view= 375x 375µm, 50% laser power for CFP at 
458nm and for YFP at 514nm; the YFP emission filter is between 
519-600, the CFP emission filter is between 470-500, the beam 
splitter 458/514nm, and the lens is a 40x 1.25 NA oil 
apochromat.  
2.20 RNA Interference against Hip-1 in unc-
54::SC + SV (I) fusion worms  
               25g l-1 of high salt LB broth (Melford Laboratories Ltd) 
was prepared and autoclaved, then 12.5 µg/ml w/v tetracycline 
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and 25 µg/ml w/v ampicillin was added to the cooled solution. A 
single colony of Hip-1 RNAi bacteria (kindly sent by Dr. A. van 
der Groot of the University Medical Centre, Groningen, the 
Netherlands) was scraped off the agar plate using a sterile 
inoculation loop and then dipped into 35 ml of sterile LB-tet-amp 
in a 50 ml falcon tube. The same procedure was used for similar 
HT115 bacteria carrying the empty L4440 feeding vector (FV) 
which were used as a control. The bacteria were grown overnight 
at 37 ºC in a shaking incubator. These overnight cultures of FV 
and Hip-1 RNAi bacteria were centrifuged at 3000 rpm at 4 ºC 
for 10 minutes to pellet the bacteria, and most of the 
supernatant was removed to leave a thick bacterial suspension. 
 
              NGM agar plates were prepared as usual by adding 
CaCl2, MgSO4 and potassium phosphate buffer to the cooling 
agar. In addition to this IPTG (1.0mM final), 12.5 µg/ml w/v 
tetracycline and 25 µg/ml w/v ampicillin were added. The 
suspension of FV or Hip-1 RNAi bacteria was then spread onto 
these IPTG/tet-amp agar plates. Half of the agar plates were 
spread with RNAi bacteria and half with empty feeding-vector 
(FV) bacteria. Plates were incubated at 37 ºC for 3 hours; 
allowing the IPTG to induce double-stranded RNA synthesis. The 
plates should not be kept at 37 ºC for more than 3 hrs, as this 
promotes overgrowth of bacteria that have lost the RNAi 
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construct. All plates were then cooled to room temperature for at 
least 1 hr. 
            The unc-54::SC+SV (I) fusion worms were grown at 20 
ºC for several days allowing them to produce offspring, followed 
by L1 filtration to obtain a synchronised L1 population. The L1 
larvae (P0 generation) were resuspended in a small volume of K-
medium and then small droplets of larval suspension were added 
at multiple locations across both the Hip-1 RNAi and FV control 
plates.  
 
          The worm plates were incubated overnight at 20 ºC for 
several days until they produced F1 offspring. Once there were 
enough L1 larvae, L1 filtration was again carried out. The larval 
suspension was transferred onto fresh RNAi/empty feeding-
vector plates.This procedure was repeated over 2 generations. 
The L1 larvae obtained from the F2 generation were allowed to 
grow for several days until they reached the L4 stage. At each 
generation, worms were washed off the plate using K-medium, 
and then transferred into a 96 well black plate, as described 
above (section 2.17). Both FRET measurements (section 2.17) 
and confocal microscopy (section 2.18.1) were performed as 
described previously. 
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2.21 Treating unc-54::SC + SV (I) fusion worms 
with Chlorpyrifos 
            Cultures of unc-54::SC+SV (I) fusion worms were 
grown at 20 ºC and synchronised by L1 filtration, as described 
above (section 2.18). Fresh agar plates with bacteria and 2 
different concentrations of chlorpyrifos (20ppm and 300ppm) 
were prepared by spreading 300 µl of chlorpyrifos solution 
(20ppm or 300ppm) onto the surface of the agar plate. The L1 
larvae were resuspended in a small volume of K-medium and 
small droplets of larval suspension were distributed onto these 
plates. Another fresh agar plate was used as a zero control with 
no added chlorpyrifos. All 3 plates were incubated for 48 hrs at 
20 ºC for the worms to reach the late L4 stage. Note that ppm 
(parts per million) is equivalent to mg.l-1 or µg.ml-1 throughout. 
 
             Once again, FRET measurements and confocal 
microscopy were performed on washed worms from all 3 
cultures as described previously (section 2.17 and 2.18.1).           
2.22 Treating unc-54::SC + SV (I) fusion worms 
with Rotenone 
             Similarly, unc-54::SC+SV (I) fusion worms were 
exposed at the L1 stage to 2 different concentrations of rotenone 
(2ppm and 20ppm) prepared in the same way as for chlorpyrifos 
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(section 2.20), plus a zero control with no rotenone.  All 3 plates 
were incubated for 24 hrs at 20 ºC until worms reached the late 
L2 stage. Initially rotenone treatment was done over 48 hours as 
for chlorpyrifos, but because rotenone causes developmental 
arrest, the exposure period was reduced to 24 hrs. 
 
 Once again, FRET measurements and confocal microscopy 
were performed on washed worms from all 3 cultures as 
described previously (section 2.17 and 2.18.1).           
2.23 Quantification of Reactive Oxygen Species 
Production in unc-54::SC+SV (I) and NL5901 
Employing H2DCF-DA Assay 
 
           During oxidative stress ROS production can be measured 
by several methods, of which the H2DCF-DA assay (Gerber and 
Dubery 2003) LV WKH PRVW HIIHFWLYH ¶ ¶-
dihydrodichlorofluorescin-diacetate (H2DCF-DA) is a non-polar 
compound, and measurement of hydrogen peroxide (a typical 
ROS) in aqueous solution can be done by using H2DCF-DA in a 
fluorometric assay (Keston and Brandt 1965). The principle 
behind this experiment is that H2DCF-DA enters the cell straight 
away ZKHUH LW LV K\GURO\]HG WR ¶ ¶-dihydrodichlorofluorescin 
(H2DCF) by intracellular esterases.  H2DCF is a non-fluorescent 
Rakesh Kumar Bodhicharla 
87 
 
polar compound which accumulates in the cell. This compound is 
ILQDOO\ R[LGLVHG WR ¶ ¶-dichlorofluorescin (DCF) upon 
encountering intracellular ROS (Rosenkranz et al. 1992). DCF is 
a highly fluorescent compound which can then be measured by 
exciting at 501nm (maximum) and reading at 521 nm emission 
wavelength (maximum). 
 
 
Figure 2.2: steps involved in. H2DCF-DA mediated ROS measurement. 
(adapted from Gerber and Dubery 2003). (A) H2DCF-DA straight away enters 
WKHFHOOZKHUHLWLVK\GURO\]HGWR%¶¶-dihydrodichlorofluorescin (H2DCF) 
by intracellular esterases.  H2DCF is a non-fluorescent polar compound which 
JHWVDFFXPXODWHG LQWKHFHOO7KLVFRPSRXQG LV ILQDOO\R[LGLVHGWR&¶¶-
dichlorofluorescin (DCF) when it encounters intracellular ROS. (D) DCF is a 
highly fluorescent compound which can be measured by exciting at 501nm 
(maximum) and emission at 521 nm (maximum).  
Rakesh Kumar Bodhicharla 
88 
 
            The NL5901 strain is an integrated unc-54::SV strain 
produced by the Nollen lab (van Ham et al. 2008), and was 
obtained from the Caenorhabditis Genetics Centre (CGC) at the 
University of Minnesota. 
 
                 Long term treatments were started at the L1 stage 
and terminated on reaching adulthood, whereas short term 
treatments were given during the young adult stage itself. 
Synchronized L1 populations were prepared and distributed 
across control, chlorpyrifos (300 ppm) and rotenone (20 ppm) 
treated plates, as described in the preceding sections (2.20 and 
2.21). 
 
 After washing, a 50 µl volume of worm suspension was 
pipetted out in four replicates into the wells of a black 96 well 
plate. 50 µl of fresh 100 µM ¶ ¶-dihydrodichlorofluorescin-
diacetate (H2-DCF-DA) solution was added to the suspensions 
(50 µM final) and immediately basal fluorescence was measured 
in a microplate reader (Wallac Victor 1420 Multilabel Counter) at 
excitation and emission wavelengths of 485 and 520 nm 
respectively.  The plates were kept shaking at 200C for 1 hour, 
after which a second measurement was performed in the 
microplate reader. The difference in fluorescence readings was 
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determined. The resulting fluorescence was expressed as relative 
ROS production (Gerber and Dubery 2003). 
2.24 Statistics 
 
         Graphs were generated for worm sterility caused by 
gamma irradiation using a non-linear regression curve with the 
setting log (agonist) vs. normalised response. The Prism 
software (version 5) also calculated the EC50 and the 95% 
confidence intervals allowing comparison between gamma 
radiation dose and sterility. For EC50 values the use of non-
overlapping confidence intervals indicates statistical significance 
(Jeske et al. 2009). Graphs were generated using Prism software 
for worm lifespan using survival analysis but the P values were 
calculated using R statistical software with the setting Mantel-
Cox test. For longevity, pharyngeal pumping, movement analysis 
and FRET, graphs were generated using Prism software with the 
setting 'XQQHWW¶V multiple comparisons test.    
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Chapter 3       Radiation sensitivity 
 
3.1 Introduction 
 
                In general, mutations can provide useful information 
for the study of gene functions. Mutations are commonly caused 
by radiation or mutagenic chemicals. Sometimes, they disrupt 
the function of the gene completely, but other mutations may 
reduce but not eliminate gene functions, or have no apparent 
phenotypic effect. The DNA repair mechanisms of an organism 
play an important role in protection against mutation-induced 
damage.  
 
              Mutagenesis is the process of inducing mutations 
in an organism¶V JHQRPH using well-established standard 
mutagenesis protocols, e.g. in Caenorhabditis elegans (Epstein 
et al. 1974), Drosophila (Chen et al. 1993), rat (Zan et al. 2003) 
and mouse (Coghill et al. 2002). There are three broad types of 
mutagenesis, namely target-selected, spontaneous, and induced 
mutagenesis. Target-selected mutagenesis is also known as site-
specific mutagenesis because it targets a particular sequence in 
a genome whose function is known. After mutagenesis these 
sequences have one or more mismatches which can be identified 
by sequence analysis (Donald 1997). Spontaneous mutagenesis 
is caused by natural radiation such as gamma irradiation, X-
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rays, radioactive decay, cosmic rays or UV light, or by naturally 
occurring genotoxic (DNA-damaging) chemicals. Induced 
mutagenesis is caused by chemicals such as 
ethylmethanesulfonate (EMS), diethyl sulphate (DES) and N-
nitroso-N-ethylurea (ENU) or by deliberate irradiation with any 
of the above²usually at doses far higher than those 
encountered naturally.  
3.1.1 Gamma radiation 
 
                       Gamma radiation is commonly used in 
Caenorhabditis elegans (Rosenbluth et al. 1985) to produce 
specific chromosome rearrangements such as translocations, 
duplications, inversions and deficiencies. Gammacell irradiators 
SURYLGHDODUJHGRVHRIǄ-rays to samples. The most commonly 
used radioisotopes in these irradiators are Cobalt-60 or 
Caesium-137. The equipment used to irradiate the worms 
employed Caesium-137, where gamma irradiation was used to 
generate permanent integrated transgenic lines (section 2.10). 
The worms were irradiated for different lengths of time to find 
the optimum dose required for chromosomal integration, 
resulting in 100% transmission of the transgene to progeny. The 
standard dose of gamma irradiation normally used for this 
purpose is between 2000 and 4000 rads (Rosenbluth et al. 
1985).  
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                 According to Baillie and others, X-rays can be used 
instead of gamma rays as they can cause mutations and 
rearrangements similar to gamma rays. The standard dose for X-
rays is between 500-5000 rads. According to previous studies, 
stable integrated lines were successfully generated by irradiating 
transgenic worms with 1500 R of X-rays (Gallo et al. 2006). 
3.2 Materials and methods 
3.2.1 Irradiation dose 
 
The unit of gamma radiation dose is the Gray 
(abbreviated as Gy) which represents the absorption of an 
average of one joule of energy per kilogram mass of the target 
material, where 1 Gray = 100 Rads. 
Central dose rate = 8.13 Gy/min 
           Since 1Gy =100 rads 
                            = 813 rads/min 
The central dose rate is calculated to be 813 rads/min. 
 
             All other materials and methods that are related to this 
section are described in chapter 2. 
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3.3 Results 
 
3.3.1 Gamma irradiation of Line 1:unc-54:: SV 
(NI)  Fusion worms strain at different dose rates
  
The aim of this experiment was to determine whether 
line 1: unc-54::SV worms are sensitive to gamma radiation and 
to attempt integration. To achieve this, line 1:unc-54::SV (Table 
2.13) worms were irradiated at different dose rates. The P0 
parental generation was screened to find whether there were 
any dead worms or worms which were alive but not laying eggs. 
The offspring (F1) from the P0 parental generation were again 
screened, and the same procedure was carried out for unc-54::V 
and wildtype N2 worms. These two different strains were used 
as a control for the unc-54::SV worms. 
 
In my previous MRes work (Bodhicharla, 2007), the 
dose-sterility curve of line 1: unc-54::SV worms was compared  
with wild type N2 and unc-54::V worms, and was shown to be 
far more radiation sensitive than either of the other strains. How 
this relates to toxicity caused by synuclein aggregation remains 
to be explored. A brief summary of these findings is given below 
(figure 3.1). 
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Figure 3.1: sterility dose curves (adapted from Bodhicharla, 2007). 
Transgenic and wild type N2 worms were exposed at different dose rates to 
determine their sensitivity to gamma irradiation. P0 is the parental generation 
and F1 is the offspring from the P0 generation. Worm exposure to gamma 
radiation was in minutes and then converted to rads (central dose rate 813 
rads/min). The x-axis is the log gamma radiation dose (rads) and the y-axis 
is the percentage sterility. Each point represents the percentage of worms 
found to be sterile or dead (Appendix 1). Part A is the dose response curve 
for the line 1: unc-54::SV (NI) transgenic worms, Part B is the dose 
response curve for wild type N2 worms, Part C is the dose response curve for 
the unc-54::V (NI) transgenic strain.  
 
A 
C 
B 
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When comparing the level of radiation-induced sterility in 
unc-54::V (NI) with the wild type N2 worms we found that unc-
54::V (NI) is similar to the control N2 worms and shows a 
greater radiation resistance than the unc-54::SV (NI) strain, 
resulting in lower induced sterility levels as the radiation dose 
incUHDVHV 7KHVH UHVXOWV VXJJHVW WKDW WKH LQFOXVLRQ RI DQ Į-
synuclein moiety in the SV fusion protein is in some way 
responsible for the unusual radiation sensitivity of the unc-
54::SV (NI) strain. The unc-54::SV (NI) strain was found to be 
significant statistically different from unc-54::V (NI) and N2 
worms at P0 and F1 generation (p<0.05 by non-linear regression 
curve).  
 
In order to investigate further, two further lines of unc-
54::SV (NI) transgenic worms were irradiated at different dose 
rates to find out whether they are consistently radiation 
sensitive. 
3.3.2 Gamma irradiation of Line 2 and 3: unc-54:: 
SV  (NI) Fusion worms strain at different dose 
rates 
This experiment was carried out in the same way as 
described above for line 1: unc-54::SV worms. The sterility dose 
curves for lines 2 and 3: unc-54::SV in the P0 and F1 
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generations (figure 3.2) show the classic pattern found for such 
curves, i.e. a linear relationship at low doses and a plateau at 
higher doses (Rosenbluth et al. 1983). Synuclein on its own is 
known to be toxic but the effects of its fusion to YFP and rapid 
aggregation in vivo are not knRZQ 2YHUDOO WKH HIIHFWV RI Ǆ-
irradiation on F1 sterility are greater than those on P0 sterility. 
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Figure 3.2: sterility curve of line 2 and 3 : unc-54::SV (NI). 
Lines 2 and 3:unc-54::SV (NI) worms were exposed at different dose rates to 
gamma irradiation to determine their sensitivity.  P0 is the parental 
generation and F1 is the offspring from the P0 generation. Each point 
represents the percentage of worms found to be sterile or dead (Appendix 1). 
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            However, on comparing the effects of gamma irradiation 
between lines 2 and 3: unc-54::SV (NI) P0 worms and wild type 
N2 P0 worms, we found little effect on the levels of sterility in P0 
worms. Figure 3.3 shows the level of sterility in the P0 
generation for line 2: unc-54::SV  (NI) and for N2 worms 
exposed to gamma radiation. The EC50 for line 2: unc-54::SV 
(NI)  was 39614 rads (95% CI = 22450 rads ± 69901 rads) and 
for N2 worms was 28833 rads (95% CI = 25230 rads ± 32949 
rads). Figure 3.4 shows the level of sterility in the P0 generation 
for line 3: unc-54::SV  (NI) and for N2 worms exposed to 
gamma radiation. The EC50 for line 3: unc-54::SV  (NI) was 
36392 rads (95% CI = 28865 rads ± 45881 rads) and for N2 
worms was 28833 rads (95% CI = 25230 rads ± 32949 rads). It 
can be seen from the analysis of the EC50s that there is a large 
overlap in the 95% confidence intervals demonstrating that the 
two are not significantly different from one another. This shows 
that there is no effect of gamma radiation in the P0 generation, 
which contrasts with my earlier findings for line 1: unc-54::SV 
(NI)  (section 3.3.1) 
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Figure 3.3: comparing the sterility curve of line 2: unc-54::SV (NI) 
with N2 worms. Line 2:unc-54::SV (NI) worms were compared with wild 
type N2 worms in terms of sensitivity to gamma irradiation. It was found that 
there was no statistical difference between line 2:unc-54::SV (NI) and wild 
type N2 worms in the P0 generation but a highly significant difference in the 
F1 generation. 
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F1 Sterility curve
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Figure 3.4: comparing the sterility curve of line 3: unc-54::SV (NI) 
with N2 worms. Line 3:unc-54::SV (NI) worms were compared with wild 
type N2 worms in terms of sensitivity to gamma irradiation. It was found that 
there was no statistical difference between line 3:unc-54::SV (NI) and wild 
type N2 worms in the P0 generation but a highly significant difference in the 
F1 generation. 
 
 
Even so, when comparing the effect of gamma irradiation 
between lines 2 and 3: unc-54::SV (NI) F1 worms and wild type 
N2 F1 worms, we found evidence for a significant difference 
between these strains in terms of the levels of sterility in the F1 
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generation as compared to P0. Figure 3.3 shows the level of 
sterility in the F1 generation for line 2:unc-54::SV  (NI) and N2 
worms exposed to gamma radiation. The EC50 for line 2:unc-
54::SV  (NI) was 9505 rads (95% CI = 6105 rads ± 14800 rads) 
and for N2 worms was 18051 rads (95% CI = 15450 rads ±
21091 rads). Figure 3.4 shows the level of sterility in the F1 
generation for line 3:unc-54::SV  (NI) and N2 worms exposed to 
gamma radiation. The EC50 for line 3:unc-54::SV  (NI) was 8518 
rads (95% CI = 4987 rads ±14551 rads) and for N2 worms was 
18051 rads (95% CI = 15450 rads ±21091 rads). It can be seen 
from the analysis of the EC50s that there is no overlap in the 
95% confidence intervals demonstrating that the two are 
significantly different from one another. Furthermore the data 
shows that the EC50 for sterility is doubled in line 2 and 3:unc-
54::SV  (NI) as compared to wild type N2 worms. 
3.3.4 Comparison of Gamma radiation sterility 
between transgenic and wild type strains 
The effects of gamma irradiation on sterility in the P0 
generation for all transgenic worm strains gave similar results to 
those obtained with wild type N2 worms. Figure 3.6 shows the 
level of sterility (P0 generation) of all transgenic strains and for 
N2 worms when exposed to gamma radiation.  
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Strains EC50s 95% CI 
unc-54::SV (NI) 39614 rads 22450 rads ± 69901 rads 
unc-54::S+V (NI) 37863 rads 26801 rads ± 53489 rads 
unc-54::SC+SV (NI) 54907 rads 27075 rads ± 111350 rads 
unc-54::V (NI) 32118 rads 31557 rads ± 36288 rads 
N2 28833 rads 25230 rads ± 32949 rads 
 
Table 3.1: EC50 analysis for all transgenic strains and N2 worms in P0 
generation. 
 
 
It can be seen from these EC50s that the 95% confidence 
intervals overlap greatly, demonstrating that they are not 
significantly different from one another. This shows that there is 
no effect of gamma radiation in the P0 generation.                                 
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Figure 3.5: sterility curve of transgenic strains compared with wild 
type N2 worms in the P0 generation. Transgenic and wild type N2 worms 
were exposed at different dose rates to determine their sensitivity to gamma 
irradiation. P0 is the parental generation. Each point represents the 
percentage of worms found to be sterile or dead (Appendix 1).  
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Figure 3.6 shows the level of sterility in the F1 generation 
for all transgenic strains and for N2 worms when exposed to 
gamma radiation.  
Strains EC50s 95% CI 
unc-54::SV (NI) 9505 rads 6105 rads ± 14800 rads 
unc-54::S+V (NI) 8364 rads 4451 rads ± 15719 rads 
unc-54::SC+SV (NI) 11614 rads 8818 rads ± 15296 rads 
unc-54::V (NI) 18263 rads 18258 rads ± 18268 rads 
N2 18051 rads 15450 rads ± 21091 rads 
 
Table 3.2: EC50 analysis for all transgenic strains and N2 worms in F1 
generation. 
 
It can be seen from the analysis of these EC50s that there 
is no overlap in the 95% confidence intervals between those 
VWUDLQV FDUU\LQJ Į-synuclein constructs and those that do not, 
demonstrating that all the synuclein-expressing transgenic 
worms are significantly different from both wild type N2 worms 
and unc-54::V (NI) worms.  
 
Gamma radiation therefore has a drastic effect on the 
levels of sterility in the F1 generation when comparing synuclein-
expressing transgenic worms and wild type N2 worms or 
transgenic strains lacking synuclein.  
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F1 Sterility curve
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Figure 3.6: sterility curve of transgenic strains compared with wild 
type N2 worms in the F1 generation. Transgenic and wild type N2 worms 
were exposed at different dose rates to determine their sensitivity to gamma 
irradiation.  F1 is the offspring from the P0 generation. Each point represents 
the percentage of worms found to be sterile or dead (Appendix 1).  
3.3.5 Generating permanent integrated 
transgenic lines 
                 The following transgenic lines were selected for 
integration: 
x unc-54:: SV (NI) 
x unc-54:: V (NI) 
x unc-54:: C (NI) 
x unc-54:: S+V (NI) 
x unc-54:: SC+SV (NI) 
x unc-54:: CV (NI) 
x unc-54:: C+V (NI) 
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The integration procedure described in section 2.10 was carried 
out for all the above listed transgenic lines. Permanent 
integrated transgenic lines were successfully generated for unc-
54::S+V (I), unc-54::V (I), unc-54::C+V (I), unc-54::CV (I)  
and unc-54::SC+SV (I), but not for unc-54::SV (NI) and unc-
54::C (NI), which were attempted but without success. As 
illustrated by pictures in figure 3.7 (below) of the unc-54::C+V 
(I) strain, all integrated worms showed YFP and/or CFP 
fluorescence.  
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Figure 3.7: Permanent integrated transgenic lines 
Permanent integrated transgenic lines were obtained for unc-54::S+V (I), 
unc-54:: V (I), unc-54::C+V (I), unc-54::CV (I) and unc-54::SC+SV (I) 
using the protocol described in Materials and Methods section 2.10. As an 
illustration of the fluorescence patterns obtained, parts A and B show that the 
CFP (A) and YFP (B) fluorescence is diffused throughout the body wall 
muscles of unc-54::C + V (I) worms.  
 
A 
B 
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3.4 Discussion 
          . Based on the above results, line1:unc-54::SV (NI) was 
found to be more radiation sensitive than wild-type N2 worms 
(figure 3.1). In order to confirm that these worms are indeed 
sensitive to radiation due to the presHQFHRIĮíV\QXFOHLQsimilar 
experiments were performed on two further lines of unc-54::SV 
(NI)  worms (line 2 and 3), providing similar results in both 
cases. To prove further that the radiation sensitivity of the 
transgenic lines was due to the presence RI ĮíV\QXFOHLQ ZLOG
type N2 worms were also subjected to gamma irradiation and 
shown to be significantly more resistant in the F1 (but not P0) 
generation. There is a possibility that radiation sensitivity might 
be due to generating transgenic worms rather than the presence 
RI ĮíV\QXFOHLQ ,Q RUGHU WR test this hypothesis, transgenic 
VWUDLQV WKDW GR QRW H[SUHVV ĮíV\QXFOHLQ were also exposed to 
gamma irradiation and shown to be similar to wild type N2 
worms. This suggests that in terms of radiation sensitivity in the 
F1 generation our ĮíV\QXFOHLQ WUDQVJHQLF VWUDLQV are 
significantly more sensitive to radiation. The effect of gamma 
irradiation on the sterility of these worms in the P0 generation 
was similar to that of the N2 control (not statistically significant) 
whereas the F1 generation showed a large effect (P<0.05; using 
non-linear regression curve). 
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In general, gamma irradiation causes DNA strand-breaks 
WKDW DUH RIWHQ UHSDLUHG E\ WKH FHOO¶V '1$ UHSDLU V\VWHPV '1$
repair systems work well after low radiation-dose exposure but 
are much less efficient following high radiation-dose exposure²
and the damage caused by very high doses may not be 
repairable at all. There is also evidence (Herman 1978; Meneely 
and Herman 1979) that high doses cause a great deal of sterility 
among the F1 generation in C.elegans. Interestingly, my results 
show that even at relatively low doses of gamma irradiation, 
Įísynuclein transgenic strains were found to be sterile, in F1 
generation. Therefore, it could be speculated that presence of 
Įísynuclein aggregation in the cell may contribute via a yet 
unknown mechanism(s), to render these transgenic worms 
sensitive to irradiation. Also, another possibility is that the 
presence of Įísynuclein DNA as a transgene in the gonads may 
compromise the DNA repair machinery during irradiation 
mediated integration. As a result, the F1 and may be F2 
generation might have aneuploid genome causing sterility or 
even lethality. To understand, if this epigene (Įísynuclein) may 
be toxic to the cell, a control experiment using sham DNA could 
be parallel injected into the gonads and F1 observed for sterility. 
However, further experiments will have to be performed to study 
the actual status of DNA repair systems of these transgenic 
worms upon exposure to gamma irradiation.  
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Chapter 4    Behavioral changes 
triggered by synuclein expression 
in transgenic worms 
4.1 Introduction  
 
 
                 Nearly all animals undergo weakening of muscle 
strength due to normal aging, leading to functional disorders of 
motility. Even though the apparent changes in motility during 
aging are clear, very little is known about the cellular changes 
that are linked with aging and motility disorder in vertebrates 
(Kamel 2003). Therefore, to study such a complex mechanism, a 
simpler model organism would be ideal. Carnorhabditis elegans 
was selected as an experimental model to study development 
and behavior (Brenner 1974), and particularly motility and 
longevity (Guarente and Kenyon 2000).  
 
            Ageing also has an effect on general motor functions 
such as pharyngeal pumping.  The nematode C.elegans has a 
neuromuscular organ called the pharynx, which is situated in the 
head region. The pharynx is a complex organ composed of 9 
marginal cells, 5 gland cells, 5 epithelial cells, 20 neurons and 34 
muscle cells (Albertson and Thomson 1976). Several other soil 
nematodes including C.elegans, feed on bacteria such as E.coli in 
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laboratory culture. The rhythmic contraction of the pharynx 
(pharyngeal pumping) is used for pumping food into the 
digestive tract of the worm. Since C.elegans is a transparent 
animal, this process can be observed under a light microscope. 
The number of times the pharynx pumps is ~ 200- 300 times/ 
min in a young adult, but gradually decreases during aging 
(Bolanowski et al. 1981; Huang et al. 2004).  
 
Figure 4.1: C.elegans Pharynx (picture from Haun et al. 1998). 
4.2 Materials and methods 
             All the materials and methods that are related to this 
section are described in chapter 2. 
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4.3 Results 
4.3.1 Life cycle analysis for all transgenic strains 
and N2 worms 
Life cycle analysis was done at 20ºC to find out how 
much time the worm needs to grow from egg to egg laying 
adult. From this data it was confirmed that all the strains took 
70 ± 80 hrs to reach adulthood, and there were no statistically 
VLJQLILFDQW GLIIHUHQFH EHWZHHQ VWUDLQV S! 'XQQHWW¶V WHVW
against N2 as control). 
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Figure 4.2: Life cycle analysis for all transgenic strains and N2 worms 
4.3.2 Brood size analysis for all transgenic strains 
and N2 worms 
 
Analysis of brood size was done to check whether all the 
transgenic strains were similar or different to wild type N2 
worms. It was confirmed that the brood sizes for all the strains 
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were close to 300 thus confirming that they are all normal (Hirsh 
et al. 1976). There were no statistically significant difference 
EHWZHHQVWUDLQVS!'XQQHWW¶VWHVWDJDLQVW1DV control). 
Refer to Appendix 1 for detailed analysis. 
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Figure 4.3: Life cycle analysis for all transgenic strains and N2 worms 
4.3.3 Sterility analysis for all transgenic strains 
and N2 worms 
Mid-L4 larvae of eight different strains of worms were 
grown for 48 h and scored for embryo production. For each 
strain, 20 animals were scored. We found that none of their 
progeny were sterile. From this data it was confirmed that all 
these transgenic strains at least were normal in respect to 
fertility. 
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Strains % steriltiy 
unc-54::SV (NI) 0 
unc-54::SC+SV (I) 0 
unc-54::V (I) 0 
unc-54::C (NI) 0 
unc-54::CV (I) 0 
unc-54::C+V (I) 0 
N2 0 
Table 4.1: Sterility analysis for all transgenic strains and N2 worms 
 
4.3.4 Life span analysis of line 2: unc-54::SV (NI) 
 
                This aim of this experiment was to determine whether 
line 2:unc-54:SV (NI) worms have a shorter life span. Life span 
was measured at 20 °C on standard nematode growth medium 
(NGM) agar plates. The life span of each worm was then 
calculated from egg until death. Worm survival was assayed 
using 25 worms per line as described in Materials and Methods. 
The survival fraction (i.e. percent remaining alive) is plotted 
against total life time in days in figure 4.4. This experiment 
concluded that line 2:unc-54:SV (NI) worms have a shorter 
maximum life span of 14 days as compared with N2 (19 days). 
 
The life span of line 2:unc-54::SV (NI) worms at 20 °C is 
significantly reduced when compared to wild type N2 worms. The 
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statistical significance of the difference between N2 and line 
2:unc-54::SV (NI) was determined using the Mantel-Cox test, 
and the difference between them was found to be highly 
significant (P<0.0001). 
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Figure 4.4: Longevity of line 2: unc-54::SV  (NI) worms 
25 Synchronized L4 line 2:unc-54:SV (NI) worms were picked onto a NGM 
plate. After 2 hours of incubation when they begin to lay eggs, the date and 
the time were noted. The life span of each worm was then calculated from 
egg until death. The worms were monitored on a daily basis. Once the worms 
were identified as dead, the date and time were noted. A graph was plotted 
showing the percent alive against time. 
 
4.3.5 Life span analysis of line 3: unc-54::SV (NI) 
 
Similarly the life span of line 3:unc-54:SV (NI) was 
measured using the same procedure (figure 4.5). The life span 
of line 3:unc-54::SV (NI) worms at 20 °C is also significantly 
reduced when compared to wild type N2 worms. The statistical 
significance of the difference between N2 and line 3:unc-54::SV 
(NI)  was determined by the Mantel-Cox test, and the difference 
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between them was again found to be highly significant 
(P<0.0001).   
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Figure 4.5: Longevity of line 3: unc-54::SV  (NI) worms 
The life span of each synchronized L4 staged worm was calculated from egg 
until death. The graph shows percent alive against time. 
 
4.3.6 Comparison of life span between transgenic 
and wild type strains       
                Figure 4.6 compares the life spans of all transgenic 
worms lacking synuclein (V, CV and C+V) with wild type N2 
worms at 20 °C. We found that the lifespan of these transgenic 
worms was similar to that of wild type N2 worms. Using the 
Mantel-Cox test, these transgenic worms were found not to be 
statistically significantly different from N2 worms (P > 0.05). The 
3 lines expressing one or both fluorescent markers (V, CV and 
C+V) showed only a slight (1-2 day) and non-significant (p = 
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0.08, 0.137 and 0.555; Mantel-Cox test) reduction in lifespan as 
compared to N2 worms. 
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Figure 4.6: Longevity of different transgenic strains lacking synuclein 
compared with wild type N2 worms. The life span of each synchronized 
L4 staged worm was calculated from egg until death. The graph shows 
percent alive against time.  
 
 
Figure 4.7 compares the life spans of all synuclein 
expressing transgenic worms with wild type N2 worms at 20 °C. 
We found that the lifespan of synuclein-expressing transgenic 
worms was significantly reduced when compared to wild type N2 
worms. Using the Mantel-Cox test, the life spans of synuclein 
expressing transgenic worms were found to be statistically 
significantly different from  N2 (P <0.0001). The 3 lines 
H[SUHVVLQJĮ-synuclein (S+V, SV and SC+SV) showed a marked 
decrease of ~5 days in lifespan as compared to N2 (P <0.0001 
fpr all 3 strains; Mantel-Cox test). Therefore over-expression of 
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Į-synuclein in these worms caused significant toxicity and 
reduced lifespan. 
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Figure 4.7: Longevity of synuclein expressing transgenic strains 
compared with wild type N2 worms.  The life span of each synchronized 
L4 staged worm was calculated from egg until death. The graph shows 
percent alive against time.  
 
This might be due to the aggregation of synuclein on its 
own or as a fusion protein, possibly affecting lifespan either 
directly or indirectly (e.g. through reduced motility and/or 
pharyngeal pumping rate; see sections 4.3.7 and 4.3.8) 
4.3.7 Comparison of locomotion rate between 
transgenic and wild type strains 
                   Locomotion rate was averaged across 25 individual 
worms, as determined by the number of bends each worm 
performs in 30 seconds (see Materials and Methods section 
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2.13). From the results obtained we found that transgenic 
synuclein-expressing worms have a slower locomotion rate as 
compared with the transgenic strains lacking synuclein or wild 
W\SH1ZRUPV8VLQJ'XQQHWW¶VPXOWLSOHFRPSDULVRQs test, the 
transgenic synuclein worms (S+V, SV and SC+SV) were 
compared with the control wild type N2 worms and found to be 
statistically significantly different (P<0.001 for all 3 strains), 
whereas the strains lacking synuclein (V, CV  and C+V) were not 
(P> 0.05).         
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Figure 4.8: Locomotion rate of different transgenic strains compared 
with wild type N2 worms. 10 adult worms were picked onto a bacteria free 
plate. The locomotion rates were determined by the number of bends each 
worm performs in 30 seconds.  
4.3.8 Comparison of Pharyngeal pumping rates 
between transgenic and wild type strains 
                   Pharyngeal pumping rates were measured for 25 
individual worms for 1 minute each as described in Materials and 
Methods (section 2.14). From the results obtained we found that 
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transgenic synuclein-expressing worms have slower pharyngeal 
pumping rates when compared with the transgenic strains 
lacking synuclein or with ZLOG W\SH1ZRUPV8VLQJ'XQQHWW¶V
multiple comparisons test, the transgenic synuclein worms (S+V, 
SV and SC+SV) were compared with the control wild type N2 
worms and they were found to be statistically significantly 
different (P<0.01, P<0.001, P<0.05), whereas the strains 
lacking synuclein (V, CV  and C+V) were not (P> 0.05).          
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Figure 4.9: Pharyngeal pumping rates of different transgenic strains 
compared with wild type N2 worms. 10 adult worms were picked onto a 
bacteria free plate. The pharyngeal pumping rates was observed for each 
worm for 1 minute.   
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4.3.9 SDS-3$*(DQG:HVWHUQ%ORWWLQJWRGHWHFWĮ-
synuclein expression. 
 
             Two SDS-PAGE (sodium dodecylsulfate polyacrylamide 
gel electrophoresis) gels were run followed by Western blotting 
to identify WKHĮ-synuclein protein using primary and secondary 
antibodies. Total proteins were extracted from unc-54::SC+SV 
(I), unc-54::S+V (I) and unc-54::SV (NI) strains. These protein 
samples were run on a 15% SDS gel and stained with Coomassie 
blue, as described in Materials and Methods. The proteins were 
then transferred from a parallel gel onto a PVDF membrane.  
 
 
Figure 4.10: SDS- PAGE and Western Blotting to detect Į-synuclein 
SDS-PAGE followed by Western blotting to detect WKH Į-synuclein protein. 
Molecular weight markers shown in lane M; Lanes 1, 3 and 5 show the stained 
Coomasie gel of SC+SV, S+V and SV strains. Lanes 2, 4 and 6 show the 
parallel lanes of SC+SV, S+V and SV strains following Western blotting and 
probing for Į-synuclein.  
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            )LQDOO\:HVWHUQEORWWLQJZDVXVHGWRGHWHFWĮ-synuclein 
among the total proteins extracted from these 3 transgenic 
strains. In figure 4.10 the sizes of the major bands identified by 
the antibody are indicated as 47 kD (SV/SC) and 19 kD (S 
alone), as estimated from the molecular weight marker lane (M). 
The cartoon shown previously in the introduction (Figure 1.6) 
illustrates the construction of the fusion proteins, where the 
expected sizes RI Į-synuclein (S; 19.3 kD DQG Į-synuclein 
fusion proteins (SV and SC; 46.5 kD) are shown. The Western 
blot in lane 2 of the SC+SV fusion strain shows the expected 
fusion protein size of ~47 kD together with a small amount of 
cleDYHG PRQRPHULF Į-synuclein (19 kD) also present. Lane 4 
similarly shows monomeric synuclein from the S+V strain at the 
expected protein size of ~19 kD. Finally, lane 6 shows again the 
expected fusion protein size of ~47 kD for the SV fusion strain, 
together with some cleaved monomHULFĮ-synuclein. The cleaved 
PRQRPHULF Į-synuclein was not our main concern because the 
PDMRULW\RIĮ-synuclein protein expressed in the SC+SV and SV 
worms remains in the CFP-/YFP-tagged fusion form. 
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4.4 Discussion 
 
           This chapter shows that our ĮíV\QXFOHLQ WUDQVJHQLF
strains are characterized by a reduction in pharyngeal pumping, 
motility and life span. Other parameters such as life cycle, brood 
size and sterility are not affected in these strains. In order to 
confirm that the above mentioned changes are indeed due to the 
HIIHFW RI ĮíV\QXFOHLQ SDUDOOHO H[SHULPHQWVwere carried out on 
wild type N2 worms. Also, Western blotting was used to confirm 
the expression RI LQWDFW ĮíV\QXFOHLQ SURWHLQ (with or without 
reporter tags) in these transgenic worms. Using anti-
ĮíV\QXFOHLQ, some cleavage of the WDJJHG ĮíV\QXFOHLQ was 
inferred from the presence of a smaller band at ~19kD in lanes 2 
and 6 of figure 4.10. However, in this worm model, the problem 
of cleavage appears much less than that observed by McLean et 
al. (2001) using GFP-tagged ĮíV\QXFOHLQ fusions expressed in 
transfected cultures of mouse primary neurons. 
 
           Interestingly, these results show changes in cellular 
characteristics pertinent to neurodegeneration in human 
FRQGLWLRQV VXFK DV 3DUNLQVRQ¶V GLVHDVH. Since these effects are 
observed in ĮíV\QXFOHLQ WUDnsgenic worms, one could plausibly 
DWWULEXWH WKHVH HIIHFWV WR ĮíV\QXFOHLQ aggregation. However, a 
small but significant reduction (~20%) in pharyngeal pumping is 
also observed in these transgenic worms, which is unlikely to be 
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a GLUHFW HIIHFW RI ĮíV\QXFOHLn expression, because the 
ĮíV\QXFOHLQ LV H[SUHVVHG LQ WKH ERG\ ZDOO PXVFOHV XQGHU WKH
control of unc-54 promoter, whereas other major myosin genes 
(such as myo-2) are expressed in the pharynx. Reduced 
pharyngeal pumping has been previously reported in ageing 
animals (Bolanowski et al. 1981; Huang et al. 2004). One of the 
several contributing factors is structural deterioration of the 
pharynx muscles (Garigan et al. 2002; Herndon et al. 2002). It 
has also been suggested that cellular damage due to stress 
(such as ROS byproducts and mitochondrial dysfunction) may 
cause a decline pharyngeal pumping rate (Chow et al. 2006). 
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Chapter 5     Forster Resonance 
Energy Transfer (FRET) 
5.1 Introduction 
            FRET is a well-known technique for investigating the 
interactions between two proteins labeled with different 
fluorophores, and can be performed in vitro or in vivo.  
               In our FRET experiments, we used two colour variants 
of GFP, Cerulean Fluorescent Protein (CFP) and Yellow 
Fluorescent Protein (YFP) as donor and acceptor. Transfer of 
energy takes place from an excited donor to an adjacent 
acceptor. CFP and YFP protein interactions allow bimolecular 
fluorescence by means of exchange of energy from CFP to YFP 
(Miyawaki 2003; Zhang et al. 2004).  
 
Figure 5.1: Excitaiton and emission wavelengths for CFP and YFP 
Rakesh Kumar Bodhicharla 
124 
 
              A FRET signal can be observed by exciting the CFP 
fluorophore at 440nm using a CFP excitation filter, and the 
emission from YFP is captured using a YFP emission filter at 
~545nm. These are the two types of filter combinations which 
we used for FRET, and are called FRET channels.  
 
Figure 5.2: Mechanism of FRET 
               Two conditions are obligatory for obtaining a FRET 
signal:  
(i) The CFP and YFP fluorophores must be very close to each 
other (<70 Å). (ii) The proteins are properly adjusted to 
facilitate dipole±dipole interactions between fluorophores, for 
which they must be parallel to each other so that the transfer of 
energy takes place between these fluorophores (Miyawaki and 
Tsien 2000; Miyawaki 2003).        
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              In the unc-54::SC+SV (I) strain, genes encoding the 
two colour variants of GFP (CFP and YFP) are incorporated into 
the genome of C. elegans as gene-fusions to the human 
ĮíV\QXFOHLQ coding sequence, such that the CFP and YFP 
moieties are fused to the C-terminus of the synuclein protein 
sequence in both cases.  Both fusion genes are abundantly 
expressed in the body-wall muscles, as a result of using the unc-
54 major myosin promoter. However, the CFP and YFP can only 
interact when the Į-synuclein moieties come close together (<70 
Å) in the form of protein aggregates, producing FRET signals 
when the fluorophores are oriented parallel to each other.  
 
Figure 5.3: Protein-protein interaction (adapted from Zhang et al. 2002). 
CFP and YFP can only interact when the DWWDFKHGĮ-synuclein moieties come 
close together in the form of aggregates, producing FRET signals.  
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FRET measurements can be done in two different ways: 
1. Direct measurement of FRET 
2. Indirect measurement of FRET 
                     When two protein fluorophores are close enough, 
transfer of energy takes place from the donor to the acceptor 
and hence the intensity of donor fluorescence is reduced in the 
process. However, when the acceptor is photobleached it blocks 
the transfer of energy from the donor to acceptor resulting in 
increased donor fluorescence intensity. Measuring the intensity 
of donor fluorescence before and after acceptor photobleaching 
is an indirect method for measuring FRET signals. On the other 
hand, direct FRET measurement can be done by measuring the 
acceptor emissions in the presence or absence of excitation for 
the donor (Brignull et al. 2006). In our experiments we used this 
direct mode of measuring FRET signals on a standard microplate 
fluorometer (Wallac Victor 1420 Multilabel Counter) equipped 
with narrow bandpass filters for CFP excitation (430nm) and YFP 
emission (530nm). This also allows us to quantify the FRET 
signal.  
5.2 Materials and methods 
             All Materials and Methods related to this section are 
described in chapter 2. 
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5.3 Results 
5.3.1 FRET analysis for all transgenic strains    
            Alpha-synuclein has a known tendency to aggregate in 
vivo, as shown in previous studies using transgenic worms 
(Brignull et al. 2006; van Ham et al. 2008). The objective of this 
work is to show that synuclein aggregation can be monitored in 
unc-54::SC+SV (I) worms using FRET. Synchronized young 
adult worms were washed off the plate and transferred in equal 
aliquots into a microplate. Each well usually has around 1-2000 
worms ±but the range in worm numbers between replicates for 
any given strain is only ±5% (see 2.18). A standard microplate 
fluorometer (Wallac Victor 1420 Multilabel Counter) was used 
with an excitation wavelength of 430nm for CFP and an emission 
wavelength of 530nm for YFP. All data have been normalized per 
1000 worms for each strain. As shown in figure 5.4, the FRET 
signal from wildtype N2 (control) worms was very low when 
compared with the other transgenic strains. The unc-54::C (NI) 
strain expressing CFP and unc-54:V strain expressing YFP 
showed a low level of FRET signal that was nevertheless 
considerably higher than N2 worms. This represents a minority 
of the emissions spilling over into the YFP emission range (for 
unc-54::C (NI)), or some part of the CFP excitation causing 
direct excitation of the YFP (for unc-54:V (I)). Only 1% of the 
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YFP signal shows through in the CFP channel when excited for 
YFP, whereas 30-35% of the CFP signal shows through in the 
YFP channel when excited at CFP. This is unavoidable using the 
filters we had available from PerkinElmer.  The negative control 
unc-54::C+V (I) worms expressing both CFP and YFP showed a 
slight increase in the FRET signal when compared with unc-54:C 
(NI)  and unc-54:V (I). The positive control unc-54::CV (I)  
expressing CFP fused with YFP in the same construct showed a 
very high FRET signal when compared with the other transgenic 
strains ± since the CFP donor and YFP acceptor are always in 
very close proximity. The unc-54::SC+SV (I) worms showed 
FRET signals intermediate between the negative and positive 
control strains. This suggests that both CFP and YFP moieties 
may be EURXJKW FORVH WRJHWKHU GXH WR WKH DJJUHJDWLRQ RI Į-
synuclein in this double transgenic strain.    
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Figure 5.4: FRET signal for all transgenic strains. Using a standard 
microplate fluorometer (Wallac Victor 1420 Multilabel Counter), the FRET 
signal was measured by excitation at a wavelength of 430nm for CFP and 
measuring emission at a wavelength of 530nm for YFP. C, V and N2 are 
controls; C+V is the negative control, CV is the positive control. The FRET 
signal for SC+SV is intermediate between the negative and positive controls. 
The graph is normalized per 1000 worms for each strain. 
 
5.3.1.1 Confocal microscopy of unc-54::SC+SV (I)  
showing  FRET 
            The unc-54::SC+SV (I) and the control unc-54::C (NI) 
worm pictures were taken using a Leica TCS SP2 Confocal Laser 
Scanning Microscope (CLSM) with Z-stacking to confirm FRET in 
unc-54::SC+SV (I) worms. A 458nm laser was used to excite 
CFP which in turn excites YFP giving the CFP and FRET images 
shown in part A (panels i and ii) for unc-54::SC+SV (I) worms. 
Subsequently, a 514nm laser was used to excite the YFP 
directly, although no CFP can be seen (part A panels iv and v). 
To confirm that FRET in unc-54::SC+SV (I) worms was not due 
to crossover, unc-54::C (NI) worms were also used. Again 
Rakesh Kumar Bodhicharla 
130 
 
458nm laser was used to excite CFP, but there is no sign of FRET 
in unc-54::C (NI) worms because of the absence of YFP (part B 
panels i and ii). A 514nm laser was used but in the absence of 
YFP no fluorescence could be observed for either CFP or YFP 
(part B, panels iv and v). 
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Figure 5.5: Confocal microscopy of unc-54:: SC+SV (I) and unc-54:: C 
(NI). (A) unc-54::SC+SV worms showing FRET signal (B) control unc-54::C 
worms showing the absence of FRET signal. All photographs comparing two 
conditions used the same gain settings:- pinhole=0.9 airy doses (long Z-
depth), point spread function (PSF) = 0.451 µm in Z sampled into PMT#2 
gain 837.0 V, offset 1.8%,  PMT#3 gain 677.0 V, offset -1.1%, Transmission 
DIC gain 170.2V, offset -2.5%, scale bar=100µm.     
 
 
B 
A 
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5.3.1.2 Confocal microscopy of unc-54:: SC+SV 
(I) 
 
            Pictures of unc-54::SC+SV (I) worm were taken using 
the same confocal settings as above (5.3.1.1) WRFRQILUPWKDWĮ-
synuclein is aggregating inside the worm to bring the CFP and 
YFP moieties close together. Figure 5.5 shows the head region of 
a young adult worm expressing both CFP (A) and YFP (B), 
showing fluorescent granular aggregates. 
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Figure 5.6: Confocal microscopy of unc-54:: SC+SV (I) 
Head region of a young adult worm with Z-stacking for CFP (A) and YFP (B), 
showing aggregated fluorescent granules. The excitation and emission 
wavelength of CFP and YFP used in the confocal microscope to capture images 
are 458/485 and 514/545. Photographs comparing these two conditions used 
the same gain settings:± pinhole=0.9 airy doses (long Z-depth), point spread 
function (PSF) = 0.451 µm in Z sampled into PMT#2 gain 460.4 V, offset 
2.4%, lens=63x 1.25NA oil apochromat, scale bar=100µm. 
A 
B 
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5.3.1.3 Confocal microscopy of unc-54:: SV+C 
(NI) 
            Pictures of unc-54::SV+C (NI) worm were taken using 
the same confocal settings as above (5.3.1.1) to confirm that 
synuclein tagged with YFP is aggregating inside the worm 
whereas CFP show a diffuse distribution along the body wall 
muscles.  
 
 
            
Figure 5.7: Confocal microscopy of unc-54:: SV+C. (A) Shows the head 
region of a young adult worm showing diffuse CFP and YFP aggregates (B) 
The head region of the worm is magnified (x40) to show aggregated 
fluorescent granules of YFP and diffuse CFP. The excitation and emission 
wavelength of CFP and YFP used in the confocal microscope to capture images 
are 458/485 and 514/545. All photographs comparing two conditions used 
the same gain settings:± pinhole=2.75 airy doses (long Z-depth), point 
spread function (PSF) = 1.379 µm in Z sampled into PMT#2 gain 610.7 V, 
offset 1.4%,  PMT#3 gain 710.1 V, offset -0.4%, zoom=12.3, scale 
bar=100µm. 
A 
B 
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 Figure 5.7 part (A) shows the head region of a young adult 
worm showing diffuse CFP (panel i), YFP-tagged synuclein 
aggregates (panel ii) and merged image showing CFP together 
with aggregate YFP (panel iii). Part (B) shows another worm 
under 40 x magnification, where the head region of the worm is 
enlarged to show fluorescent YFP-tagged aggregates (panel ii) 
and diffuse CFP fluorescence (panel i). 
 
5.3.2 FRET Analysis for unc-54::SC+SV (I) fusion 
worms and YFP fluorescence for NL5901 in terms 
of aging 
              We measured the FRET signal from synchronized L4 
larvae through the first few days of adult life. As shown in figure 
5.8 Part (A), we observed a >3 fold increase in FRET signal, 
which was maintained through several days of adult life. This 
shows that, as the worms grows from the larval L4 stage to 
adulthood, the aggregatiRQRIĮ-synuclein increases rapidly. The 
PHFKDQLVPV XQGHUO\LQJ WKLV VXGGHQ RQVHW RI Į-synuclein 
aggregation in young SC+SV adults require further investigation. 
In Part (B), worms of the NL5901 strain (which are similar to our 
unc-54::SV strain but fully integrated; van Ham et al. 2008) 
showed only a slight (~30%) increase in YFP fluorescence. This 
might be due to the expression of the unc-54 gene during the 
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early adult stage, but cannot account for the much larger 
increase in FRET signal (Part A). Because filtration was required 
to remove small larvae from the adult population, some worm 
losses are inevitable; this probably accounts for the slight drop 
seen after 5 days in part A, and possibly for the larger drop seen 
in part B (which may also reflect reduced unc-54 gene 
expression in mature adults). 
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Figure 5.8: FRET signal for unc-54::SC+SV (I) and YFP fluorescence 
for NL5901 strains from the larval L4 stage through the first few days 
of adult life. The FRET signal was measured for larval L4 stages of unc-
54::SC+SV (I) strain and YFP fluorescence for NL5901 strain. After 2 and 4 
days (once the worms reached adulthood) the FRET signal was again 
measured for unc-54::SC+SV (I) worms and YFP fluorescence for NL5901 
worms using the same worm population.  
 
A 
B 
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5.3.2.1 Confocal microscopy of unc-54:: SC+SV 
(I)  during the larval L4 and adult stage 
               Confocal images of unc-54::SC+SV (I) worms were 
captured as above (5.3.1.1), showing that Į-synuclein 
aggregates rapidly between the larval L4 stage and adulthood.  
Figure 5.9 part (A) shows small granules of aggregated YFP-
ODEHOOHGĮ-synuclein along the body wall muscles of a larval L4 
stage worm, whereas part (B) shows a clear increase in the size 
and intensity of such aggregates (after merging together) as the 
worms mature from L4 larvae to adults.  
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Figure 5.9: Confocal microscopy of unc-54:: SC+SV (I) larval L4 and 
adult stage. Body wall muscles of a Larval L4 stage worm with Z-stacking for 
YFP (A), showing small fluorescent granules; (B) showing larger granules 
along the body wall muscles of an adult worm. The excitation and emission 
wavelength of YFP used in the confocal microscope to capture images are 
514/545. All photographs used the same gain settings:- pinhole=0.9 airy 
doses (long Z-depth), point spread function (PSF) = 0.451 µm in Z sampled 
into PMT#2 gain 460.4 V, offset 2.4%, scale bar=100µm. 
B 
A 
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5.3.3 Effect of RNAi against Hip-1 for unc-54:: 
SC+SV (I) fusion worms.  
 
           Roodveldt et al (2009) used RNA interference (RNAi) to 
target the co-chaperone Hip-1 (T12D8.8) to knock down its 
function, and showed that this could promote an increase in the 
number of YFP-WDJJHG Į-synuclein inclusions in the OW40 
(effectively unc-54::SV) transgenic strain. However, this effect 
was only apparent in second-generation RNAi worms due to 
maternal expression of the Hip-1 gene (Roodveldt et al. 2009). 
In the experiment shown below, Hip-1 RNAi bacteria were fed 
continuously from the L1 stage of P0 worms for 2 generations in 
order to block Hip-1 function effectively.  Parallel control worms 
were fed with HT115 bacteria containing the empty feeding 
vector L4440 (FV). When compared with the control, the FRET 
signal was increased at least 2-fold in the unc-54::SC+SV (I)  
worms fed with Hip-1 RNAi bacteria.  
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Figure 510: FRET signal for unc-54: SC+SV (I) strain targeted against 
co- chaperone Hip-1 using RNAi. The function of co-chaperone Hip-1 was 
inactivated by using Hip-1 RNAi. The FRET signal was increased by 2 fold in 
the worms fed with Hip-1 RNAi bacteria when compared with those fed with 
feeding vector controls (FV).   
 
5.3.3.1 Confocal microscopy of unc-54:: SC+SV 
(I) worms fed with Hip-1 RNAi and empty feeding 
vector (FV) 
               Confocal images of unc-54::SC+SV (I) worm pictures 
were again captured as described previously (5.3.1,1). Figure 
5.11 part (A) shows a few small granules of aggregated CFP-
tagged Į-synuclein in the head region of unc-54::SC+SV (I) 
worms fed on bacteria expressing the L4440 empty feeding 
vector, through most of the CFP fluorescence is diffuse. The 
head region of this particular worm was magnified for a clearer 
picture of these small aggregates. In part (B), these CFP-tagged 
Į-synuclein aggregates increased markedly in size as well as 
number in worms fed for 2 generations with Hip-1 RNAi bacteria, 
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and diffuse CFP fluorescence is much reduced. Again, an 
enlargement of part of the head region emphasizes this 
difference. Note that the fluorescent granules in part B will 
appear fainter because of FRET (emissions being absorbed by 
the acceptor YFP). 
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Figure 5.11: Confocal microscopy of unc-54:: SC+SV (I) worms fed 
with Hip-1 RNAI bacteria and empty feeding vector (FV) 
Confocal images showing the head regions of young adult unc-54::SC+SV (I)  
worms: (A) fed on empty feeding vector L4440 showing CFP fluorescence; (B) 
fed on Hip-1 RNAi bacteria; inserts show head regions of each worm 
magnified. The excitation and emission wavelength of CFP used in the 
confocal microscope to capture images are 458/485. All photographs used the 
same gain settings: - pinhole=0.5 airy doses (long Z-depth), point spread 
function (PSF) = 0.250 µm in Z sampled into PMT#2 gain 566.2 V, offset -
7%, scale bar=100µm. 
A 
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5.3.4 Effects of pesticide treatment on unc-
54::SC+SV (I) and  positive control unc-54::CV 
(I)  worms 
 
            Exposure to several neurotoxic pesticides such as 
rotenone, dieldrin, paraquat and chlorpyrifos has been shown to 
stimulate Parkinsonism in various animal models (Betarbet et al. 
2000; Davis 2000; Hetman and Xia 2000; Ishiguro et al. 2001; 
Boyd et al. 2009). We have tested both chlorpyrifos and 
URWHQRQHDQGIRXQGWKDWERWKVWLPXODWHĮ-synuclein aggregation 
in unc-54::SC+SV (I) worms.  
5.3.4.1 Chlorpyrifos treatment on unc-54::SC+SV 
(I) worms 
             
            Synchronized unc-54::SV+SV (I) L4 larvae were 
exposed to two different concentrations of chlorpyrifos (20ppm 
= mg l-1 and 300 ppm = mg l-1) for 48 hours. We found a 2-fold 
increase in the FRET signal at the higher concentration of 
chlorpyrifos (300 mg l-1) but there was no detectable increase at 
the lower concentration (20 mg l-1). Using 'XQQHWW¶V multiple 
comparisons test, the effect of high but not low chlorpyrifos 
doses was found to be significant (P < 0.01) at 300 mg l-1 (P > 
0.05 at 20 mg l-1). 
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Figure 5.12: FRET signal for unc-54::SC+SV (I) worms exposed to 
chlorpyrifos. Synchronized L4 larvae were exposed to chlorpyrifos for 48 hrs 
at two different concentrations (20ppm and 300ppm). The FRET signal was 
increased by 2 fold in worms exposed to 300ppm as compared with the 
control (0ppm). 
 
5.3.4.2 Chlorpyrifos treatment of positive control 
unc-54::CV (I) worms 
             
             Synchronized unc-54::CV (I) L4 larvae were exposed to 
the same two concentrations of chlorpyrifos (20 ppm = mg l-1 
and 300 ppm = mg l-1). We found similarly high FRET signals in 
the control and in both concentrations of chlorpyrifos. Using 
'XQQHWW¶V multiple comparison test, the effects of high and low 
doses of chlorpyrifos on unc-54::CV (I) worms were not 
significant (P > 0.05). 
Rakesh Kumar Bodhicharla 
146 
 
Control 20ppm 300ppm
0
2000
4000
6000
8000
10000
FR
ET
 
si
gn
al
 
(R
FU
)
 
Figure 5.13: FRET signal for unc-54::CV (I) worms exposed to 
chlorpyrifos. Synchronized L4 larvae were exposed to chlorpyrifos for 48 hrs 
at two different concentrations (20ppm and 300ppm), using unc-54::CV  
worms as a positive control. 
 
5.3.4.3 Confocal microscopy of unc-54::SC+SV (I) 
exposed to chlorpyrifos 
           Figure 5.13 part (A) shows the head region of an unc-
54::SC+SV (I) worm with small granules of YFP-tagged Į-
synuclein aggregates in the absence of chlorpyrifos (control); 
much of the fluorescence appears diffuse. The head region of 
this worm was magnified for a clearer picture of small 
aggregates. Part (B) shows much larger and brighter granules of 
YFP-tagged Į-synuclein aggregates following exposure to 
chlorpyrifos at 300ppm. 
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Figure 5.14: Confocal microscopy of unc-54:: SC+SV (I) worms 
exposed to chlorpyrifos. Exposure of L4 larvae to 300ppm chlorpyrifos for 
48 hrs versus control (no chlorpyrifos):- (A) showing YFP fluorescence in a 
control worm with small faint granules, and (B) showing a chlorpyrifos-
treated worm (300ppm) with larger, brighter granules. The excitation and 
emission wavelength of YFP used in the confocal microscope to capture 
images are 514/545. All photographs used the same gain settings:- 
pinhole=0.9 airy doses (long Z-depth), point spread function (PSF) = 0.451 
µm in Z sampled into PMT#2 gain 460.4 V, offset 2.4%, scale  bar= 100µm. 
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B 
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5.3.4.4 Rotenone treatment of unc-54::SC+SV (I) 
worms 
 
             Rotenone was found to cause developmental arrest of 
worms after the L2/L3 stage, so synchronized L1 larvae were 
tested for a shorter (24 hour) exposure. Two different 
concentrations of rotenone (2ppm/ mg l-1 and 20 ppm/ mg l-1) 
were used to treat synchronized L1 larvae of the unc-54::SC+SV 
(I)  strain for 24 hours. We found a 2-fold increase in the FRET 
signal at the high concentration of rotenone (20ppm) but again 
there was no detectable increase at the low concentration 
(2ppm). From the 'XQQHWW¶s multiple comparisons test, the 
effect of the high rotenone dose was significant (P < 0.01) at 20 
mg l-1, but the low dose was non-significant (P > 0.05) at 2 mg l-
1.  
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Figure 5.15: FRET signal for unc-54::SC+SV (I) worms exposed to 
rotenone. Synchronized L1 larvae were exposed to rotenone for 24 hrs at 
two different concentrations (2ppm and 20ppm). The FRET signal was 
increased by 2 fold in the worms exposed to 20ppm as compared with the 
control (0ppm). 
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5.3.4.5 Rotenone treatment of positive control 
unc-54::CV (I) worms 
 
                 As before, two different concentrations of rotenone 
(2ppm = mg l-1 and 20 ppm = mg l-1) were used to treat 
synchronised L1 larvae of the unc-54::CV (I) positive control 
strain for 24 hours. We found similarly high FRET signals in the 
control and in both concentrations of rotenone. Using 'XQQHWW¶V 
multiple comparisons test, the effects of both high and low doses 
of rotenone on unc-54::CV (I) worms were not significant (P > 
0.05). 
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Figure 5.16: FRET signal for unc-54::CV (I) worms exposed to 
rotenone. Synchronized L1 larvae were exposed to rotenone for 24 hrs at 
two different concentrations (2ppm and 20ppm), using unc-54::CV (I) worms 
as a positive control. 
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5.3.4.6 Confocal microscopy of unc-54:: SC+SV 
(I)  exposed to rotenone 
               After 24 hours of exposure to rotenone, confocal 
images of unc-54::SC+SV (I) strain were captured as described 
above (5.3.1.1). Figure 5.15 part (A) shows small granules of 
YFP-labelled Į-synuclein aggregates in the head region of an 
unc-54::SC+SV (I) control worm (not exposed to rotenone). 
Part (B) shows an increase in the size and number of fluorescent 
synuclein aggregates following exposure to rotenone at 20ppm. 
Part (C) shows an arrested L1 larva following rotenone treatment 
± again with larger and brighter granules. 
 
                             
       
A 
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Figure 5.17: Confocal microscopy of unc-54:: SC+SV (I) worms 
exposed to rotenone. Exposure of L1 larvae to rotenone for 24 hrs at 
20ppm:- (A) showing YFP fluorescence in a control worm (0ppm) with small 
faint granules, (B) showing a rotenone-treated worm (20ppm) with larger, 
brighter granules and (C) showing an arrested L1 larvae also with larger and 
brighter granules. The excitation and emission wavelength of YFP used in the 
confocal microscope to capture images are 514/545. All photographs used the 
same gain settings:-  pinhole=1.2 airy doses (long Z-depth), point spread 
function (PSF) = 0.601 µm in Z sampled into PMT#2 gain 566 V, offset -
7.1%, scale bar= 100µm. 
 
  
B 
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5.3.5 Effects of Rotenone and Chlorpyrifos on the 
induction of Reactive Oxygen Species (ROS) in 
unc-54::SC+SV (I) 
                 This experiment used only the highest test 
concentrations of rotenone (20ppm = mg l-1) and chlorpyrifos 
(300 ppm = mg l-1) to determine whether or not these pesticides 
induce oxidative stress. Synchronized L1 larvae were exposed to 
each pesticide for 24 hours alongside zero controls (no 
pesticide). As mentioned earlier, the highest concentration of 
rotenone causes developmental arrest after the L2/L3 stage. The 
change in DCF fluorescence/worm was increased by 5-fold at the 
high concentration of chlorpyrifos (300ppm) but there was only a 
small increase at the high concentration of rotenone (20ppm). 
'XQQHWW¶V WHVW showed that the effect of chlorpyrifos was 
significant (P < 0.01), but that of rotenone was not (P> 0.05). 
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Figure 5.18: oxidative stress in unc-54::SC+SV (I) worms exposed to 
rotenone and chlorpyrifos. Synchronized L1 larvae were exposed to 
rotenone and chlorpyrifos for 24 hrs at high concentrations. Change in DCF 
fluorescence/ worm was measured using the H2-DC-DA assay. There was a 5 
fold increase in DCF fluorescence in worms exposed to chlorpyrifos (300ppm) 
and a slight increase when exposed to rotenone (20ppm) compared to the 
control (0ppm). 
 
5.3.6 Effect of Rotenone and Chlorpyrifos on the 
induction of ROS in a transgenic C.elegans model 
RI3DUNLQVRQ¶VGLVease (NL5901 Strain).   
                 A similar experiment was done to show the effect of 
Rotenone and Chlorpyrifos on the induction of ROS in a different 
transgenic C.elegans PRGHO RI 3DUNLQVRQ¶V GLVHDVH 1/; 
effectively an integrated unc-54::SV strain). We found similar 
results except that rotenone had a significant effect in this 
NL5901 strain. There was a > 2-fold increase in DCF 
fluorescence caused by chlorpyrifos (300ppm) and a > 3-fold 
increase caused by rotenone (20ppm). Here DXQQHWW¶V WHVW
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shows that both pesticides have a statistically significant effect 
(P < 0.01).   
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Figure 5.19: oxidative stress in NL5901 strain exposed to rotenone 
and chlorpyrifos. Synchronized L1 larvae were exposed to rotenone and 
chlorpyrifos for 24 hrs at high concentrations. Change in DCF fluorescence/ 
worm was measured using the H2-DC-DA assay. There was a 2 fold increase 
in the DCF fluorescence in worms exposed to chlorpyrifos (300ppm) and a 3 
fold increase when exposed to rotenone (20ppm) compared to control 
(0ppm). 
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5.4 Discussion 
 
           Our key purpose in creating the unc-54::SC+SV (I) 
strain is to elucidate the role RI Į-synuclein aggregation in 
PDUNLQVRQ¶V GLVHDVH Measuring FRET signals in the unc-
54::SC+SV (I) strain serves as a surrogate LQGLFDWRU RI Į-
synuclein aggregation.  From our results, the unc-54::SC+SV 
(I)  strain showed intermediate FRET signals compared to 
negative control strains (C, V and C+V) and the positive 
control (CV) strain. This is because the fluorophores CFP and 
YFP can be EURXJKWWRJHWKHUE\Į-synuclein aggregation in the 
SC+SV (I) strain, whereas they are locked together in the CV 
fusion. Confocal images were generated to confirm the 
presence of FRET. Furthermore, a 3-fold increase in FRET signal 
in unc-54::SC+SV (I) strain was observed during early adult life 
as compared to L4 larvae. This was confirmed by confocal 
images showing larger and brighter aggregates after several 
GD\V RI DGXOWKRRG 7KHUHIRUH WKH DFFXPXODWLRQ RI Į-synuclein 
aggregates seems to be age-dependent. To confirm that the 
FRET signal is genuine, the NL5901 (unc-54::SV) strain was 
used as a control. We observed only a slight increase in YFP 
fluorescence between L4 and adult stages. This accounts for 
any change in the expression of the unc-54 gene, and hence 
the remainder of the observed fluorescence increase seen in 
SC+SV worms was genuine FRET signal.  
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               In addition, RNAi against Hip-1 showed an increase 
in Į-synuclein aggregation, as monitored by FRET, supporting 
the proposed role of the co-chaperone Hip-1 in protein 
homeostasis. In agreement with previous findings (Roodveldt et 
al. 2009), this consequence of knocking down Hip-1 function was 
only apparent  in the second generation, apparently because 
maternal expression ensures continued Hip-1 function in the first 
generation worms   Similarly, a 2-fold increase in FRET signal in 
unc-54::SC+SV (I) worms was observed upon exposure to the 
pesticides chlorpyrifos and rotenone, consistent with the possible 
role of these toxicants as environmental risk factors for 
3DUNLQVRQ¶V GLVHDVH. Again, confocal images of the unc-
54::SC+SV (I) strain confirm the presence of fluorescent Į-
synuclein aggregates. Notably, these YFP-tagged Į-synuclein 
aggregates were brighter and larger in size following exposure to 
high doses of chlorpyrifos or rotenone as compared to untreated 
controls. 
 
  Finally, an increase in DCF fluorescence indicated 
oxidative stress in both unc-54::SC+SV (I) and NL5901 strains 
upon exposure to rotenone or chlorpyrifos, although the 
response to rotenone in unc-54::SC+SV (I) worms was lower 
than that in NL5901 worms. 
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Chapter 6        Discussion 
 
 
                Our overall aim in this project was to generate a 
double transgenic strain (unc-54::SC+SV (I)) and to monitor 
FRET signals  DVDELRPDUNHURIĮ-synuclein aggregation. This 
was achieved through expression of human Į-synuclein fused at 
its C-terminus with CFP and/or YFP in the body wall muscles of 
Caenorhabditis elegans (in vivo model) driven by the unc-54 
myosin promoter. Worms H[SUHVVLQJĮ-synuclein show greater 
sensitivity to gamma irradiation, shorter lifespan, reduced 
pharyngeal pumping and slower motility, whereas expression of 
&)3DQGRU<)3ZLWKRXWĮ-synuclein had little or no effect. We 
observed increases in FRET signal in this unc-54::SC+SV (I) 
strain during ageing from L4 to adult, following RNAi against 
Hip-1, and following exposure to pesticides (chlorpyrifos and 
rotenone). Finally, an increase in the levels of reactive oxygen 
species (ROS) was observed in the unc-54::SC+SV (I) strain 
when exposed to chlorpyrifos and possibly rotenone. 
 
6.1 Effect of gamma irradiation on C.elegans 
 
Hartman and Herman (1982) were the first to identify the 
genes involved that respond to radiation damage in C.elegans. 
C. elegans has a large number of DNA repair genes which 
function in highly conserved pathways. For the purpose of 
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examining the radiation response, reporter analysis of DNA 
repair gene expression would be of interest. Following gamma 
irradiation, DNA strand-breaks are generated, which the cell can 
repair up to the limit of its capacity. DNA repair systems work 
well after low-dose exposure but are much less efficient 
following high-dose exposure²and the damage caused by very 
high doses may not be repairable at all. There is also evidence 
(Herman 1978; Meneely and Herman 1979) that high doses 
cause a great deal of sterility among the F1 generation. 
 
Our work has demonstrated that moderate gamma 
irradiation does not have much effect on ZRUP¶V sterility in the 
P0 generation, whereas it has a large effect on the F1 
generation. When comparing the different transgenic strains with 
wild type N2 worms, we found that there is no statistically 
significant difference (P>0.05) in the P0 generation, but these 
differences become statistically significant (P<0.05) in the F1 
JHQHUDWLRQ 7KLV DSSOLHG WR DOO WUDQVJHQLF VWUDLQV H[SUHVVLQJ Į-
synuclein compared against wild-type N2 worms but not for 
those strains expressing CFP and/or YFP only. The synuclein 
fusion strains are more sensitive to gamma irradiation as 
compared with the wild type N2 worms. Synuclein on its own is 
known to be toxic but the effects of its fusion to YFP on the rate 
of aggregation in vivo are not known.  
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In an analysis of the dose response of C.elegans to 
gamma radiation, Rosenbluth et al. (1983) observed that at low 
doses, the curve was non-linear (Fig. 4.1). Their data show that 
low doses of radiation are non-damaging, apparently due to DNA 
repair mechanisms which can deal effectively with low doses of 
radiation (figure 6.1). 
 
         
 
Figure 6.1:  Dose response curve for gamma radiation in C.elegans. 
Data from Rosenbluth et al. (1983). 
 
               In choosing a mutagen dose for integrating transgene 
arrays, it is necessary to weigh up the desirability of screening 
as small a population as possible (using a relatively high dose) 
against the desirability of limiting the frequency of secondary 
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mutational events associated with the selected rearrangement 
(using a low dose).  
 
          Interestingly, our data show that our Įísynuclein 
transgenic strains became sterile even at low doses of gamma 
irradiation. Hence, Įísynuclein aggregation in the cell may 
cause radiation sensitivity to these transgenic worms through an 
unknown mechanism(s). Also, another possibility is that the 
presence of Įísynuclein DNA as a transgene in the gonads may 
compromise the DNA repair machinery during irradiation 
mediated integration. Further experiments will be required to 
study the relation between DNA repair systems and exposure to 
gamma irradiation in these transgenic worms. 
6.2 Behavioral defects in C.elegans linked to Į-
synuclein expression 
                 The decreased lifespan observed in our transgenic C. 
elegans strains expressing Į-synuclein (Figure 4.7) reflects a 
FKDUDFWHULVWLF GHFUHDVHG OLIHVSDQ LQ 3DUNLQVRQ¶V SDWLHQWV
(Diamond et al. 1990; Marttila and Rinne 1991).  A similar effect 
was observed upon expression of human Į-synuclein (A53T) in 
mice, with neurological abnormalities and shortened lifespan 
(Lee et al. 2002). However, surprisingly it has been reported 
WKDW ZRUPV FDUU\LQJ KXPDQ Į-synuclein fused with GFP and 
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overexpressed from an aex-3 (pan-neuronal) promoter (aex-
3::human synuclein:GFP) have a longer life span compared to 
control or non-transgenic worms (Vartiainen et al. 2006). One of 
the reasons for this increased life span is correlated with 
decreased pharyngeal pumping (Lakowski and Hekimi 1998; 
Walker et al. 2005), and a significant reduction of pharyngeal 
pumping was observed for the aex-3::human synuclein:GFP 
transgenic animals suggesting that they were under dietary 
restriction even though they were raised on thick bacterial lawns 
(Vartiainen et al. 2006). Taken together, these results suggest 
that dietary restriction may be a contributing factor for the 
observed increase in lifespan (Klass 1977; Hosono et al. 1989). 
Our transgenic strains expreVVLQJ Į-synuclein have increased 
OHYHOV RI Į-synuclein expression throughout the body-wall 
muscles, leading to a loss of motor function, resulting in 
greatly impaired mobility (figure 4.8). Along with reduced 
longevity, there seems to be reduction in pharyngeal pumping 
rate as well, but this is most likely an indirect effect, since 
myo-2 (but not unc-54) myosin is expressed in the pharynx. 
Our data (Figure 4.5) suggest that motility is more strongly 
DIIHFWHG E\ Į-synuclein expression (~50% reduction) than 
pharyngeal pumping (~20% reduction); the effect of the 
former may outweigh the latter, contributing towards an 
overall reduction in life span. 
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      Changes in oxygen concentration also affect the life 
span of C. elegans (Honda and Honda 2002). At high 
concentrations of oxygen, worm life span is shortened, whereas 
at low concentrations of oxygen, the life span increases. In 
addition, a strain with reduced levels of superoxide dismutase 
was more susceptible to the damaging effects of oxygen. These 
results indicate that oxidative damage can also speed up the 
ageing process in C. elegans. 
               According to Morley et al. (2002), polyQ aggregation 
and cellular toxicity are correlated with ageing in C. elegans. 
Accumulation of aggregates of polyQ expansions (Q19, Q25, 
Q33, Q35, Q40, Q44, Q64, and Q82) during ageing leads to 
increasing levels of cellular toxicity. Loss of motility has also 
been correlated to polyQ aggregate formation, due to the 
expression of polyQ expansions in C. elegans muscles.  
 
               So far, ten genes have been linked to inherited forms 
of human PD; of these, Į-synuclein and Parkin have been 
studied most thoroughly (Polymeropoulos et al. 1997; Kitada 
et al. 1998). Parkin is an E3 ubiquitin ligase, which plays an 
important role in the protein degradation process. Previous 
VWXGLHV VKRZ WKDW D JO\FRV\ODWHG IRUPRI Į-synuclein may be 
degraded with the help of Parkin (Shimura et al. 2001) 
Mutations in the Parkin gene are  known to cause Autosomal 
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Recessive Juvenile Parkinson disease (ARJP) resulting in death 
of dopaminergic neurons (Mouradian 2002). Reduced life span, 
loss of climbing activity and decreased flight were observed in 
Drosophila on deletion of Parkin (Greene et al. 2003).  
Similarly climbing ability was reduced in transgenic flies over-
expressing both wild W\SHDQGPXWDQW IRUPVRIĮ-synuclein in 
transgenic flies (Feany and Bender 2000).  Our data shows 
reduced life span and slower motility in transgenic C.elegans 
strains over-H[SUHVVLQJĮ-synuclein. This could possibly reflect 
impaired pdr-1 (parkin ortholog in C.elegans) function, leading 
WR UHGXFWLRQ LQ Į-synuclein degradation and hence slower 
motility and reduced life span, in our transgenic strains. 
Reduced climbing ability in Drosophila and slower motility in 
C.elegans may be caused by muscle degeneration, which is 
one of the characteristics of PD. 
 'HWHFWLRQ RI Į-synuclein using Western 
blotting 
           Į-synuclein(s) is a 19kD protein and both CFP and YFP 
are 31 kD proteins. The fusion of CFP and synuclein should 
yield a protein size of about 47 kD. Likewise, YFP-synuclein 
should also give rise to a band of about 47 kD in SDS PAGE. 
We have confirmed WKDW PRVW RI WKH LPPXQRUHDFWLYH Į-
synuclein present in both unc-54::SC+SV (I) and unc-54::SV 
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(NI)  worms is of the CFP-/YFP-tagged fusion-protein size (~47 
N' +RZHYHU D VPDOO SURSRUWLRQ RI FOHDYHG Į-synuclein was 
also detected whereas the synuclein present in unc-54::S+V 
(I) worms is of the expected untagged 19 kD size. This 
suggests that cleavage of the fusion proteins is not a major 
SUREOHP LQ RXU VWUDLQV EHFDXVH WKH PDMRULW\ RI Į-synuclein 
protein expressed in the unc-54::SC+SV (I) and unc-54::SV 
(NI) strains remains in the CFP-/YFP- tagged fusion form.  
 
           Our findings show interesting similarities and 
differences to a study by McLean et al (2001) where they 
expressed Į-synuclein tagged with EGFP (Į-synuclein:EGFP) in 
primary neurons. Using anti-Į-synuclein antibodies directed 
against the C- terminal of Į-synuclein and they found a 49kD 
Į-synuclein fusion protein and truncated 27kD band which is 
larger than the Į-synuclein 19 kD band alone. Probing the blot 
with anti-GFP antibody (C-terminal) recognized a 16kDa band, 
suggesting cleavage of EGFP from the Į-synuclein:EGFP fusion 
protein (McLean et al, 2001), so the truncated 27kD protein 
was in fact a fusion of Į-synuclein (19kD) and the N-terminus 
of EGFP (truncated). This proved that EGFP was cleaved 
whereas the Į-synuclein was not. In our study, there is some 
evidence that Į-synuclein (19kD) may became cleaved from 
the YFP and/or CFP tags (figure 4.10, lanes 2 and 6) in a 
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minority of fusion proteins, but there is no evidence for 
cleavage within the YFP or CFP protein sequence. Overall, 
cleavage of the fusion proteins appears to be far less of a 
problem in C.elegans (this study) as compared to the mouse 
primary neuron culture system described by McLean et al 
(2001). 
6.4 FRET measurement in double transgenic C. 
elegans strain (unc-54::SC+SV (I)) 
             Our key purpose in creating these double transgenic 
C. elegans VWUDLQV H[SUHVVLQJ Į-synuclein was to develop a 
rapid-throughput assay for exploring the role of environmental 
DQG JHQHWLF IDFWRUV LQ SURPRWLQJ Į-synuclein aggregation. 
Measuring FRET signals in the unc-54::SC+SV (I) strain could 
serve as a surrogate indiFDWRURIĮ-synuclein aggregation since 
FRET is only possible when CFP and YFP moieties are in very 
close proximity.  Using a standard microplate fluorometer the 
FRET signal was measured in the unc-54::SC+SV (I) worms by 
exciting at a wavelength of 430nm for CFP and measuring 
emissions at a wavelength of 530nm for YFP. Low FRET signals 
were observed in the negative control strains (C, V and C+V) 
DQGHYHQLQWKHZLOGW\SH1ZRUPVQRQHRIZKLFKH[SUHVVĮ-
synuclein. By contrast, the positive control expressing both 
CFP and YFP tags as a fusion protein under the unc-54 
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promoter, showed very high FRET signals due to the molecular 
proximity of these fluorophores at all times. As expected, the 
unc-54::SC+SV (I) strain showed intermediate FRET signals, 
because the fluorophores CFP and YFP are brought together 
RQO\ GXULQJ Į-synuclein aggregation. Confocal images of this 
strain showed the presence of FRET as compared with the 
control unc-54::V (I) strain (Figure 5.5). The relative strength 
of the FRET signal in these unc-54::SC+SV (I) worms should 
WKHUHIRUHUHIOHFWWKHH[WHQWRIĮ-synuclein aggregation. 
 
             Previous studies have used FRET as a technique to 
find protein-protein interaction between synphilin-1 and 
ĮíV\QXFOHLQ LQ KXPDQ QHXURJOLRPD FHOOV (Kawamata et al. 
2001). 0XWDQW IRUPV RI Į-synuclein that are associated with 
inherited (familial) forms of PD are the A30P and A53T variants. 
It was found that the C-terminus of synphilin-1 forms stable 
aggregates with the C-terminus of wild-W\SH ĮíV\QXFOHLQ
whereas the N-termini of these proteins do not interact strongly 
(Kawamata et al. 2001). As a result, a high FRET signal was 
observed with the C-terminus aggregates and much less with the 
N-terminal aggregates. In addition, in experiments involving 
mutant forms of Į-synuclein, lower FRET signals were observed 
between the C-terminus of synphilin-1 and C-terminus of A53T 
ĮíV\QXFOHLQ7KLVVXJJHVWVWKDWWKH$7PXWDWLRQPD\LQWHUIHUH
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in the formation of aggregates with synphilin-1. However, no 
change in FRET signal was observed between the C-terminus of 
synphilin-1 and C-WHUPLQXVRI$3ĮíV\QXFOHLQVXJJHVWLQJQR
interaction between these two proteins (Kawamata et al. 2001). 
 
            Brignull et al. (2006) used C. elegans as a model to 
VWXG\ SRO\JOXWDPLQH H[SDQVLRQV DQG WKHLU UROH LQ +XQWLQJWRQ¶V
disease, by creating transgenic animals showing pan-neuronal 
(aex-3 driven) expression of different lengths of polyglutamine 
expansions (containing 0, 19, 29, 40, 67, 86 glutamine residues) 
fused to CFP and/or YFP.  C. elegans expressing shorter polyQs 
(e.g. Q19::CFP/YFP) did not produce any FRET signal whereas 
animals expressing longer polyQs (e.g. Q86::CFP /YFP) produced 
high FRET signals. FRET data showed insoluble polyglutamine 
aggregates throughout the nervous system of C.elegans, which 
was also confirmed using confocal images (Brignull et al. 2006). 
However, none of the above mentioned studies have 
quantitatively measured the FRET signal. This may be due to 
the lack of stably integrated forms of the tagged fusion 
proteins. In our studies, the generation of stably integrated 
unc-54::SC+SV (I) double transgenic strains enables us to 
measure quantitative FRET signals as an indicator of  
ĮíV\QXFOHLQDggregation . 
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6.5 Influence of ageing on protein aggregation 
              During ageing, several physiological parameters such 
as gene expression, chaperone levels and protein degradation 
are disturbed (Cuervo and Dice 2000). In addition, ageing also 
renders the organism more susceptible to oxidative stress, with 
consequent effects on cellular components such as protein 
oxidation and nitration leading to protein degradation (Squier 
2001). Hence, in neurodegenerative diseases, these changes 
might lead to or exacerbate protein aggregation during ageing 
(Balch et al. 2008).  
 
             The study of Morley et al (2002) described above 
(section 6.4) demonstrated that protein aggregates accumulate 
during ageing. In our experiments, there was a 3-fold increase in 
FRET signal in unc-54::SC+SV (I) worms during early adult life 
as compared to L4 larvae, whereas in the control NL5901 strain 
there was only a slight increase in YFP fluorescence. Since this 
latter takes account of any changes in unc-54 expression, we 
conclude that most of the FRET signal (Figure 5.8) observed 
during aging in unc-54::SC+SV (I) ZRUPVLVGXHWRĮ-synuclein 
aggregation. Confocal images of this strain showed larger and 
brighter aggregates after several days of adulthood (Figure 5.9). 
This is in agreement with previous studies and confirms that the 
ageing process accelerates protein aggregation.    
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6.6 Effect of RNAi against Hip-1 in unc-54:: 
SC+SV (I) strain 
                The heat shock protein (Hsp70) is one of the 
important protein chaperones that play a vital role in PD and 
protein trafficking generally. This is mainly because of its anti-
aggregation functions which help to inhibit protein misfolding 
(Gragerov et al. 1992). This is supported by experimental 
evidence; for instance, over-expression of Hsp70 in Drosophila 
was found to prevent Į-synuclein aggregation (Auluck et al. 
2002), and a similar effect was also observed in neuroglioma 
cells (Klucken et al. 2004). In support of this evidence, the 
expression levels of Hsp70 were found to be highly disturbed 
(up-regulated) in the substantia nigra of 3DUNLQVRQ¶V patients 
(Hauser et al. 2005). Hsp70 inhibits protein misfolding by 
binding to hydrophobic regions and to positively charged amino 
acids of alpha synuclein (Rudiger et al. 1997a; Rudiger et al. 
1997b). If the Hsp70 is ATP-bound then it has a low affinity for 
Į-V\QXFOHLQ7KLVSUHYHQWVĮ-synuclein aggregation and there is 
no toxic fibril formation. On the other hand, if the Hsp70 is ADP- 
ERXQG WKHQ LW KDV D KLJK DIILQLW\ IRU Į-synuclein. Hence Hsp70 
and Į-synuclein co-DJJUHJDWH UHVXOWLQJ LQ Į-synuclein 
aggregation and toxic fibril formation (Mayer and Bukau 2005; 
Roodveldt et al. 2009).  
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Figure 6.2: Mechanism of Hsp70/Hip chaperone function in protein 
aggregation. (adapted from Roodveldt et al. 2009) 
The chaperone protein Hsp70 binds to hydrophobic patches and highly 
positively charged amino acids on alpha synuclein, producing a loose 
complex. In this complex, Hsp70 is in an ATP bound state and has a low 
affinity for binding to alpha synuclein. This prevents alpha synuclein 
aggregation and toxic fibril formation, resulting in moderate toxicity (left). 
Hsp70 in the ADP bound state has a higher affinity for alpha synuclein. This 
reduces the concentration of Hsp70 in solution and, as a consequence, Hsp70 
and alpha synuclein co-aggregate enabling alpha synuclein to form toxic 
amyloid fibrils. To prevent this, Hip, a co-chaperone protein, binds to an 
ATPase domain on Hsp70 and prolongs the complex between Hsp70 and 
alpha synuclein, preventing co-DJJUHJDWLRQ ULJKW +RZHYHU 3DUNLQVRQ¶V
patients have reduced Hip and Hsp70 concentration so the Hsp70/alpha 
synuclein complex is not stabilized, leading to complex co-aggregation and 
toxic amyloid fibril formation.  
 
               The co-chaperone Hip also plays an important role in 
PD. The pro-DP\ORLGDFWLYLW\RIWKH+VSĮ-synuclein complex 
can be prevented in vitro and in vivo by the co-chaperone Hip. 
This is due to the fact that Hip binds to the ATPase domain of 
+VSDQGWKHUHE\LQFUHDVHVWKHKDOI OLIHRI+VSĮ-synuclein 
complex, thus preventing co-aggregation (Hohfeld et al. 1995; 
Roodveldt et al. 2009). To validate the role of Hip, RNA 
interference was used to knock down the functions of both the 
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chaperone Hsp70 and co-chaperone Hip in a C.elegans model 
expressing an SV fusion protein (strain OW40; Roodveldt et al. 
2009). Knock down of the chaperone Hsp70 led to a slight 
increase in the number of protein aggregates, whereas the 
number of aggregates was significantly increased when the co-
chaperone Hip was knocked down (Roodveldt et al. 2009). While 
Hsp70 may be redundant, Hip function acts upstream and is 
central to the Hsp70/Hip complex activity. These results provide 
evidence that there is some kind of interaction between Hsp70 
and Hip which is vital for coordinating protein homeostasis. 
 
               Our RNAi results for RNAi against the co-chaperone 
Hip-1 show a similar result, with an increase in the number of 
Į-synuclein aggregates. This was observed as a high FRET signal 
in the unc-54::SC+SV (I) strain, and was also confirmed by 
confocal microscopy. The effect of RNAi against Hip-1 from L1 
onwards was minimal in F1 worms but much greater in their F1 
progeny (RNAi over 2 generations), as was also found by 
Roodveldt et al. (2009). One key advantage of the unc-
54::SC+SV (I) strain for studying PD is the ease of identifying 
molecular players involved in the aggregation pathway as 
measured by the FRET signal. For example, a previous RNAi 
screening study has identified some common genes involved in 
pRO\4DQGĮ-synuclein aggregation (Nollen et al. 2004; van Ham 
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et al. 2008). Our transgenic PD worm model could be used to 
test the involvement of these and other candidate genes, where 
increased FRET signals will iQGLFDWHWKHIRUPDWLRQRIĮ-synuclein 
aggregates when gene function is compromised. 
([WHUQDOVWUHVVRUVDQG3DUNLQVRQ¶VGLVHDVH               
6.7.1 Rotenone toxicity and PD 
            Intravenous exposure to rotenone (a mitochondrial 
complex I inhibitor) has been shown to cause PD-like symptoms, 
along with the depletion of dopaminergic neurons. In PD 
patients, the activity of mitochondrial complex I is suppressed, 
leading to dopaminergic neuronal cell death. Interestingly, 
rotenone causes the formation oIĮ-synuclein inclusions as well 
as subsequent neuronal cell death, a classic feature of PD 
(Betarbet et al. 2000; Sherer et al. 2003). Betarbet et al. (2000) 
showed in rats that rotenone exposure had severe effects on 
mitochondria, which could be related to PD pathogenesis. Since 
rotenone inhibits mitochondrial complex I, chronic exposure to 
rotenone may impair the energy production of mitochondria thus 
reducing the levels of ATP in the cell. As a consequence, the 
function of ATP-dependant Hsp70 may also be compromised, 
OHDGLQJ WR LQFUHDVHG Į-synuclein aggregation (figure 6.2). 
However, there is also a direct effect of rotenone in the absence 
of other cellular proteins, since rotenone significantly speeds up 
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the fibrillation of Į-synuclein in vitro (Uversky et al. 2001; 
Uversky et al. 2002).  
6.7.2 Chlorpyrifos toxicity and PD 
              Chlorpyrifos is a common organophosphate pesticide 
used in agriculture as an insecticide. Parkinsonism has been 
reported in several cases after exposure to organophosphates. 
This is one line of evidence which suggests that 
organophosphates may have a role in the pathogenesis of 
3DUNLQVRQ¶V (Bhatt et al. 1999). Organophosphates and other 
LQVHFWLFLGHV DUH WKRXJKW WR EH LQYROYHG LQ 3DUNLQVRQ¶V GLVHDVH
based on a case-control study (Hancock et al. 2008). There 
might be a balance between dopamine and acetylcholine 
systems in both humans and animal models, but when exposed 
to organophosphates this balance becomes disturbed potentially 
OHDGLQJ WR 3DUNLQVRQ¶V GLVHDVH (Hatcher et al. 2008). 
Chlorpyrifos is known to have a dose dependent effect on the 
growth and development of C.elegans. Specifically, the early 
larval stages L2 and L3 were more prone to the effects of 
chlorpyrifos (Boyd et al. 2009). 
 
             Our data shows a 2-fold increase in FRET signal in unc-
54::SC+SV (I) worms when exposed to the pesticides 
chlorpyrifos or rotenone. In addition, confocal images of the unc-
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54::SC+SV (I) strain confirm that the increase in FRET signal 
was due to the formation of larger and brighter Į-synuclein 
aggregates. When exposed to rotenone, this unc-54::SC+SV (I)  
strain displayed difficulties in egg hatching, growth and 
development (L1 arrest), whereas chlorpyrifos does not have 
any such effect. This could imply that rotenone causes a 
systemic shock to the cell (as a mitochondrial inhibitor) resulting 
in the impairment of all energy-dependent processes (such as 
egg hatching, growth and development), whereas the effect of 
chlorpyrifos (an acetylcholine esterase inhibitor) is mainly limited 
to the nervous system. Therefore, general functions such as 
growth and reproduction are not severely compromised by 
chlorpyrifos, in contrast to rotenone. This may explain why 
exposure of unc-54::SC+SV (I)  worms to rotenone not 
chlorpyrifos caused L1 growth arrest. However, most 
importantly, both toxins caused Į-synuclein aggregation as 
evidenced by increased FRET signal and confocal microscopy. 
                      The unc-54::SC+SV (I) strain should allow us 
to investigate the role of these and many other potential 
environmental risk factors for PD, both singly and combined, 
as promoWHUV RI Į-synuclein aggregation in larval and young 
adult worms. Moreover, this strain might be of great use for 
high-throughput screening of candidate drugs aimed at 
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identifying DJHQWVWKDWFRXOGGLVVRFLDWHĮ-synuclein aggregates 
or prevent their formation in vivo (Kritzer et al. 2009). 
2[LGDWLYHVWUHVVLQ3DUNLQVRQ¶VGLVHDVH
               ,Q 3DUNLQVRQ¶V GLVease, the dopaminergic neurons of 
the substantial nigra in the brain undergo neurodegenration due 
to oxidative stress (Dexter et al. 1989). It has been confirmed 
that there are elevated levels of protein nitration in Lewy bodies 
(Good et al. 1998). The Į-synuclein protein present in the Lewy 
bodies undergoes nitration of the tyrosine residues (Giasson et 
al. 2000) 7KH HDUOLHVW NQRZQ FKDUDFWHULVWLF RI 3DUNLQVRQ¶V
disease is a reduced level of the anti-oxidant glutathione (GSH) 
in dopaminergic neurons  of the substantia nigra (Yong et al. 
1986). Moreover, concentrations of iron (a catalyst for oxidative 
reactions) were found to be elevated in the substantia nigra 
(Sofic et al. 1991). 
 
             Increased protein misfolding may also be associated 
with the increased oxidative stress characteristic of PD, leading 
WRĮ-synuclein aggregates accumulates in the substantia nigra, a 
key feature of neurodegenration in PD. In addition, a reduced 
level of Hsp induction may also contribute to the increased levels 
of oxidatively damaged proteins, because increased Hsp70 and 
Hsp40 expression is known to protect against protein misfolding 
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(Takeuchi et al. 2002). Oxidative stress not only causes damage 
to intracellular components but can also trigger programmed cell 
death. Moreover, reduced levels of glutathione can also induce 
programmed cell death, which is supported by the fact that 
glutathione supplements are known to prevent dopamine-
dependent neurotoxicity (Stokes et al. 2000).  
 
             The mitochondrial complex I inhibitors N-methyl-4-
phenyl-1,2,3,6-tetrahydropyridine (MPTP) and rotenone cause a 
reduction of mitochondrial function leading to an increase in 
oxidative stress in PD (Hensley et al. 1998; German et al. 2000). 
Exposure of rodents to rotenone also UHVXOWV LQ Į-synuclein 
aggregates which accumulate in the brain in the form of Lewy 
bodies (Andersen 2004). These facts imply a link in the 
sequence of events that causes both oxidative stress and Į-
synuclein aggregation following rotenone exposure (Sullivan et 
al. 2004). 
 
Our results show an increase in FRET signal (indicating 
Į-synuclein aggregation) following exposure to both rotenone 
and chlorpyrifos. It is possible that these chemicals cause 
oxidative stress as a result of mitochondrial dysfunction, leading 
to protein misfolding in our experimental model. However, 
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further assays to measure mitochondrial activity and ROS 
production are needed in order to confirm this hypothesis.   
 
Therefore we performed the H2-DCF-DA assay 
(measurement of ROS production) on the unc-54::SC+SV (I) 
transgenic strain following exposure to rotenone and 
chlorpyrifos. Remarkably, we only observed a slight increase in 
DCF fluorescence upon exposure to rotenone, but a 5 fold 
increase upon exposure to chlorpyrifos. However, using another 
transgenic strain, NL5901 (which expresses an unc-Į-
synuclein:YFP fusion gene; van Ham et al. 2008), there was a 
significant increase in the production of DCF upon exposure to 
both pesticides. Therefore, these results support the hypothesis 
of oxidative damage facilitating protein aggregation in PD. Both 
NL5901 and our unc-54::SC+SV (I) strains might be helpful for 
examining oxidative stress after exposure to heavy metals 
and/or pesticides.  
 
The presence of non-soluble cellular inclusions containing 
aggregaWHG Į-synuclein is the neuropathological hallmark of 
KXPDQ3DUNLQVRQ¶VSDWLHQWV(Spillantini et al. 1997), whereas in 
a C.elegans PRGHO H[SUHVVLQJ  Į-synuclein  only in the 
dopaminergic neurons, aggregated cytoplasmic inclusions were 
very rarely found (Lakso et al. 2003). In our unc-54::SC+SV 
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strain and other transgenic worm models for PD (Brignull et al. 
2006; van Ham et al. 2008) confocal fluorescent imaging 
confirms the presence of multiple fluorescent aggregates in the 
expected tissues where the fusion transgenes are expressed 
(throughout the body wall muscle or nervous system). However, 
it remains to be confirmed whether these are fibrillar amyloid 
aggregates, and in vitro experiments using an SV fusion protein 
suggest that such amyloid fibrils form only very slowly over ~8 
days (van Ham et al. 2010). Nevertheless, behavioral, 
biochemical and other changes in these transgenic synuclein-
expressing worm models (Lakso et al. 2003; Vartiainen et al. 
2006) have all been attributed to synuclein overexpression. The 
same is likely to be true for our transgenic strains H[SUHVVLQJĮ-
synuclein fusion genes studied here. 
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Future work 
 
1. Can the SC+SV fusion proteins form fibrillar aggregates in 
vitro and/or in vivo?  
2. Genome wide (van Ham et al. 2008) or targeted 
(Hamamichi et al 2003) RNA interference screening for 
genetic modifiers of aggregation (either increasing or 
decreasing the FRET signal). 
3. Screening candidate metals, pesticides and other 
environmental agents across a wide range of doses for 
significant effects on Į-synuclein aggregation. Preliminary 
data (Fineberg, Nagarajan & de Pomerai, unpublished) 
suggest that low doses of mercury are particularly potent 
at inducing aggregation (increased FRET) in unc-
54::SC+SV (I) worms. 
4. Screening mixtures of such agents using chequerboard 
assays across a wide concentration range for each agent, 
looking for additive, antagonistic or (most seriously) 
synergistic effects on aggregation. 
5. Combining RNAi against genetic modifiers of aggregation 
with exposure to known environmental risk factors (above) 
to determine whether the latter cause greater aggregation 
in genetically compromised animals. 
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6. Screening candidate drugs (in older SC+SV worms) aimed 
at preventing the formation or encouraging the 
GLVVRFLDWLRQRIĮ-synuclein aggregates. 
7. Investigation of apoptosis using immunohistochemistry in 
these fusion strains.  
8. RNA interference to achieve both a single knock out of 
Hsp70 and a double knockout of Hsp70 and/ Hip-1, in 
WHUPVRIĮ-synuclein aggregation.  
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Appendix 1 
Time 
(min) 
 
rads 
 
 
 
1RRI3¶V
for gamma 
radiation 
% of 
sterility 
P0 
No of 
)¶V 
Selfed 
% of 
sterility 
F1 
2 1626 35 0% 222 19% 
4 3252 46 15% 250 25% 
4.5 3659 40 40% 300 43% 
6 4878 30 43% 200 49% 
7 5691 30 43% 100 48% 
9 7317 30 50% 50 38% 
Table 1.1 : % sterility in line 1:unc-54::SV (NI) worms 
 
 
Time 
(min) 
 
rads 
 
 
 
1RRI3¶V
for gamma 
radiation 
% of 
sterility 
P0 
No of 
)¶V 
Selfed 
% of 
sterility 
F1 
6 4878 30 0% 200 0% 
10 8130 30 7% 180 31% 
30 24390 30 26% 50 88% 
Table 1.2 : % sterility in unc-54::V (I) worms 
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Time 
(min) 
 
rads 
 
 
 
1RRI3¶V
for gamma 
radiation 
% of 
sterility 
P0 
No of 
)¶V 
Selfed 
% of 
sterility 
F1 
6 4878 20 0% 200 0% 
10 8130 20 3% 200 7% 
20 16260 20 10% 180 25% 
30 24390 20 35% 50 96% 
Table 1.3 : % sterility in N2 worms 
 
 
Time 
(min) 
 
rads 
 
 
 
1RRI3¶V
for gamma 
radiation 
%  
sterility 
P0 
No of 
)¶V 
Selfed 
% 
sterility 
F1 
5 4065 20 0% 200 10% 
10 8130 30 10% 250 42% 
20 16260 20 20% 100 66% 
25 20325 20 27% 50 100% 
30 24390 20 32% 18 100% 
Table 1.4 : % sterility in line 2:unc-54::SV (NI) worms 
 
 
 
Time 
(min) 
 
rads 
 
 
 
1RRI3¶V
for gamma 
radiation 
% of 
sterility 
P0 
No of 
)¶V 
Selfed 
% of 
sterility 
F1 
5 4065 20 0% 200 19% 
10 8130 30 4% 200 48% 
20 16260 20 12% 200 72% 
30 2439 20 28% 100 100% 
Table 1.5 : % sterility in line 3:unc-54::SV (NI) worms 
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Time 
(min) 
 
rads 
 
 
 
1RRI3¶V
for gamma 
radiation 
% of 
sterility 
P0 
No of 
)¶V 
Selfed 
% of 
sterility 
F1 
5 4065 20 4% 200 26% 
10 8130 20 12% 200 40% 
20 16260 20 22% 100 82% 
30 24390 20 36% 50 100% 
Table 1.6 : % sterility in unc-54::S+V (I) worms 
 
 
Time 
(min) 
 
rads 
 
 
 
1RRI3¶V
for gamma 
radiation 
% of 
sterility 
P0 
No of 
)¶V 
Selfed 
% of 
sterility 
F1 
5 4065 30 0% 200 5% 
10 8130 30 5% 200 23% 
20 16260 30 10% 100 73% 
30 24390 30 20% 50 100% 
Table 1.7 : % sterility in unc-54::SC+SV (I) worms 
 
 
NO OF 
WORMS 
BROOD SIZE 
 DAY 1 DAY 2 DAY 3 DAY 4 TOTAL 
1 142 63 82 9 296 
2 127 77 68 5 277 
3 168 55 61 33 317 
4 71 63 68 7 209 
5 152 89 57 24 322 
Table 1.8: Brood size analysis of N2 strain at 15ºC 
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NO OF 
WORMS 
BROOD SIZE 
DAY 1 DAY 2 DAY 3 DAY 4 TOTAL 
F NF F NF F NF F NF F NF T 
1 33 121 27 67 3 9 2 5 63 197 267 
2 47 88 29 45 6 29 12 5 82 162 261 
3 31 57 69 103 23 21 9 14 123 181 327 
4 96 87 41 24 15 26 11 20 152 137 320 
5 82 142 22 32 13 22 3 7 117 196 323 
6 28 127 33 61 5 68 9 3 66 256 334 
7 19 101 38 66 20 39 6 4 77 206 293 
                                           F- Fluorescent, NF-Non-Fluorescent 
 
Table 1.9: Brood size analysis of non-integrated line2: unc-54:: SV 
(NI) Fusion worms at 15ºC 
 
 
NO OF 
WORMS 
BROOD SIZE 
DAY 1 DAY 2 DAY 3 DAY 4 TOTAL 
F NF F NF F NF F NF F NF T 
1   97 52 82 48 37 16 0 3 216 116 335 
2 101 56 86 30 20 5 4 1 207 91 303 
3 66 25 107 39 19 11 7 3 192 75 277 
4 46 15 62 57 7 2 2 0 115 74 191 
5 59 43 77 62 33 31 11 5 169 136 321 
6 87 66 33 30 32 08 15 3 152 104 274 
7 82 39 71 41 30 25 19 6 183 105 313 
                                           F- Fluorescent, NF-Non-Fluorescent 
Table 1.10: Brood size analysis of non-integrated unc-54:: C (NI) 
Fusion worms at 15ºC 
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NO OF 
WORMS 
BROOD SIZE 
 DAY 1 DAY 2 DAY 3 DAY 4 TOTAL 
1 133 82 69 15 299 
2 123 65 78 9 275 
3 154 81 42 5 282 
4 88 75 72 43 278 
5 165 91 65 3 324 
Table 1.11: Brood size analysis of unc-54:: S+V (I) strain at 15ºC 
 
 
NO OF 
WORMS 
BROOD SIZE 
 DAY 1 DAY 2 DAY 3 DAY 4 TOTAL 
1 85 101 93 24 303 
2 121 78 87 13 299 
3 111 81 79 6 277 
4 156 99 66 4 325 
5 141 77 71 11 300 
Table 1.12: Brood size analysis of unc-54:: SC+SV (I) strain at 15ºC 
 
 
NO OF 
WORMS 
BROOD SIZE 
 DAY 1 DAY 2 DAY 3 DAY 4 TOTAL 
1 107 91 89 20 307 
2 133 106 67 8 314 
3 95 94 99 2 290 
4 127 92 77 1 297 
5 88 110 79 11 288 
Table 1.13: Brood size analysis of unc-54:: C+V (I) strain at 15ºC 
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NO OF 
WORMS 
BROOD SIZE 
 DAY 1 DAY 2 DAY 3 DAY 4 TOTAL 
1 77 80 92 32 281 
2 98 132 64 5 299 
3 123 91 69 13 296 
4 101 95 85 21 302 
5 119 73 61 9 262 
Table 1.14: Brood size analysis of unc-54:: V (I) strain at 15ºC 
 
 
NO OF 
WORMS 
BROOD SIZE 
 DAY 1 DAY 2 DAY 3 DAY 4 TOTAL 
1 125 51 90 42 308 
2 100 97 88 8 293 
3 143 119 39 16 317 
4 79 81 87 3 250 
5 93 83 77 9 262 
Table 1.15: Brood size analysis of unc-54:: CV (I) strain at 15º C. 
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Appendix 2 
2.1 Suppliers 
2.1.1 Transgenic organisms 
             The non-integrated transgenic lines of C.elegans were 
FUHDWHG LQ 'DYLG %HOO¶V ODERUDWRU\ DW WKH 8QLYHUVLW\ RI
Nottingham, U.K. The fusion constructs were prepared by Jody 
Winter and David Bell and the microinjection was performed by 
Ademola Adenle and Declan Brady. 
 
2.1.2 Chemicals 
              All chemicals were obtained from Sigma Chemicals 
Ltd., Poole, U.K. 
 
2.2 Laboratory Equipments 
x 9cm Petri dishes ± Bibby Sterilin Ltd., Staffordshire, U.K. 
x Transfer pipettes ± Samco Scientific Corporation, San 
Fernando, U.S.A. 
x 50 ml Falcon tubes ± Cellstar, Greiner bio-one, Germany. 
x Magnetic stirrer ± Hanna Instruments, Inc. 
x p1000/p20 pipettes ± Gilson Pipetman®, France. 
x Pipette tips ± Sarstedt, Germany. 
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x 24-well exposure plates ± Corning Cell- Wells, Corning 
Incorporated, U.S.A. 
x Light microscope ± Leitz Wetzlar, Germany. 
x 3.5cm Petri dishes ± Nalge Nunc International, Denmark. 
x 14cm Petri dishes ± Fisher Scientific, U.K. 
x 6-well cluster plates - Corning Cell- Wells, Corning 
Incorporated, U.S.A. 
x Fluoremeter ± Wallac Victor 1420 Multilabel Counter. 
3HUNLQ(OPHU/LIH6FLHQFHV%HUNVKLUH8. 
x Fluorescence microscope ± Olympus Model SZX12 
x Greyscale digital camera (mounted on fluorescence 
microscope) ± Model CFW ± 1310M, Scion Corporation, 
Maryland, U.S.A. 
x CCD camera software package ± 6FLRQ9LVLFDSWXUH 
x Gamma cell unit with a 137Caesium source ± NORDION 
international INC. 
x Leica TCS SP2 Confocal Laser Scanning Microscope 
(CLSM). 
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